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Preface
 Over the last 3 decades, we have become witnesses of various successful and not 
so successful attempts to minimize sequelae after brain injuries. All of these strat-
egies had one thing in common, the belief that time is brain and salvage becomes 
impossible at a point of no return. Advances in supportive care, in particular 
 neurocritical care, enhanced the functional outcome even with severe brain injury. 
For quite some time, recovery from brain injury has been extremely dynamic and 
individual. Although our understanding of brain recovery is still in its infancy, 
many eye-opening discoveries will potentially lead to a sea change of neuroreha-
bilitation. 
 We have believed for many years that injury to the central nervous system is 
permanent and does not permit compensatory revival of neuronal systems. Recent 
breakthroughs in neuroscience, however, suggest that recovery from central ner-
vous system injury arises through neuroregeneration and neuroplasticity. Neuro-
rehabilitation is transforming into a thriving field of preclinical and clinical re-
search focusing on understanding the mechanisms of neurological recovery and 
enhancing repair. Aided by computer science and biotechnology, brain-machine 
interfaces are being created that can replace lost function but may also one day al-
low to communicate with unconscious patients. Neurorehabilitation has become 
the new arena where neuropharmacology, biotechnology, molecular biology and 
computer science meet traditional approaches, such as physiotherapy, speech 
 therapy, psychology and social services. Novel therapies will require controlled 
clincial trials. New agents and procedures, such as stem cells, neurotransplanta-
tion,  electromagnetic stimulation, brain-computer hybrids and neuropharmaceu-
ticals, are being put to test to transform traditional neurorehabilitation. This book 
intends to provide a current overview of the most promising areas of research pre-
pared by clinicians and scientists entrenched in the field of neurorehabilitation. 
Each chapter intends to give a concise overview of the basic science underpinning 
and clinical consequences of the particular area in neurorehabilitation. We have 
selected the areas according to their importance from a clinical perspective. All 
authors were invited based on their personal experience in the field and were aided 
by associates where appropriate. The targeted readership includes neuroscientists, 
VIII Naritomi · Krieger
rehabilitation specialists, geriatricians, neuroscience nurses, ergo-, speech and 
physiotherapists.
 We feel very honored by the distinguished contributions of all authors and the 
fruitful collaboration with the publishers on this endeavor so close to our hearts.
 Hiroaki Naritomi,  Osaka
 Derk W. Krieger,  Copenhagen 
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 Abstract 
 Stroke is a leading cause of disability. After initial stabilization, neurologic recovery takes place even 
in the acute phase. Well-known recovery mechanisms from stroke deficits are improvement from 
diaschisis, or functional reorganization of the ipsilesional or contralesional cortex with involvement 
of uncrossed corticospinal tract fibers. The importance of coactivation of the perilesional or contral-
esional cortex is unknown; however, neuronal plasticity plays an important role in neurologic recov-
ery. With the recent advancements in knowledge regarding underlying mechanisms of neuronal 
plasticity, various functional modulating methods have been developed and studied in humans. In 
this review, basic mechanisms of functional recovery and potential targets for future research will be 
discussed.  Copyright © 2013 S. Karger AG, Basel 
 The Impact of Stroke 
 Great strides have been made in clinical stroke research over the last decade. The 
therapeutic time window of intravenous recombinant tissue-type plasminogen acti-
vator has been extended to 4.5 h, and the new Solitaire flow restoration device achieves 
better recanalization in patients with large vessel intracranial occlusion  [1, 2] . How-
ever, the majority of patients with ischemic stroke still do not benefit from these 
 advancements because of the narrow therapeutic indications. In patients with intra-
cerebral hemorrhage, treatment with aggressive blood pressure control and hemo-
static agents using activated factor VII has failed to translate into improvement in 
functional outcome  [3, 4] . Meanwhile, stroke still is the leading cause of disability 
worldwide  [5] . 
 The functional status of stroke patients spontaneously improves over 6 months 
after onset. More specifically, rapid recovery is achieved during the first month  [6] . 
From the patient’s perspective, rehabilitation is a process of regaining and relearn-
ing lost functions. Therefore, functional improvement, augmented by active reha-
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bilitation, overlaps with motor learning in terms of underlying mechanisms  [7] . 
Motor learning is associated with structural changes, such as axonal or dendritic 
growth along with new synapse formation and functional modulation including 
long-term potentiation or long-term depression, which may enhance or suppress 
synaptic activities. Together with the mechanisms above, cortical reorganization 
develops in the damaged brain, which plays an important role in recovery from 
acute stroke. Herein, we will elaborate on the functional recovery mechanisms after 
stroke.
 Structural Bases of Functional Recovery 
 Neuroblast Migration 
 A myriad of evidence from animal experiments suggests that neurogenesis does oc-
cur after stroke. Neuroblasts usually originate from their source location in the 
brain, such as the subgranular zone in the dentate gyrus of the hippocampus and 
the subventricular zone. In rodent stroke models, neuroblasts divert from the ros-
tral migratory system and move to the ischemic penumbra. These migrated neuro-
blasts may replace injured neurons or glial cells, and help with remodeling and re-
organization processes  [8] . This has long been considered a unique process in ani-
mals; however, recent evidence shows that neuronal migration occurs in adult 
human brains as well. Brain biopsy and autopsy studies in humans have shown that 
neurogenesis occurs after stroke  [9] . However, it still remains to be elucidated 
whether the neurogenesis directly translates into clinical functional benefit in the 
human brain. 
 Angiogenesis 
 Neuronal death after vascular occlusion is a major underlying pathophysiology of 
ischemic brain injury. Newly formed blood vessels might help with augmenting nutri-
ent supply and repair processes  [10] . Simply, proangiogenic balance is associated with 
mild neurologic deficit and antiangiogenesis status predicts a worse long-term func-
tional outcome in humans  [11] . However, it is still elusive whether angiogenesis is a 
since qua non for neurologic recovery. Proangiogenic growth factors promote sur-
vival of the neuronal, glial and endothelial cells in the peri-infarct tissues, and tran-
sient neovascularization in the ischemic brain helps with the clearance of damaged 
tissues. Moreover, it may create a vascular niche for neuroblast migration  [10] . There-
fore, angiogenesis has multiple beneficial roles in the ischemic brain tissue rather than 
simple blood flow augmentation. Decreased angiogenesis is frequently seen in elderly 
and those with hypertension or diabetes mellitus, which is associated with poor func-
tional recovery after stroke  [10] . Taken together, angiogenesis may be necessary, but 
not sufficient for neurologic recovery. More studies are needed to verify its clinical 
utility in humans. 
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 Axonal Sprouting and Regeneration 
 Axonal sprouting and regeneration also play a significant role in neurologic recov-
ery. The major stimuli for this process are thought to be peripheral deafferentation. 
Axonal sprouting is mainly driven by the balance between a growth-promoting sta-
tus and reduction of growth-inhibitory environment. Axonal sprouting may alter 
cortical sensory or motor maps, and robust evidence exists to show that new con-
nections are formed in peri-infarct cortex areas  [12] . Nogo-A protein is closely re-
lated with this process. It limits plasticity via inhibiting neurite outgrowth. Anti-
Nogo-A antibody enhances functional recovery and promotes reorganization of the 
corticospinal tract with axonal plasticity  [13] . Therefore, it is currently a hot topic 
for modulating regeneration. 
 Specific Issues in Intracerebral Hemorrhage 
 In intracerebral hemorrhage, extravasated blood forms a clot and generates thrombin 
which is a potent source for post-hemorrhage inflammation. However, recent animal 
research shows that thrombin might be important in the functional recovery process 
by stimulating neuroblasts, enhancing neurogenesis, promoting secretion of nerve 
growth factors, and affecting neurite outgrowth  [8] . Thrombin also enhances angio-
genesis and synaptic remodeling, and has a strong effect on brain plasticity. By con-
trast, Hirudin, a specific inhibitor of thrombin, decreases neurogenesis in a rat intra-
cerebral hemorrhage model, suggesting the importance of thrombin in neurogenesis. 
Moreover, statin has a pleiotropic effect, and has strong beneficial effects on angio-
genesis, neurogenesis and synaptogenesis in animal models. However, this should be 
re-evaluated in prospective clinical trials. 
 Functional Cortical Reorganization 
 Advanced functional imaging helps us understand the underlying mechanisms of 
functional recovery from a neurologic deficit. The suggested mechanisms of cortical 
functional reorganization are peri-infarct reorganization, recruitment of ipsilesional 
or contralesional cortex, changes in interhemispheric interactions, or bihemispheric 
connectivity  [14] . Active rehabilitation treatment might improve the neurologic def-
icit mediated by one of the above mechanisms. 
 Diaschisis 
 Several functional imaging studies using SPECT or PET have demonstrated that func-
tionally connected but structurally distant brain regions acted suboptimally after pri-
mary brain injury, which is called diaschisis  [15] . After the acute phase, spontaneous 
neurologic recovery happens with the reversal of this type of functional impairment. 
Therefore, reversal of diaschisis is one of the mechanisms of spontaneous functional 
improvement. The most common form is crossed cerebellar diaschisis which occurs 
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in the contralateral cerebellum after hemispheric stroke, mediated by the descending 
glutamatergic crossed corticopontocerebellar pathway. In middle cerebral artery in-
farction, the degree of crossed cerebellar diaschisis is well correlated with the neuro-
logic deficit early after stroke  [16] . Moreover, functional inhibition may occur ipsilat-
erally to the subcortical lesion (thalamocortical diaschisis), which is regarded as an 
underlying mechanism of subcortical aphasia or neglect  [17] . 
 Cortical Reorganization 
 Perilesional Cortex 
 Experimental studies in nonhuman primates showed that the representative hand ar-
eas in the motor cortex started to shrink after lesioning, and the cortical areas repre-
senting elbow or shoulder expanded  [18] . Even in humans, ipsilateral perilesional 
cortical activation including premotor or supplementary motor area is a common 
finding after primary motor cortex injury. The descending fibers from the premotor 
area are less dense and less excitatory, and project to the proximal part of the arm  [5] . 
Therefore, there is a possibility that chronic ipsilateral premotor area activation some-
times competitively inhibits distal hand motor recovery. Studies from well-recovered 
stroke patients suggest that ipsilateral perilesional cortical activation is associated 
with functional recovery, at least in the acute period. Inhibition of those recruited ar-
eas using transcranial magnetic stimulation resulted in reappearance of previous neu-
rologic deficit. Even in cases of aphasia, the major component of recovery is associ-
ated with perilesional tissue activation, which underscores the importance of the in-
tegrity of perilesional brain issues  [9, 19] . 
 Contralesional Cortex 
 In the recovery phase, the corresponding area in the contralateral cortex frequently 
shows coactivation. However, it is still debatable whether contralateral cortical activa-
tion is beneficial. In patients with aphasia, the contralateral nondominant hemisphere 
helps with neurologic recovery  [20] . Studies from aphasic patients showed that cere-
bral blood flow was increased in the right inferior frontal lobe along with recovery. 
Other studies showed bihemispheric temporal and frontal engagement in auditory 
verbal processing during the recovery process. Meanwhile, a new balance in the corti-
cal activation is needed in the chronic stage. Therefore, a decrease in the activation in 
the contralateral cortex is observed in patients with better functional recovery. Con-
tinuous coactivation of the mirror cortex represents maladaptive cortical mapping, 
which is related with nonoptimal functional recovery. The underlying mechanisms of 
change in contralateral cortical activation share similar physiologic changes such as 
unmasking of latent synapse, facilitation of alternating network, synaptic remodeling, 
and axonal sprouting  [21] . 
 Uncrossed Fibers from the Contralesional Hemisphere. A growing number of evi-
dence supports that the contralesional (ipsilateral) motor cortex was activated after 
stroke  [22] . Although the exact mechanism of coactivation of the contralesional mo-
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tor cortex is still elusive, the disinhibition hypothesis is the most widely accepted 
 [23] . With the development of hemispheric stroke, interhemispheric transcallosal 
inhibition is decreased from the affected side, which is translated into more activa-
tion of the contralesional motor cortex. The potential descending motor pathway 
from the contralesional hemisphere to the ipsilateral arm is via uncrossed ipsilateral 
descending corticospinal fibers, or noncorticospinal fibers, which is the corticore-
ticular projection, fibers passing through the red nucleus and pontine and olivary 
nucleus  [24] .
 Generally, the neurologic outcome of the patients who recovered with ipsilateral 
(contralesional) motor cortex activation is worse than of those who recovered with 
perilesional reorganization  [25] . Moreover, those patients experience mirror move-
ments with recovery, which is attributed to the ipsilateral motor pathway  [26] . The 
severity of mirror movements showed a reverse correlation with hand motor func-
tion. Therefore, abnormal involuntary mirror movement, or proximal-distal inter-
joint coupling may have a detrimental effect on functional recovery. Even with these 
conflicting results, the ipsilateral descending pyramidal tract helps trunk muscle re-
covery, and is an important factor in motor recovery in children.
 Recovery from Miscellaneous Stroke 
 In patients who recovered from unilateral cerebellar infarction, it seems that the cer-
ebellocortical loop on the opposite side might be important  [27] . When recovering 
from thalamic infarction, a somatosensory gaiting process plays a significant role in 
sensory improvement  [28] . 
 Pharmacologic Options Targeting Functional Improvement 
 With the help of a sound understanding of the underlying mechanisms of the neuro-
logic recovery and neural plasticity, pharmacological and nonpharmacological ap-
proaches to augment neurologic recovery were attempted. 
 Central Noradrenergic Stimulation 
 Amphetamine is a monoamine agonist which increases norepinephrine, dopamine, 
and serotonin levels in the brain. Animal experimental studies using rats and cats 
showed that administration of amphetamine concomitantly with motor practice ac-
celerated recovery from cortical injuries. Although amphetamine is a potent psycho-
motor stimulator, this effect is thought to be independent of its psychostimulatory 
effect, which is mediated by dopamine. Several human randomized clinical trials were 
performed to identify the beneficial effect of amphetamine on neurologic recovery. 
Although several anecdotal reports support that it may help a ‘speedy recovery’ in 
small numbers of patients, it is still inconclusive whether amphetamines are beneficial 
for the quality of stroke recovery  [29] . 
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 Serotoninergics 
 Antidepressants may promote neuroplastic changes mediated by surges of the amount 
of synaptic monoamines. Based on this, a pivotal randomized controlled clinical trial 
was performed and the results were recently published  [30] . Patients treated with 
fluoxetine and physiotherapy showed better distal motor power  improvement and 
less dependency at 3 months, compared with those with  physiotherapy alone. Al-
though the precise underlying mechanisms are unknown, fluoxetine seems to be ef-
fective via modulating brain plasticity. With the positive results, it is still unclear 
whether other selective serotonin reuptake inhibitors have a similar effect on neuro-
logic recovery, or whether the routine use of fluoxetine is justifiable in patients with-
out post-stroke depression. More studies are needed. 
 Dopaminergics 
 A randomized single-blind crossover trial was done before using levodopa adminis-
tration in the chronic stage of stroke patients. Although the treated dose was low (100 
mg per day), the treatment group showed better motor performance at 5 weeks after 
treatment, and better cortical excitability measured by repetitive transcranial mag-
netic stimulation  [31] . This study was based on a small number of patients; therefore, 
it needs to be verified in a larger study. 
 Nonpharmacologic Therapeutic Options 
 Noninvasive Cortical Stimulation 
 Repetitive transcranial magnetic stimulation or transcranial direct current stimula-
tion are noninvasive cortical stimulation methods to modulate cortical excitability in 
humans  [32] . These noninvasive cortical stimulation techniques administered alone 
or in combination with various methods of neurorehabilitation were reported to be 
safe in the short term. However, more studies are needed to verify their long-term ef-
fect on motor recovery. 
 Constraint-Induced Movement Therapy 
 After severe motor stroke, patients may preferentially use the nonaffected limbs. This 
pattern of movement activates the contralesional hemisphere which may inhibit the 
damaged hemisphere via interhemispheric transcallosal inhibition. Constraint-in-
duced movement therapy consists of forced use of the paretic arm aiming to decrease 
transcallosal inhibition in the affected hemisphere. Reduced unwanted inhibition im-
proves the latent pathway and helps motor recovery via unmasking of the latent path-
way. With constraint-induced movement therapy, expansion of ipsilesional motor 
maps with concomitant decreases in contralesional motor cortex activation was ob-
served, strongly correlating with motor gains  [33] . 
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 Here, we briefly reviewed the basic neurologic recovery mechanisms after stroke. 
Modern functional imaging helped with the understanding of basic mechanisms un-
derlying functional improvement; however, more studies are needed to better under-
stand the optimal mechanism in individual patients.
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 Abstract 
 Stroke remains the most frequent cause of handicap in adult life and according to the WHO the second 
cause of death in the Western world. In the peracute phase, intravenous thrombolysis and in some cas-
es endovascular therapy may induce early revascularization and hereby improve prognosis. However, 
only up to 20–25% of patients are eligible to causal treatment. Further, care in a specialized stroke unit 
improves prognosis in all patients independent of age and stroke severity. Even when it is not possible 
to prevent tissue loss, the surviving brain areas of functional brain networks have a substantial capacity 
to reorganize after a focal ischemic (or hemorrhagic) brain lesion. This functional reorganization contrib-
utes to functional recovery after stroke. Functional magnetic resonance imaging (fMRI) provides a valu-
able tool to capture the spatial and temporal activity changes in response to an acute ischemic lesion. 
Task-related as well as resting-state fMRI have been successfully applied to elucidate post-stroke remod-
eling of functional brain networks. This includes regional changes in neuronal activation as well as dis-
tributed changes in functional brain connectivity. Since fMRI is readily available and does not pose any 
adverse effects, repeated fMRI measurements provide unprecedented possibilities to prospectively as-
sess the time course of reorganization in functional neural networks after stroke and relate the tempo-
rospatial dynamics of reorganization at the systems level to functional recovery. Here we review the 
current status and future perspectives of fMRI as a means of studying functional brain reorganization 
after stroke. We summarize (a) how fMRI has advanced our knowledge regarding the recovery mecha-
nisms after stroke, and (b) how fMRI has been applied to document the effects of therapeutical interven-
tions on post-stroke functional reorganization.  Copyright © 2013 S. Karger AG, Basel 
 Background 
 Stroke and other cerebrovascular diseases remain the world’s second leading cause of 
death  [1] and stroke is the leading cause for acquired disability in adults, including 
hemiparesis, dysphasia, neglect or other focal neurological deficits. Recent advances 
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in neuroimaging enable rapid and precise diagnosis and new treatment options have 
become available for patients with acute ischemic stroke, if diagnosis is made within 
the first hours after the onset of ischemia  [2, 3] . However, the majority of patients have 
either only limited effect or are uneligible for revascularization therapy and long-term 
rehabilitation remains the most important treatment option. In patients with acute 
stroke, it is difficult to predict functional recovery and the long-term functional out-
come varies from patient to patient  [4] . A detailed assessment of lesion location and 
size with structural magnetic resonance imaging (MRI) is often of limited value in 
terms of explaining or predicting interindividual differences in long-term recovery 
because structural MRI provides only little information regarding the potential of the 
nondamaged brain regions to promote recovery of function  [5–7] . 
 Here functional MRI (fMRI) comes into the picture because the distributed neural 
activity of functional brain networks can be readily studied with fMRI at rest and 
while patients perform a specific task  [8] . In healthy individuals, fMRI has proven to 
be a valuable tool to study functional brain reorganization due to learning and long-
term practice  [9, 10] or associated with brain maturation during childhood and ado-
lescence  [11] or healthy aging  [12] . In a wide range of diseases, fMRI has been exten-
sively used to study how a given brain disease changes the functional neuro-architec-
ture at the systems level  [13–15] . In the last 10 years, cross-sectional as well as 
longitudinal fMRI studies after stroke have provided important insights into changes 
of the brain in recovery after stroke.
 In this chapter, we review the application of fMRI to study the reorganization of 
functional brain networks after stroke.
 What Is Functional Magnetic Resonance Imaging? 
 When stroke patients undergo fMRI, we measure local changes in regional neural ac-
tivity using the blood-oxygenation-level-dependent (BOLD) signal  [16] . A regional 
increase in neural activity triggers an increase in local blood perfusion. Under normal 
physiological conditions, regional oxygen supply increases as a consequence of in-
creasing perfusion, exceeding the local activity-dependent increase in oxygen con-
sumption. Accordingly, an increase in regional neural activity leads to a rise in the 
local oxyhemoglobin concentration and a decrease in the local concentration of de-
oxyhemoglobin. The activity-driven reduction of paramagnetic deoxyhemoglobin 
causes the regional increase in the BOLD signal. Hence, the BOLD signal provides an 
endogenous contrast which is sensitive to regional changes in neural activity, yet it 
needs to be borne in mind that the BOLD signal is an indirect (vascular) measure of 
neural activity which relies on neurovascular coupling  [16, 17] . This explains why 
fMRI can identify functional brain networks, which show a temporally correlated 
BOLD signal increase in response to a stimulus or in relation to an experimental task 
 [18, 19] .
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 How Can Functional Magnetic Resonance Imaging Be Used to Assess Brain 
Function after Stroke? 
 A given brain function is maintained by the functional integration of neural process-
ing among specialized brain regions. Stroke causes a focal brain lesion, which involves 
one or more specialized brain regions and their interaction with the remaining nodes 
of the functional network. In other words, the post-stroke brain is characterized by an 
altered functional network architecture, one which is less effective as opposed to the 
intact brain, but which will use its remaining processing capacities to maintain as 
much as possible functional integrity. The altered neural processing within post-
stroke brain networks can be studied with BOLD fMRI which can reveal altered levels 
of regional brain activation within the network as well as changes in the functional 
interactions between the remaining network nodes. 
 In stroke patients, fMRI can either be performed while patients are ‘at rest’ (i.e., 
resting-state fMRI) or while patients are exposed to sensory stimuli (i.e., stimulus-
related fMRI) or perform a well-defined task in response to a sensory stimulus (i.e., 
task-related fMRI). These fMRI techniques have been successfully applied in post-
stroke patients to assess functional remodeling of brain networks as reflected by re-
gional changes in neuronal activation and distributed changes in functional brain 
connectivity. Stimulus-related, task-related and resting-state fMRI capture different 
aspects of functional reorganization and should be considered as complementary 
techniques with specific strengths and weaknesses. For resting-state and stimulus-
related fMRI, it is not necessary that patients can perform a specific task. This has the 
advantage that these fMRI examinations are feasible even in severely affected stroke 
patients and can be used to study spontaneous fluctuations in regional BOLD levels 
(i.e., resting-state fMRI) or changes in regional BOLD signal driven by ‘passive’ sen-
sory stimulation (i.e., stimulus-related fMRI).
 Resting-state fMRI can be used to study alterations in functional brain connec-
tivity after stroke because the low-frequency (<0.1 Hz) BOLD signal fluctuations at 
rest are temporally correlated in functional brain networks  [8, 20] . The resting-state 
BOLD signal correlations are sensitive to head movements  [21] . Moreover, compre-
hensive filtering should be applied because physiological noise from cardiac and 
respiratory cycles causes BOLD signal changes resembling those observed in rest-
ing-state fMRI  [22] . A resting-state fMRI time series can reveal functional connec-
tivity of several functional brain networks, including the so-called default mode 
network and the motor network  [8] . Studies on healthy resting subjects have shown 
that brain networks which display correlated resting-state activity strongly overlap 
with the topography of brain networks as identified by task-related fMRI  [8] .
 In contrast, task-related fMRI offers the possibility to identify changes in the 
task-specific activation pattern after stroke and to examine how task-specific acti-
vation patterns dynamically change during the course of recovery. Task-related 
fMRI studies offer better possibilities to directly relate specific activity or connec-
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tivity changes in the relevant brain networks to the degree of functional impair-
ment  and to recovery of a specific brain function such as hand paresis, aphasia 
or neglect. In summary, resting-state, stimulus-related and task-related fMRI mea-
sure different aspects of functional integration and therefore, should be used as 
complementary approaches when assessing functional brain reorganization after 
stroke.
 The above-mentioned fMRI approaches can be combined with an intervention. 
For instance, focal transcranial brain stimulation might be combined with fMRI to 
experimentally manipulate the function of one or more of the nonaffected cortical 
areas  [23, 24] . This combined brain stimulation-fMRI approach is particularly inter-
esting if one wishes to test the functional relevance of a specific cortical area for re-
covery of a specific brain function. Another interventional approach is to map dis-
tributed changes in the BOLD signal in response to an acute pharmacological inter-
vention compared to placebo. Pharmacological fMRI might be useful to examine 
how the pharmacological manipulation of a specific neurotransmitter or ion channel 
alters the functional integration within brain networks and hereby promotes recov-
ery of function  [25] .
 Feasibility of Functional Magnetic Resonance Imaging in a Clinical Post-Stroke 
Setting 
 Stroke patients frequently undergo MRI as part of their diagnostic workup. fMRI car-
ries the same contraindications as conventional MRI scans, that is metal implants, 
claustrophobia etc. Artifacts induced by head movements remain a limiting problem 
in the acute phase  [26] . Here prospective motion correction of head movements using 
data from optical tracking systems might significantly help to reduce motion artifacts 
in future studies  [27] . 
 As pointed out above, resting-state fMRI is suited for patients with any neurologi-
cal deficit of any severity as there is no task to perform. The only practical limitation 
might be related to spontaneous body movements during the resting-state fMRI ses-
sion. The estimation of resting-state functional connectivity becomes more reliable 
the more time points (i.e., brain volumes) are acquired during a single resting state, 
because resting-state connectivity describes the temporal correlation of spontaneous 
BOLD signal fluctuations within functional brain networks. Van Dijk et al.  [28] re-
ported that a scanning session of 5 min is sufficient to acquire reliable resting-state 
fMRI data with a TR of 2.5 s and a spatial resolution of 2–3 mm. Usually, a resting-
state fMRI session lasts between 5 and 10 min which allows resting-state fMRI to be 
incorporated into existing clinical MRI protocols for stroke.
 Stimulus-related fMRI is also relatively easy to establish in a clinical setting and 
might be used even in patients with a severe deficit. For instance, an auditory lan-
guage comprehension paradigm with alternating periods during which speech or 
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reversed speech is presented via headphones can be applied in patients with acute 
aphasia  [29] . For task-related fMRI studies, selection of the experimental task is 
constrained to tasks the patient is able to perform  [30, 31] . Usually, the experimen-
tal task should be as simple as possible, but still specifically activate the neural net-
works of interest (e.g. the language system in dysphasia or the motor system in mo-
tor stroke). If a task is used that is too difficult for the patients, task-related fMRI 
will inevitably reveal an alteration of task-related brain activity in stroke patients 
relative to healthy controls, but it will be impossible to interpret the functional sig-
nificance of the change in brain activity. It is advisable to match task performance 
in terms of effort. For instance, in patients with hand paresis caused by motor stroke, 
one might use a grip force task in which patients have to produce a force level rela-
tive to their individual maximum grip force rather than a fixed grip force level that 
is identical for all subjects  [32] . Task-based fMRI paradigms may consist of inter-
changing periods of task performance and rest (i.e., blocked design) or intermingled 
trials (i.e., event-related design). Blocked fMRI designs are usually preferred as they 
reveal more robust task-related activations. Regardless of which task patients per-
form during fMRI, task performance should be monitored as closely as possible. 
Measures of task performance should be obtained and used as external variables to 







Acute (Ex1) Subacute (Ex2) Chronic (Ex3)
 Fig. 1. Temporofrontal language network activation measured in a task-based language paradigm 
in healthy controls and patients with aphasia after stroke in acute, subacute and chronic phases 
after stroke. Group analyses of 14 controls and 14 patients; marked areas are voxels significant at 
p < 0.05 corrected for multiple comparisons. Results are surface-rendered onto a canonical brain 
with the left side in the upper row and the right side in the lower row. From Saur et al.  [29] , with 
permission. 
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 Depending on the complexity of the fMRI design, stimulus- and task-related fMRI 
sessions usually last between 5 and 15 min. Once the equipment for stimulus presen-
tation and performance monitoring is established in the fMRI environment, stimu-
lus- and task-related fMRI studies can be performed in a clinical setting, even shortly 
after stroke onset  [29, 32] . However, task-related fMRI is logistically demanding, es-
pecially in the acute stage after stroke, because patients need to be familiarized with 
the task before scanning and task-related fMRI requires a nonroutine setup (i.e., stim-
ulus presentation and synchronization with fMRI data acquisition as well as task per-
formance monitoring).  Figure 1 illustrates changes in activation pattern in a longitu-
dinal task-based fMRI study of patients with aphasia after stroke compared with 
healthy controls.
 Network Reorganization after Stroke 
 Early fMRI studies in stroke have focused on changes in regional brain activation 
rather than assessing the functional interaction between the activated brain regions. 
In recent years, fMRI has been successfully applied in analyses of functional and ef-
fective connectivity on fMRI data acquired in post-stroke patients to investigate how 
the focal brain lesion caused by stroke alters the interaction between the nonaffected 
areas of a functional network and how changes in connectivity relate to functional 
impairment and recovery  [33] . 
 Interactions between functionally specialized areas can be described in terms of 
functional or effective connectivity  [34, 35] . Studies of patterns of ‘functional connec-
tivity’ are based on coherence or correlation of signal changes among cortical regions 
and thus, merely reflect statistical dependencies among brain regions. It should be 
noted that functional connectivity neither makes any explicit reference to specific di-
rectional effects or causal interactions between brain areas nor refers to an underlying 
structural network model. Functional brain connectivity can be estimated in a variety 
of ways, for example through computing cross-correlations in the time domain or 
mutual information  [35] .
 ‘Effective connectivity’ describes causal interactions among distinct neural nodes. 
In contrast to functional connectivity, effective connectivity specifies directional ef-
fects of one neural element of a brain network over another. Functional connectiv-
ity patterns are often extracted from fMRI time series that have been acquired in a 
(task-free) resting state, whereas effective connectivity is usually inferred from task-
based fMRI time series  [36] . It should be mentioned that BOLD fMRI is not the only 
method with which one can study functional and effective connectivity. Other neu-
roimaging modalities such as electroencephalography and magneto-encephalogra-
phy can also be used to analyze functional or effective connectivity patterns in the 
human brain. The techniques used for extracting effective connectivity patterns 
from a BOLD fMRI time series are either based on a prespecified anatomical model 
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(e.g. dynamic causal modeling) or largely model free (e.g. Granger causality  [37] ). 
Especially dynamic causal modeling has been successfully applied to fMRI data in 
subcortical motor stroke to reveal impaired integration within the motor network 
 [38] .
 Assessment of Brain Reorganization after Stroke 
 As pointed out above, fMRI studies in stroke patients can broadly be divided into task-
related and resting-state fMRI studies and the focus of interest can be on the distribu-
tion of activation within a network (‘activation pattern’) or on changes in functional 
integration (‘connectivity pattern’). Due to space restrictions, we only review key 
fMRI studies of stroke-induced reorganization in the motor system. However, we 
wish to stress that fMRI has been successfully used to study functional reorganization 
in post-stroke patients presenting with other neurological deficits such as spatial ne-
glect or dysphasia  [29, 39–41] . 
 Cross-Sectional Functional Magnetic Resonance Imaging Studies in Motor Stroke 
 fMRI studies on motor stroke have focused on recovery of motor hand function by 
mapping task-related brain activation during whole hand grasp or finger movements. 
Since most studies were restricted to patients with subcortical lesions, little is known 
about motor reorganization following cortical or corticosubcortical stroke. This com-
plicates the comparison with animal studies, which have almost exclusively examined 
motor reorganization triggered by cortical stroke lesions  [42, 43] . 
 After subcortical motor stroke, patients commonly show overactivations in sec-
ondary motor areas, including the dorsal premotor cortex (PMd), ventral premotor 
cortex, supplementary motor area (SMA) and cingulate motor area in the affected and 
unaffected hemisphere as well as the contralesional primary motor cortex. As a rule 
of thumb, activation of secondary cortical motor areas is more pronounced in patients 
with poorer outcome, suggesting stronger recruitment in those patients ‘with greatest 
need’  [44] . Several studies associate persistent overactivation negatively with function 
and recovery, while refocusing and normalization of activation patterns point to-
wards new network organization akin to the network before stroke and correlate with 
better outcome  [23, 45–47] . Yet other studies showed a persistence of movement re-
lated overactivity, even after nearly full functional recovery  [48–50] . This divergence 
may be explained through differences in the degree of impairment, time after stroke 
and the imaging task.
 Using the coordinate-based activation likelihood estimation (ALE) method, a re-
cent meta-analysis of 36 task-related neuroimaging studies specifically addressed the 
question which motor activation patterns are consistent across studies  [51] . Increased 
activation in contralesional M1 and bilateral premotor areas was a highly consistent 
finding after motor stroke despite considerable differences among studies in terms of 
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fMRI tasks and motor impairment levels. With respect to motor outcome, the recruit-
ment of the original functional network rather than on contralesional activity was as-
sociated with good motor recovery. However, Ward et al.  [52] showed that the ipsi-
lateral PMd showed a linear increase in task-related activation as a function of hand-
grip force in chronic stroke patients with significant impairment, but not in chronic 
stroke patients with good outcome or in healthy controls. This observation suggests 
that activity in ipsilateral motor cortical areas such as PMd might also be functionally 
relevant in patients with poor outcome.
 Another important question which can be addressed with fMRI is how a focal 
stroke lesion affects the functional integration among brain regions forming a func-
tional network. In patients with subcortical motor stroke, a task-related fMRI study 
employed dynamic causal modeling to demonstrate a reduction in intrinsic connec-
tivity between ipsilesional SMA and ipsilesional primary motor hand area very ear-
ly after stroke (less than 72 h after symptom onset)  [53] . The reduction in positive 
coupling between ipsilesional SMA and primary motor hand area was found during 
finger movements with the affected and unaffected hand and correlated with indi-
vidual motor impairment  [53] . While these data point to impaired information flow 
between ipsilesional brain regions, other fMRI studies suggest that changes in inter-
hemispheric connectivity between homologous motor regions might be associated 
with poor recovery. In patients with subcortical motor stroke, the primary motor 
cortices express an abnormal pattern of interhemispheric effective connectivity with 
the contralesional motor cortex exerting an abnormal inhibitory drive towards the 
ipsilesional M1 during movements with the affected hand  [53] . Likewise, a recent 
resting-state fMRI study showed that a loss in homologous interhemispheric func-
tional connectivity in the somatomotor network predicted individual impairment 
of upper extremity function in 23 patients with acute stroke  [54] . Finally, it should 
be noted that interleaving transcranial magnetic stimulation (TMS) with fMRI 
could be used to test changes in effective connectivity in specific cortical connec-
tions by targeting a specific cortical area with focal TMS  [55] . This possibility was 
exploited in a recent concurrent TMS-fMRI study  [23] , in which short bursts of 
TMS were applied to the contralesional PMd during fMRI. Interleaved TMS-fMRI 
revealed that the contralesional PMd had a stronger influence on the ipsilesional 
sensorimotor cortex when patients moved the affected hand in patients with great-
er clinical impairment  [23] .
 It needs to be borne in mind that the results obtained with fMRI are correlative 
in nature. While fMRI can be used to demonstrate a task-related overactivation of 
a cortical area or a change in corticocortical connectivity, this does not imply that 
these changes are functionally relevant. In contrast to fMRI, focal TMS is an inter-
ventional method that can transiently interfere with ongoing neuronal activity in 
the stimulated brain area. The ‘interventional nature’ of TMS opens up unique pos-
sibilities to probe the functional relevance of a change in regional activity as revealed 
by fMRI  [55] . For instance, the observation that the PMd is overactive during motor 
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tasks in patients with motor stroke does not prove that this constitutes a function-
ally mechanism for recovery. However, this was demonstrated by disrupting neural 
processing in the PMd with focal TMS: focal TMS given to ipsilesional  [56] or con-
tralesional PMd  [57] affected the performance of a simple motor task in patients 
with chronic stroke but not in healthy controls. The disruptive effect of TMS to con-
tralesional PMd was found to be stronger in patients who showed greater motor 
impairment  [57] .
 Longitudinal Functional Magnetic Resonance Imaging Studies in Motor Stroke 
 Cross-sectional fMRI studies provide a snapshot of the change in functional neuro-
architecture at a given time point after stroke, but they are not suited to clarify how 
functional reorganization dynamically evolves after stroke. Using a grip force task, a 
longitudinal fMRI study of motor recovery after subcortical stroke found an initial 
overactivation in many primary and secondary motor regions when patients per-
formed manual motor tasks with their affected hand  [32] . This was followed by a 
gradual focusing of movement-related activation, in a way that is typical for motor 
skill learning in healthy individuals. The degree to which the activity pattern shrunk 
towards a normal (minimized) activity pattern correlated with long-term motor re-
covery. Poor recovery was associated with a persistence of task-related overactivation, 
whereas the activation pattern normalized in patients with good recovery. Another 
longitudinal fMRI study also found dynamic changes in task-related activation dur-
ing the first 2 weeks after subcortical motor stroke, which depended upon the degree 
of initial motor impairment. In that study, bilateral increases of activity in the pri-
mary motor cortex, lateral premotor cortex, and SMA correlated with short-term mo-
tor recovery  [47] . 
 With respect to impaired connectivity, a longitudinal fMRI study used dynamic 
causal modeling to show reduced positive coupling of ipsilesional SMA and lateral 
premotor cortex with the ipsilesional primary motor hand area in the acute stage 
( ≤ 72 h  [58] ). This ipsilesional premotor-to-motor coupling increased over time and 
the increase was associated with better recovery. The same study also found dynamic 
changes in interhemispheric effective connectivity. In the acute stage, the negative 
coupling strength from ipsilesional motor areas to the contralesional primary motor 
hand region was attenuated. The subacute stage was characterized by a positive influ-
ence of the contralesional primary motor cortex on ipsilesional primary motor cortex. 
The negative coupling between ipsilesional areas and the contralesional primary mo-
tor hand area M1 normalized over time. Interestingly, poor recovery in the chronic 
stage was associated with enhanced negative coupling from the contralesional to ip-
silesional primary motor cortex.
 Repeated resting-state fMRI measurements also revealed dynamic changes in 
functional connectivity in the motor network after stroke  [59] . Patients with subcor-
tical motor stroke underwent 5 resting-state fMRI measurements in the first year 
after stroke. A functional connectivity matrix among 21 motor brain regions was 
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constructed and analyzed using graph-theoretical approaches. Overall, the topology 
of the motor execution network gradually became more random over time, indicat-
ing a less efficient network topology. The ipsilesional primary motor area and con-
tralesional cerebellum showed increased regional centralities within the network, 
whereas the ipsilesional cerebellum showed decreased regional centrality over time. 
These topological connectivity measures correlated with different clinical outcome 
measures.
 Together, the fMRI studies on patients with motor stroke consistently show that a 
focal stroke lesion typically affects neural integration of the entire motor system, and 
clearly emphasize the relevance of a network-based neuroimaging approach to under-
stand functional brain reorganization after stroke  [60] . Yet the reported findings are 
partially conflicting and the functional relevance of specific connectivity changes for 
motor recovery, for instance the relevance of interhemispheric versus (ipsilesional) 
intrahemispheric connectivity changes, remains to be clarified.
 Predicting Recovery Based on Early Functional Magnetic Resonance Imaging 
 In recent years, several groups have started to address the question whether fMRI 
can contribute to predict recovery of a focal neurological impairment in a single pa-
tient. In patients with acute ischemic stroke, there are well-established clinical vari-
ables such as age and NIHSS score within 6 h of symptom onset that help to predict 
3 months’ survival and independence (Barthel index  ≥ 95)  [61] . However, these clin-
ical variables are too nonspecific to enable prediction of recovery with  respect to 
specific deficits such as upper limb or language improvement. Accurate prediction 
of upper limb or language recovery might inform rehabilitation planning and assist 
clinicians and patients in realistic goal setting. This has prompted some researchers 
to measure brain activation with fMRI in the first few days after stroke in order to 
test whether the fMRI data contain some information that  predicts subsequent im-
provement in manual motor function  [62, 63] or language abilities  [64] . 
 Marshall et al.  [62] studied 23 patients with fMRI within the first days after acute 
stroke. During fMRI, patients performed a simple repetitive hand closure task in syn-
chrony with a 1-Hz metronome click alternating with rest. A multivariate analysis 
yielded a correlation between brain activation and change in Fugl-Meyer score over 
the next 3 months as indicator of motor recovery. Additionally, voxel-based univari-
ate statistical analysis revealed 2 small clusters in the ipsilesional postcentral gyrus and 
cingulate cortex where initial task-related activation correlated with subsequent re-
covery. Using the same motor task, the same group subsequently reported that the 
distributed fMRI activation pattern in combination with the initial Fugl-Meyer score 
improved the prediction of upper limb recovery in patients with severe initial upper 
limb paresis (predictive explanation: 47%) as opposed to the Fugl-Meyer score alone 
(predictive explanation: 16%)  [63] . However, this improvement in outcome predic-
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tion did not reach significance. In patients with mild initial paresis, the clinical predic-
tive variable (i.e., initial Fugl-Meyer score) already predicted motor recovery with a 
very high accuracy (predictive explanation: 96%)  [63] . It should be mentioned that 
other mapping techniques such as TMS and diffusion tensor imaging might also help 
prediction of upper limb recovery  [65] . Therefore, the additional value of task-related 
fMRI needs to be determined.
 Saur et al.  [64] applied a multivariate machine learning approach (i.e., support vec-
tor machine) in 21 stroke patients with moderate or severe aphasia to show that lan-
guage fMRI data obtained early after stroke contain substantial predictive informa-
tion about subsequent recovery of language function. In that study, fMRI was ac-
quired during an auditory comprehension paradigm 2 weeks after stroke. Outcome 
after 6 months was either classified as good or bad. In addition to the fMRI activation 
pattern, age and initial language deficit were included in the predictive model. Of 
note, the classification algorithm allowed for the possibility that within a given voxel, 
the same outcome could be coded by either an increase or decrease in activity during 
the language comprehension task. A bad outcome could be coded by both high and 
low activation, while medium activation would then predict a good outcome or vice 
versa. The multivariate machine learning approach correctly separated patients with 
good and bad language performance 6 months after stroke in 3/4 of patients when 
classification was only based on the fMRI activation pattern. Classification accuracy 
further improved to 86% when age and the initial language impairment were includ-
ed for classification. A comparable accuracy was reached for the relative language im-
provement when fMRI data were restricted to a region of interest in the right frontal 
gyrus.
 Together, these initial studies support the idea that the task-related fMRI activation 
pattern performed early after stroke might be used to predict the recovery of specific 
brain functions. The same may hold true for fMRI-based connectivity patterns, both 
at rest or during a specific task. For instance, interhemispheric functional connectiv-
ity as revealed by resting-state MRI in combination with clinical variables may con-
stitute a useful predictive marker for recovery  [60] .
 Mapping Treatment-Induced Functional Reorganization  
 Many prospective fMRI studies have shown that therapeutic interventions can induce 
significant changes in task-related activation and connectivity  [33, 66] . Even short-
term interventions such as a single session of TMS  [24, 67] or a single pharmacologi-
cal challenge  [25] can cause consistent shifts in brain activation and connectivity. 
Other fMRI studies have reported changes in task-related activation or connectivity 
after long-term training of motor or language functions that were correlated with 
training-induced improvement  [57, 66, 68] . For instance, James et al.  [68] used rest-
ing-state fMRI to investigate the impact of 3 weeks of intensive upper limb rehabilita-
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tion therapy on interhemispheric connectivity between the ipsi- and contralesional 
PMd. Structural equation modeling of the fMRI data yielded a stronger influence of 
ipsilesional PMd on its contralesional homologue after therapy. 
 In summary, the majority of studies showed that remodeling of cortical functions 
is possible even years after stroke, including homologous ipsilesional and contrale-
sional regions. Usually, therapy-induced reorganization occurred within the pre-ex-
isting functional brain network rather than recruiting new brain regions that belong 
to other functional brain networks.
 Methodological Considerations 
 It is recommended to screen for macrovascular abnormalities in the arteries  supplying 
the brain. The presence of uni- or bilateral stenosis or occlusion in the major intra- 
or extracranial arteries supplying the brain may hamper downstream perfusion in 
specific vascular territories and alter the temporal dynamics of the BOLD response 
in specific vascular territories. This might be of relevance when  assessing stimulus-
induced or task-related changes in regional brain activity or connectivity. 
 Another phenomenon which needs to be considered when performing fMRI in the 
acute phase of stroke is diaschisis. Diaschisis is defined as a dysfunction of preserved 
cortical brain regions that are remote but functionally connected to an acutely dam-
aged brain area. This dysfunction leads to a depression of regional neuronal metabo-
lism and cerebral blood flow and thus, will affect the regional activation and interre-
gional connectivity patterns as revealed by fMRI in acute stroke patients. It is there-
fore difficult to determine how much the patient’s initial deficit and subsequent 
recovery can be attributed to the focal brain damage or secondary diaschisis-related 
phenomena  [41] .
 Another intrinsic problem relates to the heterogeneity of patient populations. 
Patients usually present with a combination of neurological deficits, which vary in 
magnitude from patient to patient. Deficits such as aphasia, hemianopsia or neglect 
might affect task performance in other tasks because patients might not understand 
the instruction or fail to appropriately perceive the stimulus that instructs the task. 
The same applies to the interindividual variability of the localization and extent of 
brain lesions. Here voxelwise lesion-behavior mapping might help to figure out 
which areas of the brain need to be damaged by stroke to result in a specific neuro-
logical deficit  [69] . To this end, the infarcted brain area is delineated manually and 
a binary brain map is generated containing either affected or preserved voxels for 
each patient. Patients are further classified according to the presence or absence of 
a specific neurological deficit. By pooling the data of a large group of stroke patients, 
a statistical brain map can be generated which identifies those clusters of voxels 
where local brain damage is most consistently associated with the symptom of inter-
est. Another strategy to cope with the large interpatient variation in terms of ana-
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tomical lesion and clinical deficits is to apply more stringent inclusion criteria by 
including only patients with a prespecified neurological deficit or stroke location. 
While this increases the comparability among patients, the results of such fMRI 
studies cannot easily be generalized to the general stroke population. As pointed out 
above, the majority of fMRI studies on motor stroke have only included patients 
with subcortical stroke. Therefore, the fMRI results obtained in this subgroup of 
patients might tell little about motor reorganization that occurs in stroke patients 
with cortical involvement.
 Finally, the potential for functional reorganization critically depends on the 
nondamaged brain regions and connections that offer the anatomical substrate 
supporting functional recovery. Therefore, thorough structural mapping of the 
nondamaged brain will greatly facilitate the interpretation of the fMRI data. In this 
context, diffusion-sensitive MRI techniques are of great value as they not only allow 
to define the infarcted area, but also to test whether and how much the major fiber 
tracts in the cerebral white matter are still intact after stroke. Here diffusion MRI-
based tractography can be used to find out which corticocortical or corticosubcor-
tical routes are still available for compensation after stroke-induced focal brain 
damage  [70] .
 Summary and Outlook 
 Within the last decade, the use of fMRI in patients with stroke has substantially ad-
vanced our understanding of the mechanisms underlying functional brain reorgani-
zation in response to a focal brain lesion. There is also some evidence to suggest that 
fMRI in the acute phase might have some potential to predict recovery. It also appears 
possible that the results obtained with fMRI will inspire the development of new re-
habilitation strategies and assist the planning of future intervention trials. However, 
the clinical use of fMRI in post-stroke patients is still in its infancy and the establish-
ment of clinically feasible fMRI applications remains a challenge for translational 
 research. 
 Previous fMRI work in stroke has been confined to small-scale single-center stud-
ies and most studies were designed as proof-of-principle studies. Future studies 
should aim at investigating larger patient cohorts and should include a broader range 
of stroke patients in terms of lesion location. This will facilitate the generalization of 
the results and help to identify subgroups of patients that show distinct patterns of 
functional reorganization. Further, the isolated use of fMRI to study functional reor-
ganization after strokes has clear limitations. We anticipate that a multimodal assess-
ment of functional reorganization that combines different methods, such as fMRI, 
diffusion MRI and TMS, but also magnetic resonance spectroscopy or electroenceph-
alography will offer a deeper understanding of the mechanisms underlying post-
stroke reorganization and its functional relevance. Longitudinal studies starting al-
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ready few days after stroke are preferable to cross-sectional studies in the chronic 
stage because they can unravel the spatiotemporal dynamics of recovery. Finally, 
fMRI research of post-stroke recovery is mainly limited to academic neuroscience 
centers. It remains a challenge to implement the fMRI approach into nonacademic 
community hospitals where the majority of patients are treated  [71] . This requires the 
establishment of simple fMRI protocols and automated analysis pipelines that can be 
implemented as clinical routine. All these considerations need to be taken into ac-
count if one wants to foster the clinical use of fMRI in post-stroke patients. This re-
quires a close interaction between ‘Imaging Neuroscience’ and ‘Clinical Neurology’ 
to fully realize the potential of fMRI as a means of monitoring the efficacy of thera-
peutic interventions and stratifying patients based on the likely response to a thera-
peutic intervention.
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 Abstract 
 There is evidence showing that white matter changes are clinically relevant and can be associated with 
cognitive disorders, slower mental processing speed or motor impairment. The complex structural or-
ganization of the white matter can be depicted in vivo in great detail with advanced diffusion-weight-
ed imaging (DWI). From the simplest and most commonly used technique (e.g. the mapping of appar-
ent diffusion coefficient values) to more advanced techniques (e.g. diffusion tensor imaging), it is now 
possible to visualize white matter fibers of the brain in a noninvasive way. This chapter will first provide 
a basic understanding of the principles of these techniques and describe the current clinical applica-
tions of DWI and tractography in two common brain diseases, stroke and traumatic brain injury. We will 
emphasise on what these techniques may add to our understanding of the natural course of the pathol-
ogy and especially, how they can help in predicting the outcomes of the rehabilitation phase. We will 
discuss how DWI and tractography techniques can shed light on possible compensatory disease mech-
anisms and propose future developments of these techniques in a clinical setting. 
 Copyright © 2013 S. Karger AG, Basel 
 Imaging White Matter Damages 
 Clinical Relevance of Studying White Matter 
 The central nervous system is composed of gray matter, containing the cell bodies 
(dendrites and axon terminals of neurons) and white matter. White matter makes up 
to 60% of the total brain volume and is composed of bundles of myelinated nerve cell 
fibers or axons forming up the structural connectivity of the brain. White matter con-
tains major fasciculi, i.e. corticocortical commissural and association fibers as well as 
cortical projections connecting many regions including the striatum, brain stem and 
many more. The main feature of white matter in the brain, besides acting as a connec-
tion, is to regulate the speed of electrical signals propagating along axons. 
 The conductance speed regulation is obtained in combination by changing axon 
diameter and the oligodendrocyte arms wrapping around the axons as tight layers of 
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myelin. Myelin significantly increases the speed of signal propagation over long dis-
tances and therefore helps ensure the necessary conductance speed in the central ner-
vous  system to achieve various sensory, motor and cognitive functions. Clinically, 
white matter damages can result in serious temporal or permanent disabilities,  ranging 
from mild cognitive impairments to gross deficits, motor injuries and altered  sensorium.
 To appreciate and understand the crucial role of white matter in functional recov-
ery, noninvasive imaging techniques, such as magnetic resonance imaging (MRI), are 
important clinical tools. They can detect and monitor degenerative disorders and 
document cerebral mechanisms that underlie brain injuries.
 Characterizing White Matter Damages 
 Very often, the diagnostic workup of a patient is determined by the abnormalities seen 
on the conventional MR images, such as T2-weighted lesions, but these changes in white 
matter are nonspecific and they likely have more than one cause. Advanced MR tech-
niques, such as diffusion-weighted imaging (DWI), further enhance the diagnostic sen-
sitivity and specificity of MRI by more accurately identifying and differentiating the 
above pathological processes  [1] .  Figure 1 shows examples of T2-weighted lesions with 
the associated axonal integrity present in various brain diseases. Not only does DWI via 
for example diffusion tensor imaging (DTI) provide insight into the status of tissue mi-
crostructure, but it also allows insight into brain connectivity via tractography. It is es-
sential to understand the basic contrast mechanism of diffusion when applied to biolog-
ical tissue to understand the possibilities of DWI-based techniques for clinical purposes. 
 DWI measures the scatter of free water molecules due to random thermal motion, 
i.e. Brownian motion or diffusion. When observed over a time period of milliseconds 
(called the diffusion time) molecules in free water can freely displace in any direction 
i.e. isotropic diffusion. In biological tissue however, obstacles in the cellular spaces 
having boundaries formed by the cell membranes influences molecular motion by 
making it less free; Diffusion within the intracellular space is restricted by the bound-
aries of the cell membrane whereas those outside in the extracellular space is hindered 
by these. The restricted/hindered molecular motion in different microstructural en-
vironments is the unique contrast of DWI. For obtaining the contrast, the diffusion 
time should be selected long enough to allow molecules to displace over distances 
longer than the physical size of the cellular space, which can rang up to about 10 μm 
in diameter [2] (we often assume that during the diffusion time molecular exchange 
across cell membranes is minimal). On the MR scanner, by changing the b-value pa-
rameter, one also indirectly controls the diffusion time and a parameter called the q-
value that basically acts as a filter controlling the maximal molecular displacement 
range. So the higher b-value selected (typically > 1500-2000 s/mm^2) the more sensi-
tive the diffusion weighting (DW) images gets to restricted diffusion and hence to the 
information of the intracellular space. The reason for the increasing intra cellular con-
trast with b-value is that, in the extracellular space molecules are not restricted and 
therefore have displaced over longer distances than the q-value allows.
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 Fig. 1. Summarizes the various axonal integrities from normal to pathological states as revealed by 
histological techniques and the associated T2w signal intensity changes seen in conventional MRI 
exams. The schematic illustrations for the DWI voxel show how the fraction of the isotropic (grey) 
and the anisotropic component in a DWI voxel can be affected for the different pathologies. The 
fraction of the isotropic component typically increases with changes in the extracellular space e.g. 
as for demyelination. The intracellular space (anisotropic diffusion due to restriction) might in-
crease for Wallerian degeneration for a short period of time when the axon is degenerated and 
myelin sheaths still persist . T2w = T2-weighted; MS = multiple sclerosis; ALS = amyotrophic lateral 
sclerosis; TBI = traumatic brain injury. Diffusion MRI voxels represent the measured DWI by the frac-
tion of an isotropic (dark gray), i.e., extracellular space and a restricted and hindered component. 
Courtesy of Matthew Liptrot. 
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White matter, composed of a high density of myelinated axons, can simply be in-
terpreted as impermeable parallel tubes. Indeed when measured radial to the axons, 
diffusion is more restricted/hindered by the boundary (cell membranes) than when 
measured axial to the axons i.e. anisotropic diffusion. Anisotropic diffusion in a vox-
el is therefore always aligned along with the main direction of the underlying tissue 
microstructure, as known for the white matter fibre tracts.
 The degree of anisotropy is an index highly sensitive to a wide range of  microstruc-
tural changes. Changes in radial diffusivity (RD) may reflect changes in fibre density 
(e.g. due to Wallerian degeneration, see next section), cell swelling or change in axon 
diameter. For example, local loss of myelination can be associated with an increased 
RD whereas greater fibre density or re-myelination is associated with decreased RD. 
Axial diffusivity (AD) is mostly sensitive to macroscopic fiber incoherence such as 
bending, fanning as well as undulating axons [3].
In DWI series of DW image volumes are acquired with a b-value (typical around 
1000 s/mm^2), each been sensitized to diffusion (or also known as diffusion encoded) 
along one (unique) direction in space. Beside the DW image volumes, the DWI dataset 
often also include a number of non-diffusion weighted images (b-value = 0 s/mm^2) to 
be used for DTI [4]. Due to the many obstacles in brain tissue, the diffusion process is 
not really Gaussian as for free water, and the physical diffusion coefficient is therefore 
referred to as an Apparent Diffusion Coefficient (ADC). Hence, the signal in an ac-
quired DW image relates (via an exponential relation and the diffusion weighting b-
value used) to the ADC along that specific direction of the diffusion encoding. The ADC 
will therefore be different when measured radially or axially to the fibre tract direction .
 Using mathematical models, it is possible to map microstructure anisotropy inde-
pendent of the orientation of fibers and tracts. DTI is such a method that applies the 
tensor model  [5] to the acquired DWI dataset. For compartments with anisotropic 
diffusion, the tensor has an ellipsoidal shape aligned with the fiber direction, whereas 
for compartments with isotropic diffusion, the tensor takes on the shape of a sphere 
(see fig. 1). The diffusion tensor  D is spanned by 3 eigenvectors (e 1–3 ), which deter-
mine its orientation. For example, e 1 is always aligned with the main fiber direction 
(axial), whereas e 2–3 are perpendicular to the fibers (radial). Correspondingly, the 
shape of the tensor is formed by the 3 values λ 1 , λ 2 and λ 3 , which are quantitative mea-
sures describing the diffusivity along e 1 , e 2 and e 3 , respectively. DTI reflects the aver-
age anisotropy within a voxel typically represented by a mixture of compartments, 
each with different degrees of anisotropy, as described in the previous section.
 Clinically, DTI is a powerful diagnostic tool. The most commonly used anisotropic 
index is fractional anisotropy (FA), normalized between 0 and 1. In addition, DTI 
provides clinically unique quantitative diffusivity measures of AD (λ 1 ), RD [(λ 2 + 
λ 3 )/2] and mean diffusivity (MD) [(λ 1 + λ 2 + λ 3 )/3] (measured in square meter per 
second)  [6] . Although both RD and AD can be more informative than FA and MD, 
they are rarely used clinically. Note that DTI is a nonspecific measure; therefore, it 
remains challenging to assess the underlying biological changes associated with DTI 
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perturbations. Intravoxel incoherence, such as bending, spreading and crossing fi-
bers, impacts on DTI and will result in decreased FA values.
 Tractography corresponds to the ability of noninvasively segmenting gross white 
matter fiber tracts, as opposed to the voxelwise DTI estimates. This can be used for 
visualization purposes, e.g. to investigate the tract structure around a tumor or to 
study the microstructure along a fiber tract, i.e. FA, RD, AD, or MD, and to study 
brain connectivity, i.e. corticocortical connections. Validation studies have shown 
that fiber projections found with tractography results correlate well with those of 
invasive tracers  [7] . Different tractography methods are available. DTI tractography 
is the simplest and seemingly a robust tractography method also available on many 
clinical MRI systems. It draws streamlines along fiber directions identified with the 
diffusion tensor model. The tractography technique mainly includes two steps. First, 
the fiber direction(s) in each voxel is (are) found and second, the streamline(s) em-
anating from a start (seed) region is (are) drawn step by step along the fiber direc-
tions until a certain stop criterion has reached as for example the cortex  [8] . Note, 
however, that DTI tractography is based on a single-fiber model (DTI) that often 
fails in complex regions compared to tractography with multifiber  models  [9] .
 The current applications of DWI and tractography in various clinical contexts 
highlight the high potential of the technique to improve our understanding of damage 
and recovery after brain injuries. This has been observed in various disorders of the 
central nervous system such as in spinal cord and traumatic brain injury (TBI), in 
some forms of vascular dementia, hypoglycemia or stroke  [10] . In the next section, we 
will focus on the main clinical applications of DWI and tractography in two patholo-
gies: stroke and TBI.
 Current Clinical Applications 
 DWI and tractography can provide a new source of clinically relevant biomarkers fol-
lowing brain injuries. Here, we will emphasize the use of DWI and tractography as 
diagnostic and prognostic tools: from early detection of a local injury to the prediction 
of outcomes. In addition, DWI and tractography can also be considered as analytic 
tools: to track the changes in neural tissue accompanying recovery and to get new in-
sights into the neural repair mechanisms. 
 Diagnosis and Functional Prognosis of Brain Injuries 
 Example of Stroke 
 At least 20% of ischemic strokes involve predominantly white matter lesions as a con-
sequence of the occlusion of small penetrating arteries that supply the deep areas of 
the cerebral hemispheres. Ischemia preferentially alters the intra-axonal environ-
ment: the axons are swollen, forming what is known as axonal beading, which causes 
local diffusion dead space or restricted diffusion. 
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 DWI signal intensity is of particular interest in purely white matter lesions but also 
in cortico-subcortical lesions. While no abnormalities are typically seen on conven-
tional MR images, DWI shows changes in ischemic brain tissue within minutes after 
symptom onset, using very short scanning sequences (approx. 2 min, 1 non-diffusion-
weighted and 3 gradient directions). Reported sensitivity of DWI in early diagnosis of 
early infarcts ranges from 88 to 100% and specificity ranges from 86 to 100%  [11] . The 
time course of the ADC signal can also provide temporal information regarding stroke 
onset: ADC values decline rapidly after the onset of ischemia and subsequently increase 
to supranormal values within 24 h to 17 days  [12] .
 Besides the primary damage caused by the stroke, DWI can also reveal secondary 
loss of structural integrity, namely Wallerian degeneration, in chronic stroke patients 
 [13] . DW images show Wallerian degeneration lesions as hyperintense (decreased 
diffusivity), which presumably represents axonal, intramyelinic or astrocytic swell-
ing that likely introduces a larger restricted diffusion component. This indicates de-
generation of axons and their myelin sheaths after injury of a proximal axon or cell 
body.
 DWI data have proven to be a great tool for following disease development and 
progression, but they can also predict clinical outcome. Large lesions, greater than 
30 cm 3 have been reported as poor prognosis factor  [14] . Significant correlations be-
tween the acute DWI stroke lesion volume and both acute and chronic neurologic 
scores have been demonstrated (including the National Institutes of Health Stroke 
Scale, the  Canadian Neurologic Scale or the Barthel index)  [15, 16] . There is also a 
significant correlation between the acute ADC ratio (lesion ADC to normal contra-
lateral hemisphere ADC) and chronic neurologic assessment scale scores  [17] .
 Although less commonly used in acute care, DTI in acute stroke also reveals a 
rapid reduction of RD, which correlates with oligodendrocyte swelling, compres-
sion of the axoplasm and dendritic injuries. Decreased anisotropy (FA) is often re-
lated to the fiber tracts with severe axonal destruction  [18] . Motor weakness is one 
of the most serious impairments after stroke survival. Prediction of an accurate 
prognosis for motor function in stroke patients is crucial, as it can provide useful 
information for clinicians, in order to indicate neurological intervention or spe-
cific rehabilitation strategies. Reduced FA is associated with poorer outcome, quan-
tified with specific neurological scores. Jang et al.  [19] found that the FA ratio at the 
lesion correlated with the motor Barthel index at 3 months after stroke. The predic-
tive value of DTI for motor outcome in stroke patients has been widely demon-
strated, especially for the upper limb functions (for a review, see Jang  [20] ). Fewer 
studies examined the structural correlates of recovery of the lower limb. In a recent 
study, Jayaram et al.  [21] reported that asymmetrical FA values between the two 
hemispheres (reflecting reduced structural integrity of the lesioned corticospinal 
tract) are associated with greater walking impairment. Jang et al.  [19] also demon-
strated the ability of the DTI technique to distinguish the primary lesion core from 
the (secondary) degenerated tract early after stroke. This is very valuable for out-
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come predictions, since it provides the opportunity to differentiate irreversibly 
damaged from restorable tissue where recovery takes place on a longer term.
 Finally, in contrast to the local voxelwise DTI indices, tractography enables the in-
vestigation of changes along specific tracts or in brain networks. For example, the de-
termination of precisely which white matter pathways have been affected by a stroke 
can predict some of the symptoms. Right posterior cerebral artery strokes might lead 
to visuospatial neglect but only when the lesions include the region of the white mat-
ter through which the parahippocampal gyrus and the angular gyrus are connected 
 [22] . Similarly, tractography of the language pathways can help understand the pat-
tern of deficits in different types of aphasia  [23] .
 Example of Traumatic Brain Injury 
 Diffuse axonal injury associated with TBI shows shear strain deformation in the first 
few hours because rotational acceleration-deceleration ultimately results in axonal 
disconnection. Subsequent to axonal disconnection, the formation of axonal ‘retrac-
tion balls’ is observed, which is thought to be the result of the accumulation of axo-
plasm at the site of axonal disconnection  [24] . 
 DWI-related biomarkers of regional brain injury can inform clinicians and re-
searchers about the injury severity but also which neurobehavioral systems were 
i njured in patients with TBI. Lesions are more visible on DW images than on conven-
tional T2-weighted images. As a consequence, DWI may be important for the pro-
spective determination of the extent of traumatic injury, the degree of irreversible 
injury or for long-term prognoses. For example, the number of lesions, characterized 
by low ADCs, is an indication of cytotoxic edema which then correlates with indices 
of clinical injury severity  [25] .
 DTI has been used as a tool for in vivo quantification of white matter microstruc-
tural alterations following TBI  [26, 27] . Sidaros et al.  [26] examined the association 
between white matter DTI indices in late subacute patients with severe TBI and clin-
ical outcome. They found that FA values within the cerebral peduncles and the corpus 
callosum are reduced in TBI patients in the late subacute phase compared to controls. 
These values increased over time in patients with a favorable outcome. Some studies 
also identified significant correlations between DTI indices and cognitive function. 
The degree of white matter pathology (large areas of reduced FA, increased MD and 
RD) might predict cognitive deficits (memory or executive function)  [28] . Other stud-
ies combining DWI and DTI were able to quantify indirectly both edema and damage 
to the integrity of white matter fiber bundles  [29] .
 Probing Compensatory/Adaptive Mechanisms after Brain Injuries 
 One key aspect of research in neurorehabilitation is to effectively facilitate recovery 
and potentially to offer a powerful methodological framework for new neuroreha-
bilitative interventions. To achieve these goals, processes involved in neural repair 
after brain injury must be characterized to then develop sensitive and clinically mean-
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ingful markers of neural repair. In this context, not only can DWI pinpoint an area of 
pathology, but it can also shed light on longitudinal adaptive mechanisms of neuro-
plasticity and repair operating during recovery. Brain plasticity is likely to be the main 
mechanism for recovery and includes multiple substrates (e.g. increased axonal ex-
pression of sodium channels, synaptic changes, increased recruitment of parallel ex-
isting pathways or ‘latent’ connections, and reorganization of distant sites). 
 In stroke patients, increased activity in nonprimary motor areas and in motor areas of 
the nonlesioned hemisphere is commonly reported and this ‘over’ activity has an impor-
tant role in functional recovery  [30] . The functional reorganization seems to be pre dicted 
by structural damage to motor output pathways. For example, Newton et al.  [31] observed 
that the amount of overlap between the lesion and tracts found with tractography is pro-
portional to the degree of functional overactivation in nonprimary motor areas.
 Hence, there is increasing evidence supporting the aberrant use of the existing 
tracts corresponding to the nonlesioned hemisphere. However, it might be possible 
that more extensive adaptive changes occur in response to brain damage. Massive 
axonal rearrangements are likewise seen in primates after brain injury  [32] . This re-
markable finding suggests that rerouting of axon trajectories could also mediate func-
tional recovery in humans. This raises the challenge to find new in vivo markers and 
DWI-based technologies such as DTI, since tractography has the potential sensitivity 
for detecting such axonal rearrangements after brain damage.
 Future Methodological Challenges and Clinical Applications 
 DWI is a powerful and clinically sensitive diagnostic tool. Based on the DWI technique, 
DTI has however some limitations. For example, DTI can only resolve one main direc-
tion and indices get incorrect in voxels with crossing and curving fibers (bending, kiss-
ing or axonal incoherence). Indeed DTI provides a unique in vivo insight into the 
brain’s microstructural environment, but it remains nonspecific. It is impossible to 
infer whether disruptions in FA and MD parameters are the result of disturbances in 
axonal membranes, myelin sheath, microtubules, neurofilaments, or other factors. The 
integration of DWI and tractography with other imaging modalities could help to de-
lineate the biological implications of alterations in white matter fibers. These could 
include functional-related modalities like fMRI (both resting state and task driven) and 
more tract-specific investigations of the corticospinal tract via motor-evoked poten-
tials probed by transcranial magnetic stimulation  [21] . Finally, magnetization transfer 
imaging  [33] can provide information on myelin loss or remyelination via a ratio be-
tween free water molecules and those bound to macromolecules such as myelin. 
 Many promising imaging modalities have arisen, which in combination can poten-
tially improve the diagnostic specificity and sensitivity. However, these modalities are 
often too time-consuming for a routine use for most clinical settings where the time 
needed for the diagnostic workup is a key factor. Clinically, DWI has proven powerful 
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because of its sensitivity to tissue microstructure. It can be further optimized and adapt-
ed for a specific investigation by simply optimizing the sequence parameters, e.g. using 
active imaging, which is a design-based (sequence) optimization  [34] . This approach 
simply provides a sparse set of optimal sequence parameters giving a priori information 
about the tissue microstructure of interest (i.e. axon diameter or cell swelling), scanner 
hardware and maximal scan time. The active imaging approach has been used for gener-
ating optimized sequences to obtain axon diameter indices in the living human brain 
 [35] , information about neurite orientation  [36] and magnetization transfer ratio  [37] .
 Conclusion 
 DWI and tractography have proved to be useful tools in clinical neuroscience, offering 
exciting opportunities to test hypotheses that could not previously be addressed in the 
living human brain and providing in biomarkers of disease severity, progression or 
functional recovery. Future developments in image acquisition and applications of high 
and ultra-high fields offer the promise of high-resolution imaging in the clinical setting. 
These developments should lead to the investigation of more detailed anatomy and will 
afford greater accuracy and precision in tracing the white matter pathways of the brain. 
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 Abstract 
 Many people escape sudden death from ischemic brain stroke, but suffer from severe disabilities 
such as aphasia and/or paralysis. These survivors of focal brain injury need chronic care to recover 
from and/or compensate for the impaired sensory and motor functions previously controlled by the 
focal ischemic core. Functional compensation not only involves the remaining brain areas around 
the infarction but also the areas contralateral to the stroke lesion, with the need for remodeling of 
neuronal circuits in some cases. In this review, recent human and animal studies are presented to aid 
in the understanding of such plasticity in areas contralateral to the stroke lesion providing a new 
model for rehabilitation. It is well known in the medical field that the intact contralateral hemisphere 
is recruited for functional remodeling of modalities such as speech. However, the detailed mecha-
nisms underlying these phenomena are less clear. In rodents, in vivo imaging techniques combined 
with other traditional techniques such as electrophysiology and behavior have revealed that func-
tional recovery is achieved by specific synaptic (neuronal circuit) remodeling of the contralateral area 
in the 1st week after a focal stroke. The intact contralateral hemisphere can therefore potentially 
adopt a bilateral function, even in adults, following proper remodeling of neuronal circuits. These 
recent results suggest a possible new pathway using the intact hemisphere’s function to recover lost 
functions stroke patients.  Copyright © 2013 S. Karger AG, Basel 
After stroke, unlike following heart attacks, survivors often remain debilitated and 
thus severely reducing their quality of life and burdoning their families. Stroke is the 
leading cause of chronic adult disability and the third leading cause of death in Japan 
(resulting in 130 thousand deaths per year)  [1] . In the case of Japan, although the fa-
tality rate has decreased in the last few decades, a large number of survivors still suffer 
from functional disabilities that lead to the second largest (1.1 million person-years) 
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loss of disability-adjusted life years  [1] . Despite advances in medical care for stroke, 
more efficacious medical intervention, including research and rehabilitation, are nec-
essary to reduce this health burden. Survivors of focal brain stroke need chronic care 
to facilitate recovery from/compensation for the specific functions that were impaired 
by damage to the neural pathways involved. These functions include speech and oth-
er sensory and motor functions. Functional compensation utilizes the remaining 
brain areas in the peri-infarction area but also incorporated brain areas contralateral 
to the lesion that can be remodeled to adopt new or expanded functions. Rehabilita-
tion strongly contributes to this recovery/compensation process and plays an impor-
tant role to achieve a good post-stroke quality of life. 
 In this review, we concentrate on the neuronal adaptations that occur in the con-
tralateral area during recovery from stroke damage. We hope this review provides an 
enhanced comprehension of the contralateral neuroplasticity and to help facilitate 
more focused medical care and rehabilitation that ultimately improves recovery of 
functions.
 Contribution of the Area Contralateral to the Stroke Lesion: A Human Case and 
Animal Models 
 The fully developed healthy brain is highly flexible during development as new con-
nections are formed and removed through use-dependent processes. Environmental 
experience from infancy to adulthood and likely in the fully matured brain can mark-
edly affect this plasticity and the resultant function of the human brain. Neuronal cir-
cuits in the adult brain are also plastic – being maintained and adapted to life events 
such as learning new tasks and recovering from brain injury  [2] . Recent advances in 
functional imaging of human brain activity using, for example, positron emission to-
mography and functional magnetic resonance imaging have revealed the reorganiza-
tion of the human brain during recovery from stroke showing important changes in 
the areas contralateral to the injured site  [3, 4] . 
 In humans who suffered a focal stroke in the language areas, it is well known that 
there is some recovery of language by using the nondominant hemisphere, usually the 
right hemisphere  [4] . Some research has also highlighted the contribution of the peri-
infarction area for recovery from aphasia. There is also clinical evidence showing that 
the post-stroke reorganization within the somatosensory system in the contralateral 
(intact) hemisphere plays an important role in the compensation for impaired func-
tions  [5, 6] . Thus, the underlying mechanism of this compensation occurring in the 
intact hemisphere is important for optimizing the functional recovery of human 
stroke patients  [3] .
 As with these clinical cases, animal experiments have shown that cortical finger 
representations adjacent to partly damaged finger representations became enlarged 
during rehabilitation, while they remained unchanged in the control untreated mon-
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keys  [7] . This experiment and others have provided evidence that reorganization oc-
curs in the adult nervous system in regions adjacent to a damaged region that leads to 
plastic changes of the sensory representation of the affected modality. Also in animal 
models of stroke, unilateral experimental infarctions in the somatosensory cortex 
(SSC) and motor cortex result in functional and structural changes in the remaining 
intact contralateral hemisphere. Infarction in the SSC changes the receptive field at 
the contralateral SSC at 1 week after stroke  [8] . After the recovery of motor function 
that was impaired by cerebral infarction, the topographic map is reorganized and the 
dendritic branching of layer V pyramidal neurons is increased in the contralateral 
motor cortex  [9] , and this is enhanced by an early onset of rehabilitation-like tasks in 
mice  [10] . These results suggest that a change in the underlying neuronal circuits in 
the contralateral hemisphere may occur during functional recovery from stroke.
 Axons sprout from the neurons in the contralateral SSC and motor cortex follow-
ing stroke, projecting into the deafferented regions of the cervical spinal cord and 
midbrain that previously received a projection from the now infarcted area  [11, 12] . 
This sprouting can be unequivocally demonstrated, as it results in a novel contralat-
eral projection. Formation of these new axons and branches involves specific molecu-
lar events, and these appear to be at least partially distinct from those that regulate 
axonal growth cone behavior during development  [13] . In terms of functional assess-
ment, pharmacological stimulation of axonal sprouting from the contralateral cortex 
into the cervical spinal cord and brain stem is correlated with improved functional 
recovery after stroke  [14, 15] .
 Although there is now strong evidence for the contribution of the contralateral 
(intact) hemisphere to functional recovery after stroke, the nature of the neuronal and 
circuit remodeling had until recently been less well understood because of the limita-
tions in the resolution of positron emission tomography/functional magnetic reso-
nance imaging. However, recent intense studies using higher-resolution in vivo two-
photon laser microscopy have revealed a number of neuronal events during the re-
covery phase after stroke. These include neuronal circuit remodeling (e.g. spine 
turnover  [16] ), and glial contribution to synapse remodeling  [17] in the damaged 
hemisphere, as well as neuronal remodeling induced in the contralateral hemisphere, 
which occurs with different mechanisms and time course  [16, 18, 19] .
 Acute Phase Remodeling Achieves Compensation: The Case of the Area 
Contralateral to the Lesion 
 A focal stroke in the SSC in mice results in paralysis and sensory loss in the contralat-
eral side (e.g. left-hemisphere stroke induces right-side paralysis). However, mice 
show strong functional recovery by 2–4 weeks after stroke, even if the size of the isch-
emia and damage covered the whole SSC  [18] . A key question is: what is happening 
in the area contralateral to the lesion during this functional compensation? 
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 A focal stroke increases the receptive field of the SSC not only in the peri-infarction 
area but also the area contralateral to the lesion  [8] . After focal stroke, uptake of glu-
cose (radio-labeled glucose;  18 F-FDG) is increased in the area contralateral to the le-
sion  [18] indicating that the neuronal (and/or glial) activity of the area is increased. 
This enhanced activity in the area contralateral to the lesion returns to normal levels 
by 4 weeks after stroke. What happens to the fine neuronal circuit structures in the 
contralateral SSC during this time of enhanced brain activity has been observed using 
the two-photon laser microscopy technique in vivo. The turnover of mushroom-type 
(stable) dendritic spines in the contralateral SSC was increased after stroke, but only 
at 1 week ( fig. 1 a)  [18] . This time-limited change in the turnover of spines is also seen 
in the case of stroke within the visual cortex  [19] . This restricted period of increased 
spine turnover is quite different compared with that of the peri-infarction area, where 
the turnover rate is high even 6 weeks after stroke  [16] . Mushroom spines are more 
stable compared to other spine types (thin and filopodial) being stable for more than 
a month, or even for a year, in the nonischemic healthy brain  [20, 21] . It has also been 
reported that such mushroom spines become more apparent in response to focal and 
repetitive neuronal circuit activation and a stimulus that mimics the induction of 
long-term potentiation  [22] . The conclusion is that mushroom spines seem to be nec-
essary for long-term memory and maintaining normal function of neuronal net-
works. Thus, an increase in the turnover of mushroom spines following stroke in-
duces some kind of adaptation in brain function. Interestingly, smaller spines tend to 
be preferentially eliminated in the contralateral SSC [Takatsuru and Nabekura, un-
publ. obs.] as observed in the SSC of a chronic pain model (enhanced afferent activity 
 [23] ). Thus, in readjusted neuronal networks, smaller (weak) synapses could be re-
placed by newly generated synapses. Note again that the increase in the turnover of 
mushroom spines in the contralateral area was only induced within 1 week after 
stroke, i.e. a limited time period.
 Following this transient increase in mushroom spine turnover, novel neuronal 
circuits appear that correlate with ipsilateral limb stimulation. For example, a nov-
el neuronal circuit is detected in the right SSC in the case of left SSC stroke that 
now responds to the (ipsilateral) right limb stimulation. This finding suggests that 
the increase in the early turnover of mushroom spine actually induces a change in 
the neuronal circuit that contributes to the remodeling of brain and functional re-
covery. After this neuronal circuit remodeling, bilateral processing of somatosen-
sory function is achieved in the intact hemisphere ( fig. 1 b). In the 2nd week after 
stroke, local application of 6-cyano-7-nitroquinoxaline-2,3-dione, a potent 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid type glutamate receptor 
antagonist, into the intact hemisphere prevents the behavioral response to stimula-
tion of both the right and left hind limb  [18] . Yang et al.  [24] reported an increase 
in mushroom spines in the motor and sensory cortices during motor training or 
somatosensory stimulation, respectively. In case of motor learning, the number of 
newly formed mushroom spines was correlated with the performance of motor co-
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 Fig. 1. Structural and functional remodeling in the cortex contralateral to infarction.  a Left: typical 
in vivo images of dendritic spines in the SSC taken during the first and second imaging sessions (6 h 
later). The arrows in the upper panels and the arrowheads in the lower panels show the appearance 
(gain) and disappearance (loss) of spine. Scale bars, 10 μm. The insets show higher-magnitude im-
ages (scale bars, 2 μm). Right: note that significantly greater gain (upper panel) and loss of spines 
(lower panel) in the SSC contralateral to infarction was limited at 1 week. Error bars represent ± SEM. 
n.s. = Not significantly different compared with both control and sham by the Bonferroni test; D = 
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ordination, and such newly formed mushroom spines had a long survival time. 
Similarly, in the case of functional recovery from stroke, the over 85% of mush-
room spines in the contralateral area newly formed during 2–7 days after stroke 
survived for 5 days or longer [Y. Takatsura and J. Nabekura, unpubl. data].
 Taken together, important structural and functional changes in the neuronal cir-
cuit occur in the area contralateral to a stroke lesion during a very limited time period 
(1 week) after stroke in the animal model ( fig. 1 ). It will now be important to correlate 
the time course of this sequence of changes (increased activity, increased mushroom 
spine turnover, neuronal circuit remodeling and functional recovery) to the improved 
outcome for human stroke patients.
 Correlation of Rehabilitation: Acute Is Best? 
 Rehabilitation is an important process for the recovery from, and/or compensation 
for, the loss of function following a focal brain injury. To prevent or reduce the sus-
tained loss of function, rehabilitation should be started as soon as possible after stroke. 
However, it is sometimes difficult to start the rehabilitation in the early post-stroke 
phase because of the necessity of acute medical care. Thus, when is the appropriate 
timing to start the rehabilitation? 
 The consensus from human imaging studies is that the most successful recovery 
occurs in individuals that exhibit relatively normal lateralized patterns of sensory ac-
tivation in the hemisphere in which the stroke has taken place. It is said that patients 
with larger strokes who often show bilateral cortical activation typically have less com-
plete recovery  [25, 26] . However, the timing of rehabilitation has not been reported 
in those cases and there is some possibility that less complete recovery was related to 
a delayed or inappropriate timing of rehabilitation.
 Animal studies indicate that many of the genes and proteins that are important for 
neuronal growth, synaptogenesis and the proliferation of dendritic spines are ex-
pressed at their highest levels during early brain development. Similarly, there is an 
increased expression of these genes for a limited period following stroke  [27, 28] . Fur-
thermore, animals given early rehabilitation resulted in significant recovery, whereas 
animals given delayed treatment exhibited little improvement. Notably, early enrich-
ment increased the dendritic branching of layer V cortical neurons, whereas enrich-
days; W = weeks.  b A focal infarction in the right SSC induced the appearance of new neuronal cir-
cuits in the left SSC. Current source density maps of electrical responses in the SSC (left), contralat-
eral to infarction in the right hemisphere, to stimulation of the left limbs. The dashed circle repre-
sents the spatial and temporal distribution of the strongest sink and source of the current source 
density. Note that the neuronal circuit activity in response to left limb stimulation in stroke mice 
gradually developed and became particularly distinct at 4 weeks. W = Weeks; D = days. Adopted and 
modified from Takatsuru et al. [18]. 
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ment that was delayed until 30 days after stroke had no effect  [10] . An early onset of 
rehabilitation achieves good clinical results  [29] . These data provide strong evidence 
for a critical period after stroke, during which the brain is most receptive to modifica-
tion by rehabilitative experience, and suggest that earlier therapy is better.
 As a precaution, other animal studies have shown that very early, intensive therapy 
may have detrimental effects and exacerbate brain injury through overuse of the af-
fected limb  [30, 31] . However, if we think about the timing of the structural plasticity 
in mice after stroke, mushroom spine turnover in the contralateral area is not seen 





























 Fig. 2. Schematic illustration of the time course of plasticity and remodeling of the contralateral (in-
tact) hemisphere following a stroke in mice, which can ultimately result in some compensation for 
the loss of sensory function. Immediately after a stroke in the SSC, the peripheral sensations from the 
side contralateral to the ischemic area are lost. During the acute post-stroke phase (within 2 days 
after stroke), the neuronal activity in the brain contralateral to infarction is increased (line 1). This 
increase in neuronal activity is followed by an increase in the turnover rate of mushroom spines in 
the intact SSC. This dendritic remodeling occurs during a limited time window, i.e. about 1 week 
(line 2). Subsequently, a new electrical pattern of neuronal circuits in response to ipsilateral sensory 
stimulation is gradually generated in the intact hemisphere (line 3). These new neuronal circuits con-
tribute to a compensation or recovery of behavioral function which had been impaired by the infarc-
tion (line 4). We propose that rehabilitation plans should account for these different post-stroke 
phases – making new synapses and/or using new synapses, reorganization of functional circuits – 
and thus, could differ depending on these time phases of remodeling. 
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 [18] . Hence, discrete rehabilitation strategies may have individual time windows dur-
ing the rehabilitation process after stroke. In mice, brain activity is high in the contra-
lateral area at 2 days after stroke, but not yet structurally adapted plastic (which is seen 
at 7 days). There seems to be an individual time window for any contralateral remod-
eling and functional recovery, such as a ‘making new synapses’ phase, a ‘using new 
synapses’ phase, and ‘reorganization of circuits’ function ( fig. 2 ). It is important to 
think about these specific time windows, and to assess more precisely ‘what happens 
during stroke recovery in mice’ may lead to advances in post-stroke care and reha-
bilitation. 
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 Abstract 
 Stroke is a leading cause of long-term disability with early accelerated followed by gradual recovery 
during the first 6 months after the ictus. The most important mechanism concerning early recovery 
is thought to be brain plasticity provided by anatomical and functional reorganization of the central 
nervous system after injury. Recent advances in noninvasive, functional brain imaging techniques 
provided some insight indicating the contribution of ipsilateral uncrossed corticospinal tracts in mo-
tor recovery after stroke. Since motor tracts vary considerably among subjects, the ratio of contra-
lateral corticospinal tract fibers and their interhemispheric control versus the amount and function 
of ipsilateral corticospinal tract fibers may affect the scale of motor recovery after stroke. Further 
studies are needed to clarify the mechanisms of motor recovery after stroke in humans. 
 Copyright © 2013 S. Karger AG, Basel 
 Brain injury after stroke causes damage to intrinsic neural networks affecting the func-
tion of motor, sensory, cognitive and other functional domains. Motor dysfunctions 
including dysphagia, hemiparesis and gait disturbance are important aspects of activities 
of daily living and affect the long-term psychosocial welfare. It is well known that some 
deficits, such as hemiparesis or imbalance, often recover spontaneously, suggesting that 
inherent plasticity within neural networks compensates for lost motor function. 
 While many patients achieve independence in their activities of daily living after 6 
months, the most significant recovery in motor function happens within the first 
month regardless of the initial stroke severity. Mild to moderate stroke patients re-
cover within the first month, while moderate to severe stroke patients continue to 
recover for prolonged periods after stroke  [1] .
 Several mechanisms have been proposed to explain the pattern of recovery after 
stroke. We believe that the main mechanism implicated in early recovery after 
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stroke is an inherent blueprint  of pre-existing anatomical pathways and functional 
rearrangement of networks within the central nervous system. This rebuilding 
 process may involve various mechanisms, including (1) redundant pathways that 
 perform similar functions being able to substitute one another if one pathway has 
been damaged, (2) unmasking of silent pathways, and (3) sprouting of fibers from 
surviving neurons with formation of new synapses  [2–4] . The temporal profile 
of recovery observed very likely reflects the variant mechanisms involved. Short-
term changes are probably related to functional enforcement of existing circuits, 
such as unmasking of silent synapses  [5, 6] , whereas long-term changes involve 
other  processes, such as axonal regeneration or synaptic sprouting. When damage 
to the system is only partial, complete recovery may occur within the system. More 
extensive damage, however, requires the recruitment of a functionally related 
 system.
 Role and Plasticity of the Pyramidal Tract 
 The pyramidal tract, which is mainly involved in motor function, consists of descend-
ing nerve fibers that originate in the cerebral cortices (Brodmann’s areas 4, 6 and oth-
ers) and extend longitudinally through the bulbar pyramid into the spinal cord. Ana-
tomically, 75 and 90% of the corticospinal fibers cross the midline in the lower me-
dulla or upper cervical cord forming 3 separate corticospinal tracts on each side  [7] . 
The largest one is, naturally, the lateral corticospinal tract that crosses in the medul-
lary decussation and extends caudally in the dorsolateral fasciculus to the last sacral 
segment. The fibers of this tract terminate mainly on the ipsilateral motoneurons of 
the ventral horn of the spinal cord. The anterior or ventral corticospinal tract consists 
of fibers that do not cross in the medullary decussation and extend caudally only un-
til the upper thoracic cord. These fibers are known to decussate at various levels of the 
cervical cord through the anterior white commissure to largely terminate on contra-
lateral motoneurons within the medial portion of the ventral horn. Additionally, a 
third uncrossed corticospinal tract, which varies individually in size and may be a 
compact, well-delineated tract, is known to exist  [7] . Whereas the function of this 
third tract has not been elucidated, it may be dormant, and activated only in case of 
damage to the central motor control system. We speculate some role within early mo-
tor recovery after stroke in humans. 
 It is well established that motor recovery in children goes beyond that seen in 
adults. In fact, prenatal brain damage, such as congenital hemiplegia, induces exten-
sive reorganization of the corticospinal tract particularly of transient projections to 
the ipsilateral spinal cord. Studies using transcranial magnetic stimulation (TMS) 
 revealed that topographic rearrangement of representations from the primary motor 
cortex occurs in both, paretic and nonparetic limbs in patients with congenital hemi-
plegia  [8, 9] .
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 Preserved Ipsilateral Corticospinal Tract Function Is a Plausible Mechanism of 
Motor Recovery after Stroke 
 Brain plasticity implies adjustment of neural function over time, which in turn results 
in behavioral adaptation after brain injury. Behavior-related plasticity can be quanti-
fied by repeated computation of the distribution of neural activity following sequen-
tial task repetitions. Comparison of patterns of activation as a function of time iden-
tifies brain areas in which time-related modification of activity appears. This concept 
has been applied to functional brain imaging studies examining changes of brain 
function during the acquisition of motor skills  [10] . Similarly, the recovery of brain 
function after stroke has been studied using noninvasive functional imaging tech-
niques, such as positron emission tomography, functional magnetic resonance imag-
ing (fMRI) and electrophysiological techniques represented by TMS. In the early 
1990s, the significance of bilateral cerebral and cerebellar regional activation involv-
ing the ipsilateral sensorimotor cortex and motor pathways in motor recovery of 
stroke patients was discovered  [11–13] . Technological improvements in MRI meth-
odology made fMRI the predominating functional brain study since the late 1990s. 
The principle of fMRI is based on blood oxygenation levels in comparable brain re-
gions between rest and activated states. When neurons become active, local blood 
flow to those brain regions increases, and oxygenated blood displaces deoxygenated 
blood around 2 s later. This rises to a peak over 4–6 s before falling back to the orig-
inal level (and typically undershooting slightly). Deoxygenated hemoglobin is para-
magnetic as opposed to oxygenated hemoglobin being resistant to magnetism. This 
difference leads to an improved MR signal that can be mapped to reveal which neu-
rons are active at a time. Using blood-oxygenation-level-dependent technology, it 
could be shown that the contralateral primary sensorimotor cortex is activated dur-
ing passive movement of the paretic limb in patients with hemiparetic strokes  [14] . 
The results indicated that in patients recovering from hemiparesis contralateral mo-
tor pathways became involved in the reorganization of motor function possibly in-
volving the contralateral brain regions via uncrossed corticospinal tracts or other 
indirect uncrossed pathways. In contrast, stroke patients with infarcts not involving 
the primary motor cortex exhibit a linear relationship between recovery scores and 
task-related brain activation in many parts of the associated motor system  [10] . It can 
be speculated that differences among patients are likely the result of variable ana-
tomical damage and cognitive parameters such as motivation, concentration and at-
tention. Moreover, TMS studies revealed that motor evoked potential amplitude cor-
relates with the extent of hand motor recovery after subcortical stroke when stimu-
lating the affected side of the cerebral cortex  [15, 16] . In summary, motor recovery is 
best when motor cortices remain structurally preserved, functionally connected, and 
can magnify information processing. While there is no doubt about the contribution 
of cerebral reorganization to functional recovery after stroke, the processes and fac-
tors affecting it remain elusive. A detailed sequential analysis of stroke patients re-
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covering from motor deficits with highly sophisticated functional imaging tech-
niques may help to reconcile therapeutic strategies to enhance motor recovery in the 
future. 
 Role of the Ipsilateral Corticospinal Tract in Patients with Motor Recovery 
after Stroke 
 Recently, several patients with a prior recovered hemiparesis after stroke were report-
ed to experience worsening of their motor function after a new contralateral stroke 
recurrence. The important unifier is the lesion site in all these cases  [17–20] . These 
cases reveal that the ipsilateral, uncrossed corticospinal tract may have helped to com-



























Ago et al. [18], 2003 59 male Lt hemiparesis Rt IC + basal 
ganglia
hemorrhage
Song et al. [19], 2005 62 female Lt hemiparesis Rt IC +
thalamus
hemorrhage
41 male Lt hemiparesis Rt CR infarction
Yamamoto et al. [20],
2007
74 male Rt hemiparesis +
aphasia
Rt CR infarction










Our case, 2013 83 female Lt hemiparesis Rt CR infarction
 SA = Stroke attack; Rt = right; Lt = left; mRS = modified Rankin Scale score; IC = internal capsule; CR = corona 
radiata; T-P = temporoparietal; O = occipital; F-P = frontoparietal.
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pensate motor recovery after the earlier stroke.  Table 1 shows the previous case re-
ports including a patient that we recently investigated.  
 In what follows, we will present the features of this patient in more detail. An 
83-year-old right-handed female with hypertension was admitted to our institute 
(National Cerebral and Cardiovascular Center) because of suddenly developed left 
hemiparesis, dysarthria and sensory disturbance; 1.5-tesla MRI revealed an acute 
small infarcted lesion in the left corona radiata on diffusion-weighted images ( fig. 1 a). 
Previously, the patient had experienced left hemiparesis caused by right corona ra-
diata infarction as shown on a brain computed  tomography scan ( fig 1 b). The previ-
ous left hemiparesis fully recovered within several months after the first stroke, and 
no residual motor weakness remained. Her recurrent left hemiparesis recovered 
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Anterior corticospinal tract Anterolateral corticospinal tract of Barnes Lateral corticospinal tract
 Fig. 1.  a, b Our patient’s neuroimages.  a Diffusion-weighted image reveals the recent infarct lesion 
in the left corona radiata (arrow).  b Brain computed  tomography scan reveals the past infarct lesion 
in the right anterior corona radiata (arrow).  c A plausible mechanism of motor recovery in our pa-
tient. The right pyramidal tract had been damaged in the corona radiata at the initial infarction and 
left hemiparesis occurred (A). However, her motor deficit was fully recovered by the compensatory 
role of the left, contralesional corticospinal tract (B). Recently, a second infarction damaged the left 
corticospinal tract in the left corona radiata, resulting in left hemiparesis (C). Rt = Right; MO = me-
dulla oblongata; CST = corticospinal tract. 
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suspect that the left hemiparesis caused by the first stroke at the right corona radiata 
recovered completely due to the compensation with the uncrossed left-sided corti-
cospinal tract. During the second stroke at the left corona radiata, the compensating 
uncrossed left-sided corticospinal tract was damaged, and hence left hemiparesis 
again manifested. Interestingly, the patient did not show right hemiparesis during 
the second stroke in spite of damage to the left corona radiata. Presumably, the sec-
ond stroke affected only the left-sided uncrossed corticospinal tract and did not in-
volve crossing the corticospinal tract controlling right motor function ( fig. 1 c).
 Several possible explanations have been proposed in terms of the relationship of the 
ipsilateral corticospinal tract with motor recovery following stroke. (1) The ratio of 
uncrossed corticospinal fibers in the whole pyramidal tract seems to vary between 10 
and 25%, but there is considerable variability of the ratio  [7] . A higher ratio may cor-
respond to a superior recovery of hemiparesis after stroke. Reports of ipsilesional 
hemiparesis after cerebral injury in some patients imply the possibility of primarily 
dominant ipsilateral corticospinal fiber architecture  [21, 22] . (2) The lesion size and 
topography of brain injury are crucial for motor recovery. At least 60% of neural fibers 
of the pyramidal tract originate in the primary motor cortex, premotor frontal and 
supplementary motor areas. Most of the corticospinal fibers from the primary motor 
cortex cross at the decussation, while corticospinal fibers from premotor, frontal and 
supplementary motor cortices connect with the ipsilateral primary motor cortex, con-
tralateral homologous areas, and to various levels of the spinal cord via both sides of 
the corticospinal tract  [23] . Furthermore, premotor frontal and supplementary motor 
areas promote reticulospinal tract function via rich projection from those cortical areas 
to brainstem reticular formation  [24] . Fibers of the reticulospinal tract descend to the 
spine and send axonal branches to spinal gray matter to control proportional move-
ments of proximal limb muscles. Motor deficit caused by the localized lesion at the 
primary motor cortex is considered to show good recovery in adults as well as children. 
(3) The activity of motor cortices can be modulated via transhemispheric connection 
to the contralateral motor cortices  [25] . Low-frequency repetitive TMS applied to the 
motor cortex inhibits motor cortical excitability in the homonymous motor represen-
tation of the opposite hemisphere. Therefore, the presence of a balance of reciprocal 
inhibitory projections between both hemispheres has been proposed. Recent studies 
have suggested that this balance is disturbed during voluntary movement of the pa-
retic hand in patients with cortical infarcts. Specifically, more severely paretic patients 
demonstrate greater interhemispheric inhibition between the primary motor cortices 
than those less affected  [26] . Therefore, it is conceivable that decreasing the inhibiting 
effect of the ipsilateral, intact, motor cortex may enhance motor recovery of the pa-
retic hand. Recent case studies have revealed that inhibitory regional TMS of the unaf-
fected hemisphere is effective even in chronic stroke patients with severe motor deficits 
 [27] . Similarly, regional TMS of the contralesional primary motor cortex can improve 
motor function in patients with subcortical infarction, presumably by balancing neural 
activity in both hemispheres documented by fMRI  [28] . The durability of these effects 
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 Abstract 
 Stem cells possess a definitive role in neuronal rejuvenation following a cerebral injury. Whether 
endogenous, from the neurogenic niches of the subventricular zone and subgranular zone, or re-
cruited from the bone marrow through peripheral circulation, accumulating evidence demonstrates 
that stem cells ameliorate the consequences of cerebrovascular events, particularly cerebral isch-
emia. In this chapter, we review milestone studies implicating the role of stem cells in response to 
disease. Furthermore, we outline specific mechanisms of action along with their clinical potential as 
therapeutic treatments for ischemic stroke.  Copyright © 2013 S. Karger AG, Basel 
 The idea that stem cells may reconstitute regions of neuronal damage has prompt-
ed much research interest in using bone marrow (BM) as a donor source for trans-
plantation therapy in neurological disorders, notably stroke. The heterogeneous 
mixture of cells populating the BM includes: hematopoietic stem cells (HSCs), mes-
enchymal stem cells (MSCs), endothelial progenitor cells (EPCs), and very small 
embryonic-like stem cells (VSELs). A collection of in vivo and in vitro research 
suggests these cells may mobilize into the peripheral blood (PB) upon cerebro-
vascular injury and respond by secreting essential growth factors for survival  [1] , 
along with possibly undergoing neuronal differentiation on exposure to inducing 
regimens  [2] . 
 As stroke remains a primary cause of death worldwide, this chapter pursues the 
possibility of the aforementioned cell lines to afford brain plasticity and remodeling 
 [3] . In the clinic, minimally invasive intravascular transplantation is an appealing 
approach for stem cell therapeutic measures. However, this scheme requires con-
certed mechanisms to ensure that cells, or their secreted therapeutic molecules, 
 Regeneration of Neuronal Cells following 
Cerebral Injury 
 Travis Dailey  • Naoki Tajiri  • Yuji Kaneko  • Cesar V. Borlongan 
 Department of Neurosurgery and Brain Repair, University of South Florida College of Medicine, 
 Tampa, Fla. , USA 
Naritomi H, Krieger DW (eds): Clinical Recovery from CNS Damage.
Front Neurol Neurosci. Basel, Karger, 2013, vol 32, pp 54–61  (DOI: 10.1159/000346407 )
 Regeneration of Neuronal Cells following Cerebral Injury 55
reach the site of injury. The mechanisms involved in migration, homing, isolation, 
and the potential therapeutic effects of these cells will be discussed within this 
theme.
 Hematopoietic Stem Cells 
 In addition to the defining feature of repopulating ablated BM  [4] , HSCs can also 
migrate to PB in response to injury. During homeostasis, HSCs are quiescent and low 
in number, a characteristic attributed to chemokine regulation. Yet, in response to 
injury, these cells can become motile, with increased migration into blood circulation 
 [5] . Stromal cell-derived factor 1 (SDF-1; also termed CXCL12) contributes to an es-
sential chemoattractant pathway via the receptor CXCR4  [5] . When SDF-1 is active, 
HSCs cross the endothelial blood-BM barrier and populate the PB  [6] . The SDF-1/
CXCR4 interface is highly expressed in several stem cell niches, notably the brain 
endothelium  [7] . With the central nervous system (CNS) contributing to HSCs mo-
tility, conditions of stress (i.e. stroke) can amplify recruitment of HSCs into the brain 
 [4, 5] . 
 One such mechanism of CNS control in the migration of BM-derived HSCs is the 
induction of cytokines. Recently proposed, the neurotransmitter catecholaminergic 
signaling pathway may promote HSC mobilization through sympathetic secretion 
into the blood or via a more paracrine fashion from the BM nerve endings  [4, 8] . This 
neurotransmitter-mediated interaction is bidirectional. Accumulating evidence sug-
gests human HSCs can affect the nervous system and modulate its action. The homing 
of BM-derived stem cells through the catecholaminergic system involves multiple 
signaling pathways, including Wnt and β-catenin, as well as specific migratory mol-
ecules, such as membrane-bound enzyme MT1-MMP and SDF-1, which all contrib-
ute to proliferation, increased motility, and engraftment capability of CD34 HSCs  [8] . 
In terms of clinical stroke data, it is noted that following human acute stroke, the ex-
tent of PB immature hematopoietic CD34+ (HSCs) mobilization directly correlates 
with the recovery of function  [9] . Following neurorestorative events such as neoan-
giogenesis, the upregulation of SDF-1 within ischemic tissue will recruit CXCR4+ 
HSCs from PB.
 HSC mobilization may also serve an integral role in early host repair mecha-
nisms for many other neurological disorders. Endogenous reparative responses 
have been seen in pathological conditions such as: elevated BM CD34+ HSCs ac-
companying chronic spinal cord injury, cord blood (CB) CD34+ cells reducing heat 
stress symptoms upon injection, delays in disease progression of amyotrophic lat-
eral sclerosis upon injection of human CB mononuclear cells into mice, and CB 
mononuclear injection decreasing β-amyloid deposits in animal Alzheimer models. 
With the experimental evidence surmounting, influence of the CNS in the mobili-
zation of HSCs suggests potential for the maintenance and repair of the nervous 
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system upon insult. Furthermore, HSCs have been proposed as an ideal donor graft 
source because of their safety and efficacy profile in the clinical treatment of other 
diseases  [10] .
 Mesenchymal Stem Cells 
 MSC transplantation has been utilized in experimental stroke models and demon-
strates improvement in functional recovery of neurological deficits induced by cere-
bral ischemia. The following sections within this topic will expand upon potential 
mechanisms that may mediate the therapeutic effect of MSCs in cerebrovascular 
 incidents. 
 The proposition of stem cell differentiation into neuronal cells remains controver-
sial. Upon transplantation, via intravenous, intracarotid, or intracerebral delivery, the 
graft survival is modest at best, therefore adequate levels for differentiation seem  unlikely 
 [11] . A more plausible mechanism involves the production of trophic factors such as: 
hepatocyte growth factor (HGF), vascular endothelial growth factor, nerve growth 
 factor, brain-derived neurotrophic factor, basic fibroblast growth factor ( FGF-2), and 
insulin growth factor 1, which may each activate ischemic brain endogenous repair 
through particular mechanisms  [12] . For example, early increases (1 h after stroke) 
could increase blood-brain barrier (BBB) leakage, exacerbating ischemic cell damage, 
but when administered 48 h after stroke, vascular endothelial growth factor could en-
hance angiogenesis in the ischemic border zone to improve recovery  [13] .
 HGF has demonstrated an influential role in vascularization. Upon treatment with 
HGF, the amelioration of BBB destruction without exacerbating cerebral edema, de-
creased intracranial pressure, and induction of angiogenesis have all been reported. 
Although it seems unlikely that MSCs differentiate into neurons themselves, research 
indicates that transplantation with MSCs may promote migration and induction from 
subventricular zone and subgranular zone neurogenic sites within the brain to regions 
of ischemia  [12] . This process of neurogenesis appears to be regulated by the neuro-
trophic factors being secreted by the transplanted MSCs.
 A limitation of human MSCs is their lack of telomerase activity, leading to a popu-
lation doubling of approximately 18, with decreased expectations upon passaging of 
the stem cells  [14] . A mechanism to circumvent this issue is the use of retroviral trans-
fection of human HSCs with the human telomerase gene, termed hTERT-MSCs  [15] . 
Expanding gene manipulation of human MSCs, transfection of genes such as FGF-2, 
HGF, and brain-derived neurotrophic factor has also been incorporated into hTERT-
MSCs before transplantation to extend and increase neurotrophic efficacy  [15] .
 As an alternative to genetic manipulation, studies have also utilized trophic factors 
as adjuvants with MSC delivery. Studies show that transplantation with brain-derived 
neurotrophic factor markedly improved stroke recovery in the animal models  [16] . 
The use of other adjuvants, such as cell-permeable inhibitor of caspases (Z-VAD), 
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enhances graft survival and behavioral recovery when intracerebrally infused with 
MSCs into the region of ischemia  [17] . Additionally, intravenous infusion of MSCs 
with a nitric oxide donor (DETA/NONOate) demonstrates enhancement of vessel 
perimeter and endothelial cell proliferation, leading to improved functional recovery 
in stroke animals  [18] . Nitric oxide donor adjuvants have also contributed to in-
creased subventricular zone neurogenesis alongside vascular endothelial growth fac-
tor and basic fibroblast growth factor expression within ischemic regions  [18] . The 
use of grafted MSCs may also impart benefits by way of glial cell proliferation includ-
ing neuron remyelination as well as synaptogenesis and a reduction in apoptosis. 
 As previously mentioned, the SDF-1/CXCR4 chemoattractant pathway serves as a 
homing signal for stem cell populations. In the nonhematopoietic system, SDF-1 sim-
ilarly serves as a signal from injured organs to influence migration of CXCR4 cells. 
SDF-1 expression is regulated by the hypoxia-responsive transcription factor HIF-1 
(hypoxia-inducible factor 1). With transplanted MSCs expressing CXCR4, the SDF-1 
gradient pattern associated with the hypoxia gradient provides a signal for attracting 
both HSCs and nonhematopoietic stem cells  [19] to migrate from the periphery to the 
site of ischemic injury.
 Endothelial Progenitor Cells 
 Although hematopoietic in origin, EPCs can be found in the PB of adults on the one 
hand as well as derived from umbilical cord blood (UCB). In pioneering studies, 
transplanted EPCs isolated from human UCB, populated endothelial neovasculariza-
tion in regions of ischemia. The ability of EPCs to participate in re-endothelialization 
during neovascularization makes EPCs an exceptional candidate for management of 
cerebrovascular disease. 
 Currently, EPCs display a variety of markers for isolation such as: CD31, VE-cad-
herin, E-selectin, eNOS, and von Willebrand factor  [20] ; however, substantial evi-
dence suggests that only the CD34+ EPCs from BM or UCB are capable of differenti-
ating into mature endothelium  [21] . A contributing factor to the lack of clearly de-
fined methods for cell isolation may be the rare prevalence of EPCs in adult PB 
(0.01%). Until recently, neovascularization, the formation of new blood vessels, was 
thought to occur exclusively from proliferation and migration of pre-existing endo-
thelial cells; this process is known as angiogenesis. Juxtaposing neovascularization, 
vasculogenesis (also known as vascularization) is the differentiation of endothelial 
cells from precursor cells and was thought to only occur in the embryo during devel-
opment. Yet, current evidence suggests that BM-derived EPCs in circulation are ca-
pable of homing to neovascularization sites for proliferation and differentiation of 
subsequent endothelial cells  [22] .
 Over the last few years, clinical research has suggested that circulating EPCs as a 
biomarker may predict clinical outcome of cardiovascular disease, with low EPC 
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counts correlating to more severe functional impairments. Expanding upon this ob-
servation, clinical studies have also been initiated to assess the higher risk for athero-
sclerotic events in populations with lower EPC numbers. In terms of clinical applica-
tions for neurovascular disease, the observational studies are limited and with notable 
discrepancies.
 The primary mechanisms of stroke pathogenesis remain unclear; however, there is 
mounting evidence that implicates an immunological attack upon the brain and/or 
its vasculature, which provides a novel therapeutic stroke target involving EPCs. This 
immunological attack could result in altered interendothelial junction integrity, lead-
ing to vascular endothelial damage and breakdown of the BBB. Therefore, restoration 
of this barrier through EPC therapy may serve to abrogate the consequences of stroke 
pathogenesis.
 Very Small Embryonic-Like Stem Cells 
 Present in a variety of adult organs, specifically the brain, VSELs express several 
progenitor stem cell markers. These very tiny stem cells can be mobilized into the 
PB following tissue and organ injuries. Human VSELs, smaller than an erythrocyte, 
belong to the nonhematopoietic fraction of leukocytes (Lin-/CD45 cells) expressing 
CD34, CD133, and CXCR4 antigens  [23] . Due to their low constitution of PB, 
 special flow cytometric protocols have been established for identification. VSEL 
phenotypic markers include: CD45 (mouse and human), positive expression of 
 Sca-1 (mouse), CXCR4, CD133, and CD34+ (mouse and human), positive progen-
itor stem cell markers (i.e. Oct-4, Nanog, and SSEA), and express markers of 
 epiblast/germ line stem cells  [23] . In addition to PB, purified VSELs can be isolated 
from BM. 
 With the notion being that VSELs are epiblast-derived stem cells deposited early 
in embryonic development, these stem cells may present as a good candidate for tis-
sue rejuvenation and regeneration. The ease of harvesting should also be considered 
as a therapeutic potential. The patients’ own BM, stored UCB, and mobilized PB are 
sources readily accessible in harvesting VSELs for autologous transplantation. With 
respect to allotransplantation, histocompatible-related or unrelated donors could 
serve as another source. Yet, despite the ease of harvesting these cells, expansion strat-
egies must be employed due to the relatively low number of cells yielded.
 Treatment strategies for the acute and subacute stage (time 0–1 week after injury) 
appear to provide the best opportunity to initiate therapeutic intervention. Due to this 
immediate need for intervention, purifying these cells from BM aspirates, UCB, or 
mobilized PB through multiparameter staining and regular high-speed sorting may 
not be feasible  [24] . To counter this challenge, the Ratajczak group  [25] proposed a 
relatively short and economical three-step method for isolation that allowed approx-
imately 60% recovery of the initial number of Lin–/CD45–/CD133+ UCB-VSELs. 
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This novel procedure takes 2–3 h per UCB unit (ideally applicable using BM aspirates 
as well as mobilized PB) and should produce VSELs freshly isolated from BM, PB, or 
UCB that are precommitted to neurological lineage in ex vivo cultures  [25] .
 Conclusion 
 The developmental biology research elucidating stem cell plasticity has served as the 
impetus for advancing regenerative medicine in many neurological disorders, includ-
ing stroke. Some of the most commonly explored cell lines include: HSCs, MSCs, 
EPCs, and VSELs, all with specific therapeutic potential. Each of these cell lines does, 
however, impart its own individual challenges. 
 The ability of HSCs to develop into differentiated neurons has yet to be deter-
mined. Opposing this notion, transdifferentiation may be explained as a transient 
change in phenotypic expression induced by neural tissue-derived spherical mem-
brane fragments called microvesicles. These fragments, also termed exosomes, may 
transfer neural cell surface receptors, mRNA, and miRNA to the HSCs employed for 
regeneration  [26] .
 An emerging concern in the use of MSCs involves the potential to cause neoplastic 
tumor formation upon deposition into the brain. Similar to the initial impression of 
HSC differentiation, it was challenged whether MSCs are able to develop into neuro-
nal cells. One possible explanation for this finding was in vitro contamination in the 
cell culture media that may alter the morphology of MSCs  [27] . Therefore, the work-
ing postulate is that, upon homing of the stem cell to the site of injury, the production 
of trophic factors influences the microenvironment. Evidence that grafted stem cells 
do not persist after delivery and are rapidly eliminated supports this proposal.
 More recently, my research group has explored EPC transplantation for repair of 
the BBB after stroke  [28–30] . The working hypothesis suggests that tissue plasmino-
gen activator may exacerbate the breakdown of the already vulnerable BBB. Current-
ly, much of the stroke therapy implemented does not consider the capacity of BBB 
damage after stroke. It is our contention that if EPC transplantation promotes resto-
ration of the vascular endothelium, the clinical effects could be far reaching and sub-
stantially help a large population of patients that may be excluded from the current 
3-hour guideline for tissue plasminogen activator.
 Lastly, another appealing therapy for stroke is the use of VSELs. A prominent re-
striction in cell therapy is their ability to cause embolism, especially accompanying 
the large quantity necessary for a therapeutic effect. This caveat makes the use of 
VSELs appealing. Because the isolation and expansion of this cell line may be more 
tedious and longer, the use of allogenic transplants and faster expansion protocols are 
to be considered.
 In summary, the plethora of accumulating stem cell research is quickly translating 
into clinical trials. The use of HSCs, MSCs, EPCs, and VSELs all appear to provide 
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specific insight into treating neurological disease from many facets. However, it is im-
portant to acknowledge that these mechanisms are yet to be fully determined and 
there is still a gap in our translational laboratory-to-clinic understanding of stem cell 
therapy. Therefore, as the research transcends theory and progresses into treatment, 
we must ensure that systematically designed preclinical studies precede initiation of 
clinical trials to allow rigorous investigations as to the safety and efficacy of these stem 
cells. 
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 Abstract 
 There is increasing evidence that the transplanted bone marrow stromal cells (BMSC) significantly 
promote functional recovery after central nervous system (CNS) damage in the animal models of 
various kinds of CNS disorders, including cerebral infarct. However, there remain several challeng-
es before considering BMSC transplantation for patients with ischemic stroke. In this review, 
 therefore, the authors discuss what should be clarified to establish cell transplantation therapy in 
the clinical setting and describe their scientific contributions in this matter. The BMSC have the 
ability to alter their gene expression profile and phenotype in response to the surrounding envi-
ronment and to protect the neurons by producing certain neurotrophic factors. They also promote 
neurite extension and rebuild the neural circuits in the injured CNS. The BMSC can be expanded 
in vitro using the animal serum-free medium. Pharmacological modulation may accelerate the 
in vitro proliferation of the BMSC. Using in vivo optical imaging technique and MRI, the transplant-
ed BMSC can noninvasively be tracked in the living animal for at least 8 weeks after transplanta-
tion. It is urgent to develop a clinical imaging technique to track the transplanted cells in the CNS 
and  evaluate the therapeutic significance of BMSC transplantation in order to establish it as a 
definite therapeutic strategy in the clinical setting in the future. 
 Copyright © 2013 S. Karger AG, Basel 
 Ischemic stroke still has a high incidence all over the world and can oftentimes cause 
long-standing disability. There are a few if any drugs that are effective to protect or 
repair the central nervous tissue (CNS) tissue in the clinical setting in spite of numer-
ous numbers successful applications in animal models  [1] . However, recent discover-
ies strongly suggest that cell transplantation therapy may promote functional recov-
ery after various kinds of CNS disorders, including ischemic stroke. A variety of cell 
types have been studied as cell source of transplantation in animal models of CNS 
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disorders, including embryonic stem cells, neural stem cells, induced pluripotent 
cells, and bone marrow stromal cells (BMSC). Of these, the BMSC may have the most 
enormous therapeutic potential, because they can be harvested from the patients 
themselves without posing ethical or immunological difficulties  [2, 3] . Although the 
results obtained from basic research are quite encouraging, a variety of questions or 
problems still remain to be solved  [4, 5] . In this review, we present recent progress in 
basic and translational research on the field of BMSC transplantation for ischemic 
stroke, and critically discuss what should be clarified to establish BMSC transplanta-
tion therapy as a scientifically proven method in the clinical setting. 
 Basic Aspects of Bone Marrow Stromal Cell Transplantation 
 There is increasing evidence that the transplanted BMSC enhance functional recovery 
by differentiating into the neural and endothelial cells and/or by producing various 
kinds of cytokines or growth factors that can restore the host neurons  [5, 6] . They dif-
ferentiate into fat, bone, and cartilage, but can also transdifferentiate into embryo-
logically unrelated tissues, including neural cells  [7, 8] . It may sound strange that the 
BMSC have the ability to differentiate into neural cells. However, the BMSC per se 
express the genes related to neuronal and glial cells  [9] . They can also have the poten-
tial to modify their gene expression profile under certain experimental conditions  [9] 
and start to differentiate into neurons without evidence of cell fusion  [6] . Further-
more, the BMSC are also known to produce some neuroprotective or neurotrophic 
factors and support the survival of the host neural cells  [10] . It is quite close to their 
primary function that BMSC generally support the homing and proliferation of the 
hematopoietic cells in the bone marrow  [11] . The conditioned medium of BMSC sig-
nificantly promotes neurite outgrowth from the dorsal root ganglion  [12] . More in-
terestingly, when the BMSC are co-cultured with the neurons exposed to glutamate, 
they significantly increase their release of soluble neuroprotective factors such as 
nerve growth factor and brain-derived neurotrophic factor and ameliorate the neuro-
nal injury  [6] . According to these observations, the BMSC may consist of heteroge-
neous cell populations and protect and/or repair the damaged CNS through multiple 
mechanisms  [6] . 
 Recent in vivo studies have gradually elucidated their actions in the injured brain. 
According to new research, the engrafted BMSC maintain their aggressive prolifera-
tion property even after intracerebral transplantation into the infarct brain  [13] . They 
migrate towards the infarct tissue through chemokine systems such as monocyte che-
moattractant protein 1, stromal cell-derived factor 1 and hepatocyte growth factor 
 [14–16] . Numerous numbers of experimental studies have proven that the engrafted 
BMSC express the proteins specific for neurons, astrocytes, and endothelial cells in 
the peri-infarct area  [17–20] . Alternatively, they may support the survival of the host 
neurons through their paracrine production of soluble factors (see above).
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 However, it still remains to be defined how the engrafted cells contribute to func-
tional recovery after cerebral infarct. A recent study has shown that the engrafted 
BMSC express γ-aminobutyric acid receptor and improve the binding potential for 
 125 I-iomazenil in the peri-infarct area  [21] . They also improve glucose metabolism in 
response to sensory stimuli when transplanted into the rat cold injury model  [22] . 
Furthermore, an  18 F-fluorodeoxyglucose PET study has very recently shown that the 
BMSC markedly improve the recovery of glucose metabolism in the peri-infarct 
 neocortex, when stereotactically transplanted into the infarct brain at 7 days after 
ischemia  [23] .
 According to a recent study by Liu et al.  [24] , the BMSC may enhance axonal 
sprouting from the survived cortical neurons in the peri-infarct area. Furthermore, 
Chiba et al.  [25] have recently found that the BMSC are integrated into the neural cir-
cuits of the host spinal cord and promote functional recovery. These biological prop-
erties of BMSC may play a key role in the enhancement of functional recovery after 
ischemic stroke.
 Translational Aspects of Bone Marrow Stromal Cell Transplantation 
 As described above, the observations in basic experiments are quite encouraging, 
and some clinical trials of BMSC transplantation have already been started in pa-
tients with ischemic stroke. Bang et al.  [26] intravenously injected autologous BMSC 
into 5 patients with severe neurological deficits due to ischemic stroke at 5–9 weeks 
after the onset, and preliminarily concluded that autologous BMSC infusion is a 
feasible and safe therapy that may improve functional recovery. Honmou et al.  [27] 
intravenously transplanted BMSC into 12 patients with ischemic stroke 36–133 days 
after stroke. Very recently, Lee et al.  [28] performed an open-label, observer-blind-
ed clinical trial of 52 patients with ischemic stroke, and followed them up for up to 
5 years. These authors conclude that intravenous transplantation of autologous 
BMSC could be a safe and effective strategy for ischemic stroke.  
 However, there are many variables that may affect the efficacy of BMSC transplan-
tation in the clinical setting. They include donor cell factors (safety, autologous or al-
logeneic, ex vivo cell expansion), patient factors (age, stroke type), treatment factors 
(interval since onset, delivery route, cell dose), and validation factors (neurological 
assessment, imaging)  [29, 30] .
 First, allogeneic cells permit ‘off the shelf’ use even within 24 h after onset, but 
they imply long-term medication of immunosuppressants. Autologous BMSC from 
patients themselves would be ideal as donor cells for restorative medicine, but re-
quire several weeks for ex vivo expansion. Therefore, it should be scientifically prov-
en that the BMSC can enhance functional recovery after ischemic stroke even when 
transplanted several weeks after the onset. More importantly, it would be critical to 
establish a feasible protocol to ‘safely and rapidly’ expand the BMSC. Thus, BMSC 
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have been cultured in medium including fetal calf serum (FCS) in the majority of 
animal experiments and even clinical trials  [26] . However, FCS carries the potential 
risk of prion, viral, or zoonoses contamination. Alternatively, autologous serum is 
employed to expand the BMSC, but this may require a large amount of serum  [27] . 
Very recently, human platelet lysate has been proven useful to expand BMSC as an 
alternative substitute. The human BMSC expanded with the FCS-free, platelet ly-
sate-containing medium retain their capacity of migration, survival and differentia-
tion, and significantly promote functional recovery when stereotactically trans-
planted into the infarct brain. Therefore, platelet lysate may be a clinically valuable 
and safe substitute for FCS in expanding human BMSC to regenerate the infarct 
brain  [17, 20, 31] .
 Second, BMSC were transplanted within 24 h or 7 days after the insult in the 
majority of animal studies, whereas they were usually transplanted several weeks 
(or even several months) after stroke onset in previous clinical trials  [26–28] . In 
order to resolve this problem, pharmacological modulation may be useful to pro-
mote in vitro proliferation of cultured BMSC to shorten the interval between stroke 
onset and cell therapy. For example, granulocyte colony-stimulating factor signifi-
cantly enhances the proliferation and growth factor production of the cultured 
BMSC and accelerates functional recovery by BMSC transplantation into the in-
farct brain  [32] . Such pharmacological modulation would be essential in consider-
ing autologous stem cell therapy for older patients with ischemic stroke, because 
adult stem cells, including BMSC, suffer from ageing effects and reduce their self-
renewal and differentiation capacity  [33] . A very recent study has also demonstrat-
ed that granulocyte colony-stimulating factor significantly promotes the prolifera-
tive capacity of BMSC harvested from the aged rats  [34] . These observations should 
be taken into consideration when establishing the treatment protocol in the clinical 
setting.
 Third, the BMSC can be transplanted directly, intravenously, intra-arterially, or 
intrathecally. Although direct, intracerebral, or stereotactic injection permits most 
efficient delivery of the donor cells to the damaged tissue, a less invasive procedure 
would be more favorable. Intravenous or intrathecal transplantation is attractive 
because of its noninvasive, safe technique for the host CNS, but has been reported 
to result in less pronounced cell migration and functional recovery than direct cell 
transplantation  [35] . Alternatively, the intra-arterial injection of BMSC may be 
valuable to noninvasively deliver them to the damaged CNS  [19, 36] . Therefore, an 
optimal transplantation technique should be developed leading to maximally safe 
and efficient results. Currently, there are limited numbers of studies that directly 
compare the therapeutic effects of these delivery routes under the same conditions. 
It is an urgent need to test the effects of each delivery route on functional recovery 
after cerebral infarct. Recently, Kawabori et al.  [37] transplanted BMSC into the in-
farcted brain, directly or intravenously, at 7 days after the insult, which is a clini-
cally relevant timing. The authors conclude that intravenous administration of 
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BMSC has limited effectiveness at a clinically relevant timing and intracerebral ad-
ministration should be chosen for patients with ischemic stroke. Furthermore, they 
directly transplanted the BMSC (1 × 10 5 or 1 × 10 6 ) into the infarct brain at 1 or 
4 weeks after the insult, and found that earlier transplantation requires a smaller 
number of donor cells for beneficial effects  [38] . These observations strongly sug-
gest the importance of timing, delivery route, and cell dose to yield therapeutic ef-
fects of BMSC transplantation for ischemic stroke. Similar translational research 
should thoroughly be conducted to establish a scientifically proven protocol prior 
to the start of clinical testing.
 Finally, it is essential to develop techniques to serially and noninvasively track 
the fate of the transplanted cells in the host CNS. A cell tracking technique would 
also be important as a ‘biologically relevant end point’  [1] . Magnetic resonance im-
aging, nuclear imaging, and optical imaging are candidate modalities. The donor 
cells can be identified on magnetic resonance imaging by labeling with a superpara-
magnetic iron oxide agent  [20, 39] . On the other hand, the optical imaging tech-
nique may also serve future technology to visualize the BMSC engrafted in the dam-
aged CNS. Quantum dot emits near-infrared fluorescence with a longer wavelength 
(800 nm) that can easily penetrate the living tissue. A very recent study has shown 
that quantum dot-labeled BMSC can be clearly visualized under in vivo fluores-
cence imaging through the skull and scalp for at least 8 weeks when transplanted 
into the infarct brain of rats  [18, 19] . Imaging technology is valuable to assess the 
effects of BMSC transplantation on the function of the host brain. As described 
above,  18 F-fluorodeoxyglucose PET may be a useful tool to visualize the beneficial 
effects of BMSC transplantation for ischemic brain in the clinical setting  [22, 23] .
 Conclusion 
 Recent studies have strongly suggested the therapeutic potential of BMSC transplan-
tation for ischemic stroke. While mostly still in the experimental stage, the authors 
would like to emphasize that further translational studies are warranted to establish it 
as a scientifically proven strategy in the clinical setting. 
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 Abstract 
 Neurogenesis is principally restricted to the subventricular zone of the lateral ventricle wall and the 
subgranular zone of the hippocampal dentate gyrus in physiological situations. However, neuronal 
stem cells are known to be mobilized into the post- and peristroke area and we have demonstrated 
that appropriate support of these stem cells, achieved by therapeutic angiogenesis, enhances neu-
roregeneration followed by neuronal functional recovery in an experimental stroke model. We also 
found that neural stem cells are mobilized in patients after stroke, as well as in animal models. Based 
on these observations, we have started cell-based therapy using autologous bone marrow-derived 
stem/progenitor cells in patients after stroke. This review summarizes the findings of recent experi-
mental and clinical studies that have focused on neurogenesis in the injured brain after cerebral 
infarction. We also refer to the challenges for future cell-based therapy, including regeneration of 
the aged brain.  Copyright © 2013 S. Karger AG, Basel 
 Stroke is the third leading cause of death in developed countries after heart disease 
and cancer  [1] , and the leading cause of disability worldwide. More than 50% of stroke 
survivors are unable to completely recover and 20% of stroke patients require assis-
tance with their daily activities  [2] . Although thrombolysis can improve the function-
al outcomes of stroke patients, patients must be treated within 3 h (or 4.5) of the onset 
of a stroke  [3] and no definitive treatment exists after that period other than rehabili-
tation. To improve functional recovery after stroke, clinical trials of various drugs 
have been conducted but have achieved either only mild or nonsignificant therapeutic 
effects, or have sometimes even had serious adverse effects  [4, 5] . Thus, development 
of novel and safe therapies is eagerly awaited. 
 Recently, a number of studies have focused on cell-based therapies to promote the 
neuronal regeneration in the ischemic brain  [6–8] . In this chapter, we present current 
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basic and clinical findings that focus on therapeutic neurogenesis after stroke. We also 
refer to a novel cell-based therapy that may enable regeneration of the aged brain.
 Neuronal Regeneration Is Activated after Cerebral Ischemia 
 Neuronal tissue in the central nervous system is well known for its limited reparative/
regenerative capacity. Physiologically speaking, neurogenesis is principally restricted 
to the subventricular zone of the lateral ventricle wall and the subgranular zone of the 
hippocampal dentate gyrus, where unique niche architectures permit continuous neu-
rogenesis  [9, 10] . In pathological situations, recent studies using experimental models 
have revealed that endogenous neurogenesis is activated around injured areas where 
neurogenesis does not occur under normal conditions  [11] . Consistent with these 
findings, histopathological studies in stroke patients have pointed out the presence of 
neural stem/progenitor cells in the post-stroke human cerebral cortex, and that the 
peak in endogenous neurogenesis occurs approximately 1–2 weeks after a stroke  [12] . 
These findings indicate the potential for a novel therapeutic strategy using injury- 
induced neurogenesis for functional recovery in patients with cerebral infarction. 
 Angiogenesis Is Essential for the Survival of Injury-Induced Neuronal Stem Cells 
 The post brain-injury neurogenic response eventually yields only a very small number 
of mature neurons, as most of them die after the initial boosting  [11] . To achieve func-
tional recovery by endogenous neuroregeneration, appropriate support for their sur-
vival is essential and angiogenesis has been proposed as the key element in this  [7] . In 
the adult songbird, testosterone-induced angiogenesis leads to neuronal recruitment 
into the higher vocal center  [13] . In the adult rat, endogenous neurogenesis and neo-
vascularization occur in proximity to one another in the cortex following focal isch-
emia  [14] . Moreover, angiogenesis and neurogenesis have been shown to use the same 
molecules for their regulation; sphingosine-1-phosphate, for example, plays a critical 
role in neurogenesis and angiogenesis during embryonic development  [15] . This ac-
cumulating evidence indicates a close relationship between the vascular system and 
neurogenesis in the central nervous system, and recent studies have focused on the 
promotion of neurogenesis in association with angiogenesis  [6] . 
 Cell-Based Therapy to Enhance Neurogenesis in Ischemic Brain 
 To achieve angiogenesis in ischemic tissue, an approach using bone marrow-derived 
mononuclear cells, a rich cell source of both hematopoietic stem cells and endothe-
lial stem/progenitor cells, has been proposed. Local transplantation of bone marrow-
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derived mononuclear cells in experimental models of limb ischemia significantly in-
duces angiogenesis and releases ischemic stress in experimental models  [16] . Based 
on these results, clinical trials were initiated, and a cure for ischemic ulcer, with sig-
nificant angiogenesis in ischemic limb, has been reported  [17] . The potential for 
transplantation of bone marrow-derived mononuclear cells to myocardial ischemia 
patients was also investigated and demonstrated a therapeutic effect in experimental 
models. Clinical trials were initiated in patients with ischemic heart disease and the 
therapeutic potential for improvement in regional perfusion and heart function has 
been reported  [18] . 
 Based on these experimental and clinical findings, we investigated the effect of in-
travenous transplantation of bone marrow-derived mononuclear cells  [19] and hema-
topoietic stem cells  [7] in an experimental model. As a result, we found the following 
three effects: (a) cell therapy enhances neovascularization at the border of the isch-
emic zone; (b) neovascularization is essential for the survival of injury-induced neu-
ronal stem cells, and (c) supporting the survival of endogenous neurogenesis im-
proves functional outcomes  [19] . The positive effect of bone marrow-derived mono-
nuclear cells was negated by administration of an anti-angiogenesis reagent  [19] . It is 
noteworthy that survival of transplanted cells was rarely observed, despite significant 
activation of angiogenesis by cell therapy. These findings indicate that the differen-
tiation of the stem cells into endothelial cells in the ischemic brain is not essential for 
angiogenesis after stroke and therapeutic angiogenesis could be a novel therapeutic 
strategy to enhance functional recovery after stroke.
 To examine the effects of the mobilization of hematopoietic stem cells from bone 
marrow by drug administration, granulocyte colony-stimulating factor was given in 
an experimental stroke model and found to impair functional recovery with brain at-
rophy and with exaggerated inflammatory response at the border of the ischemic re-
gion  [20] . This result suggested that the mobilization of bone marrow cells, including 
both granulocytes and hematopoietic stem cells, by granulocyte colony-stimulating 
factor might augment the inflammatory response consequent to ischemic tissue dam-
age. We also investigated the effect of intravenous transplantation of bone marrow-
derived mesenchymal stem cells in an experimental stroke model but found only a 
mild or nonsignificant effect on functional recovery (unpublished data), though mes-
enchymal stem cells have the potential to suppress excessive inflammation  [21] .
 In a preclinical trial, we investigated the appropriate cell numbers and optimal ther-
apeutic time window using a highly reproducible murine stroke model  [22] and found 
that administration of a relatively small number of bone marrow-derived mononuclear 
cells had a significantly beneficial effect on the regeneration of injured brain tissue  [23] . 
Analysis of the therapeutic time window revealed that administration of bone marrow-
derived mononuclear cells at 24 h after stroke had a mild or nonsignificant effect on 
regeneration following ischemia, but administration of these cells between day 2 and 
day 14 after the ischemic event had a significantly positive effect. This result may be at-
tributed to the time lag between the onset of stroke and the peak of neurogenesis  [12] .
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 Clinical Trials to Enhance Neurogenesis in Patients after Stroke 
 Based on these results, we initiated a clinical trial to enhance neurogenesis and func-
tional recovery through activating angiogenesis in patients with cerebral infarction. 
A  schematic representation of this therapy is shown in  figure 1 . Our clinical trial 
is  an  unblinded, uncontrolled phase 1/2a study (ClinicalTrials.gov Identifier: 
NCT01028794). The major inclusion criteria are patients with cerebral embolism, day 
7 after stroke, a National Institutes of Health Stroke Scale (NIHSS) score of more than 
(or equal to) 10, and an improvement in the NIHSS score of less than (or equal to) 5 
since admission. On days 7–10 after stroke, either a 25-ml (low-dose group, n = 6) or 
a 50-ml (high-dose group, n = 6) aspiration of bone marrow cells was performed. 
These mononuclear cells were purified by Ficoll-Paque Premium (GE-Healthcare, 
USA) and administered intravenously on the day of the bone marrow aspiration. The 













progenitor cells Apoptotic cell death
Stroke-induced neuronal stem/
progenitor cells Newly formed microvessel Maturation into neuron
 Fig. 1. Schematic representation of cell-based therapy for patients with cerebral infarction.  a–c Neu-
rogenesis after stroke without therapeutic angiogenesis. Endogenous neurogenesis is activated 
around the stroke area ( a ). However, stroke-induced neuronal stem/progenitor cells do not survive 
because of the lack of an appropriate environment ( b ), and do not contribute to functional recovery 
( c ).  d–f Neurogenesis with angiogenesis. Stroke-induced neuronal stem/progenitor cells ( d ) survive 
in an environment with angiogenesis ( e ). Neuronal stem/progenitor cells differentiate into mature 
neurons and contribute to functional recovery ( f ). 
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treatment and frequency of change for the worse on the NIHSS at 30 days after treat-
ment, compared with historical control. Though this clinical study is currently still 
underway, we have already treated 11 patients (6 in the low-dose and 5 in the high-
dose group), and no side effects or safety problems have been observed to date. Results 
related to the therapeutic effects of the treatment are expected in a year. Similar clin-
ical trials are being carried out in other countries, including the USA, UK, Brazil and 
Spain, with promising results  [24, 25] . Though the route of administration (intrave-
nous or intra-arterial) and cell source (bone marrow mononuclear cells or CD34-
positive cells) vary, no side effects or safety problems with cell therapy have been re-
ported. The current status of most of these ongoing clinical trials can be searched 
through http://clinicaltrials.gov/. 
 Future Cell-Based Therapy for Prevention of Cerebrovascular Diseases 
 Previously, we have shown that patients with cerebrovascular disease have a decreased 
level of circulating bone marrow-derived immature cells, the latter associated with 
impaired cerebrovascular function  [26] and impaired cognition  [27] , whereas in-
creased levels of bone marrow-derived immature cells are associated with neovascu-
larization of the ischemic brain  [28] . In addition, we have demonstrated that partial 
rejuvenation of bone marrow stem cells in aged rats improves vascular function and 
reduces ischemic damage after induction of stroke in stroke-prone spontaneously hy-
pertensive rats  [29] . Furthermore, we investigated the effect of bone marrow-derived 
stem cells on white matter damage in a mouse model of cerebral hypoperfusion and 
found that administration of bone marrow-derived stem cells has a significant protec-
tive effect against white matter damage by enhancing cerebral blood flow via the ac-
tivation of nitric oxide synthase  [30] . These findings clearly indicate that bone mar-
row-derived stem/immature cells have the potential to improve microvascular circu-
lation and prevent cerebrovascular diseases, and the challenge to find novel strategies 
using autologous, allogeneic or induced pluripotent stem cell-derived hematopoietic 
stem cells to regenerate the aged brain is ongoing. 
 Conclusion 
 Currently, for patients after stroke, there is no specific recovery-targeted treatment 
other than physical and cognitive rehabilitation techniques after the period of throm-
bolysis. However, accumulating evidence indicates significant activation of neuro-
genesis after stroke, and utilization of the stroke-induced neuronal stem cells, we 
believe, will become a major therapeutic target for the acceleration of functional re-
covery. The mechanism that links angiogenesis and neurogenesis cannot be attrib-
uted to a single molecule or signaling pathway. It is likely that multiple cytokines, 
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growth factors, and cell adhesion molecules are involved, and the balance between 
these molecules may determine the fate of injured brain tissue. Careful, step-by-step 
investigation will lead to more efficient neurogenesis with a longer therapeutic time 
window. Experimental and clinical research focusing on neuroregeneration is need-
ed to enhance functional recovery in patients after stroke. 
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 Abstract 
 The identification of strategies by which the central nervous system (CNS) can transform itself in 
response to injury has incited the systematic exploration of methods to enhance neurological re-
covery after CNS injury. Several pharmaceuticals have been shown to promote such recovery; how-
ever, more rigorous clinical trials are necessary to establish their clinical relevance. The major im-
pediment for these strategies in the clinical arena is the astounding heterogeneity surrounding 
neuroplasticity and regeneration. Tolerance to injury and varied rates of recovery are likely governed 
by genetic and environmental factors that remain largely elusive. The extraordinary complexity of 
the neural networks in the CNS impedes the assessment of ‘plain’ pharmacological interventions in 
therapeutic trials. ‘Proof-of-principle’ studies of pharmacological interventions enhancing neuro-
plasticity or regeneration may therefore at first focus on surrogate markers, such as functional MRI, 
magnetoencephalography and diffusion tensor imaging, or investigate seemingly more uniform 
systems, such as spinal cord injuries. The discovery that experimental adult CNS lesions can essen-
tially regenerate has rejected the conviction that adult axon injury is always permanent and spurred 
research into determining whether the circumstances under which such regeneration occurs can 
be created in human CNS injury. The hostility of the microenvironment preventing axonal regrowth 
has been linked to key molecular targets involving myelin-associated factors and glial scar compo-
nents. While the mechanisms involved are better understood now and potential therapeutic targets 
are identified, the crucial question whether manipulating the molecular regulation of axonal repair 
is feasible and will benefit patients remains uncertain. While factual repair of brain tissue may still 
be years away, research into the mechanisms of adaptation after brain injury offers more tangible 
return on the short run.  Copyright © 2013 S. Karger AG, Basel 
 Traumatic and vascular brain injuries are among the leading causes of adult disabil-
ity in the developed world  [1, 2] . In recent years, basic and clinical research results 
have triggered re-emphasis on recovery from chronic disability following brain and 
spinal cord injuries. Basic science discoveries have determined mechanisms underly-
ing neurological recovery while clinical research identified redress processes that oc-
cur within the injured brain or spine during recovery  [3, 4] . Therapeutic perspectives 
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related to these discoveries have spurred much clinical interest in this area. In gen-
eral, neuroregeneration, consisting of axonal reconstruction and/or collateral sprout-
ing, is distinguished from neuroplasticity, the ability of nervous tissue to adapt to in-
jury by reorganizing its intrinsic network to regain and/or modify functionality. 
When recovering from brain and spine injury, these mechanisms may occur simulta-
neously, at various intensities and at different time periods after injury. While initial 
clinical improvement is thought to be mediated by neuroplasticity accompanied by 
moderate sprouting from collateral axons, persistent neurological deficits are believed 
to indicate the lack of axonal regrowth/sprouting and/or maladaptive plasticity. Giv-
en the extraordinary size and redundancy of the neural circuitries, many brain lesions 
can be completely corrected by plasticity, while others, depending on extension and/
or location, may not respond to system adaptations alone. Furthermore, it is likely 
that genetic factors affect tolerance to injury, or modify neuroplasticity, axonal re-
growth or sprouting resulting in heterogeneity of recovery after brain injury  [5, 6] . 
This chapter assumes a proportionate clinical deficit according to location, extension, 
patient characteristics and acute treatment-related factors that triggers a uniform cas-
cade of adaptive/reparative responses. The corresponding clinical deficit is the base-
line variable from which complete or incomplete recovery may occur as a result of 
neuroplasticity and neuroregeneration. 
 Mechanisms Underlying Clinical Recovery 
 Variability in recovery from brain injury is substantial across human patients. The 
mechanisms for this disparity are largely unknown but experimental and human 
studies suggest a broad range of underlying molecular and physiological events. Re-
cently, brain mapping studies in human patients recovering from brain injury have 
provided insight into the plasticity on a systems level and may help to tailor and mon-
itor responses to rehabilitative strategies  [4] . Rather than being driven by functional 
deficits alone, treatments may need to be tailored according to the lesion topography 
and the temporospatial activation pattern detected by functional MRI. Reorganiza-
tion of central nervous system (CNS) networks after injury awards recovery by alter-
ations in interhemispheric lateralization  [7] , activity of association cortices linked to 
the injury and/or reorganization of cortical representational maps  [8] . Recovery af-
forded by neuroplasticity alone usually remains incomplete, such as known from 
spastic hemiplegia after stroke or paraplegia after spinal cord injury. Deficiencies de-
riving from axonal disconnections cannot be rectified by reorganization alone. Strat-
egies to recover or replace neurons consumed by the injury and/or disease processes 
are ultimately required to fully restore the preinjury function. In this regard, patient 
characteristics, including demographics, behavioral experiences, and genetics greatly 
influence recovery and are important covariates to be considered in future trials of 
restorative agents/devices that target recovery from brain injury. 
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 Genetic Variability 
 In recent years, much research has been conducted to explain the heterogeneous re-
covery from brain injury. Variations in recovery from brain injury may be related to 
genetic polymorphisms within the systems generating plasticity and regeneration or 
depend on variability in tolerance to the inciting brain injury. Studies assessing the 
genetic variants of dopaminergic, serotoninergic neurotransmission, or genes in-
volved in synaptic plasticity, including brain-derived neurotropic factor and kidney- 
and brain-expressed protein, have revealed influences on cognitive domains  [9, 10] . 
These polymorphisms may explain various clinical responses to pharmacological 
therapies and physical or cognitive training after brain injury. So far, research in this 
area is still in its infancy; however, future investigations may help to tailor individual 
rehabilitative efforts depending on biologically distinct genetic patterns. In addition, 
variability in myelin-associated inhibitors, such as the Nogo-A family of proteins, and 
astroglial scarring, involving chondroitin sulfate proteoglycans, influence neural re-
generation. In a genomic association study, two single nucleotide polymorphisms in 
close proximity to  NINJ2,  encoding ninjurin-2, were associated with an increased risk 
of stroke. Ninjurin-2 is a transmembrane protein that has been induced and shown 
to promote axonal regeneration in peripheral nerve injury models  [11] . In the CNS, 
it is constitutively expressed at low levels by radial glia and may when induced coun-
teract inhibition of axonal regeneration and sprouting by myelin-associated inhibi-
tors, in particular Nogo-A. Experiments with knockout mice suggest that the level of 
ninjurin-2 expression may affect the tolerance of the brain to injury  [12] . 
 Plasticity 
 The ability of nervous tissue to reorganize its network in response to intrinsic or ex-
trinsic stimuli by retooling connections and functions is the hallmark of neuroplas-
ticity. Plasticity after brain injury describes changes in the intrinsic network incited 
by damaged fibers and correlated functional loss. It can be conceived on different 
levels, from molecular to cellular to systems and cognition. It appears during devel-
opment and in response to the environment, including socialization, learning, in-
jury or recovery. In principle, neuroplasticity can be adaptive or maladaptive. When 
adaptive, neuroplasticity may result in functional gains, such as recovery after brain 
injury. When maladaptive, it may result in deficiencies, such as reflex sympathetic 
dystrophy following peripheral nerve damage or dystonia after brain injury. Clinical 
neuroplasticity has most intensively been studied in motor recovery after stroke  [7, 
13] . Connective adaptations within the injury-diminished network occur via abun-
dant molecular changes affecting synaptic connections of residual neurons aiming 
to renovate the corrupted circuitry. Spontaneous motor recovery after stroke illus-
trates that injury to a region in the motor network can induce intrahemispheric 
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changes, such as changes in the representational maps, while the interhemispheric 
balance can shift to enhanced activity in relation to movement at the same time. 
Similar adaptations have been demonstrated in recovery from aphasia and neglect 
although the underlying networks employ different anatomic pathways. Many ex-
amples of plasticity in the human brain involve biochemical changes in synaptic ac-
tivity without anatomic reorganization. Neuroplasticity during recovery in patients 
can be exposed by brain activity mapping using functional MRI or magnetoenceph-
alography. Exposing brain activity patterns during spontaneous recovery after brain 
injury may reveal temporospatial motifs of alternate or latent pathway recruitment 
and provide insight into mechanisms of favorable versus failing rehabilitation. These 
advanced techniques to detect and associate brain activity may also provide a win-
dow into the mechanism of pharmacological approaches to recovery after brain in-
jury  [14] . Monitoring brain activity over time during recovery may also establish 
temporal patterns and help defining time windows for various candidate drugs. 
Pharmacological approaches affecting neuroplasticity are thought to facilitate recov-
ery by modulating certain neurotransmitter and neurotrophic systems altering syn-
aptic plasticity and assist in the progress of resuming lost capacities. In spite of the 
above-outlined self-repair mechanisms of adaptive reorganization, adult human 
brain and spinal cord damage commonly produces persistent deficits with only lim-
ited recovery. Persistent deficits result from the restricted capacity of the adult hu-
man brain and spinal cord to re-extend and rearrange severed axonal connections 
and replace expired neurons. 
 Regeneration 
 The term ‘neuroregeneration’ describes the growth of injured or damaged axons over 
longer distances and longer periods of time. Sprouting refers to growth from injured 
or damaged fibers or from intact fibers over shorter distances. Regeneration is the 
most time-consuming of these mechanisms taking weeks to months to produce func-
tional improvements while sprouting and particular plasticity may occur within days 
or even hours of injury. Injury-related axonal damage opposes neuroregeneration by 
triggering a cascade of axonal deterioration comparable to apoptosis after nonlethal 
neuronal damage. Presumptive mechanisms, including poor axonal transport, mito-
chondrial dysfunction and calcium influx have been identified. Four responses delin-
eate possible axonal responses to injury and may occur both concomitantly or sequen-
tially. (a) A wide range of insults triggers axon degeneration impairing the prospects 
of recovery  [15] . Proactive axonal death programs and genetic factors may determine 
the scope of deterioration but need to be understood in more detail before they can 
be affected. (b) Ordinarily, only minimal if any axonal regeneration occurs after in-
jury. Axonal growth can be stimulated after various injuries under experimental con-
ditions  [16] . Axons severed by a disease process may extend themselves from the dis-
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tal severed end or regrow as collaterals from the intact proximal segment. Adjacent 
neuronal networks, not involved in the primary injury, can stimulate collateral path-
ways. Finally, altered sensory input and even injunction from nonneuronal tissue 
damage can stimulate axonal regrowth. (c) Axonal regeneration after injury is time 
sensitive. Chronic adjustments may depend on the contingency of certain early mod-
ifications within the network. Without proper initiation, long-term repair may result 
in functional discord. (d) In spite of the often meandering course within the CNS, 
regrowing fibers are able to connect with proper targets in experimental studies. Al-
though many mechanisms of axonal regeneration are elusive at this time, further re-
search into the development of therapeutics to spur axonal growth and halt stagnation 
by axonal degeneration at the same time are needed to move the field into the clinical 
arena  [3] . Promoters of axonal regrowth are being identified and provide possible 
therapies to stimulate regeneration  [17] . In addition, inhibitory proteins derived from 
myelin and the astroglial scar enacting as major barriers for successful regeneration 
of injured CNS neurons can be targeted as well  [18] . 
 Stimulating Plasticity by Neuropharmaceuticals 
 Cellular and molecular events underlying neuroplasticity include specific neuro-
chemical processes accessible to pharmacological interventions. All of the agents in 
the current clinical evaluation represent accidental discoveries and systematic re-
search is still in its infancy. Several medications already in clinical use for other in-
dications and even naturally occurring intermediates have been shown to manipu-
late cellular and synaptic pathways possibly assisting in neuroplasticity after brain 
injury, especially when used to augment task-specific training  [19] . The administra-
tion of selective serotonin reuptake inhibitors has been shown to improve clinical 
motor function in parallel with an increased activation of the ipsilateral motor cortex 
 [20] . In contrast, similar pharmacological manipulation of cellular and synaptic 
pathways may also retard neuroplasticity as shown for dopamine antagonists  [21] or 
GABA stimulants  [22] . Pharmacological facilitation of recovery has mostly been 
studied in the motor system and recently extended to other areas, such as language 
recovery and return of wakefulness from coma. In addition to pharmaceuticals in-
volved in synaptic transmission, several cytokines, experimentally known to affect 
survival of brain cells, have been found to peak during brain development and to be 
upregulated after brain injury. Erythropoietin (EPO) and its variants and granulo-
cyte colony-stimulating factor (G-CSF) may exert beneficial effects during recovery 
by modulating synaptic repair, stimulating neurogenesis, and enhance neuronal dif-
ferentiation. Enhanced hippocampal responses during memory retrieval have been 
demonstrated by functional MRI in normal volunteers  [23] . In this chapter, clinical 
studies of agents affecting neurotransmission and network modulation after brain 
injury are reviewed. 
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 Amantadine 
 Amantadine hydrochloride is one of the most commonly prescribed medications for 
patients with prolonged disorders of consciousness after traumatic brain injury. The 
acute phase of recovery from severe traumatic brain injury shows a brief period of neu-
ronal excitability followed by a long period of hypoexcitability with depletion of neu-
rotransmitters, including dopamine. Amantadine may facilitate dopaminergic activity 
and promote favorable neurobehavioral effects by interacting with dopamine-depen-
dent nigrostriatal, mesolimbic and frontostriatal circuits mediating arousal, drive and 
attentional functions  [24] . A recent international, multicenter, randomized con-
trolled trial involved 184 patients in a vegetative or minimally conscious state 4–16 
weeks after traumatic brain injury receiving inpatient rehabilitation (ClinicalTrials.gov 
NCT00970944). Patients were assigned to receive amantadine increasing weekly from 
100 mg twice daily to 200 mg twice daily in weekly 50-mg increments or placebo for 
4 weeks and were followed for 2 weeks after treatment was discontinued. Amantadine 
accelerated the pace of functional recovery during active treatment but did not result 
in improved functional recovery 2 weeks after discontinuation. In particular, the brief 
treatment interval of only 4 weeks leaves the important question unanswered whether 
treatment with amantadine, as compared with placebo, improves the long-term out-
come or simply accelerates recovery to an injury-defined level of function  [25] . 
 Catecholaminergics 
 Amphetamine exerts its behavioral effects by modulating several key neurotransmitters 
in the brain, including dopamine, serotonin and norepinephrine. The activity of am-
phetamine throughout the brain appears to be region specific and closely related to the 
brain’s reward circuitry. In spite of the notion that amphetamines enhance the effects 
of motor training in healthy volunteers, clinical trials in stroke patients showed hetero-
geneous results. Five controlled trials demonstrated a tendency to an improved out-
come when dexamphetamine was paired with physiotherapy and administered within 
3–60 days after stroke. The most recent small double-blind placebo-controlled study 
randomized 16 hemiparetic patients within 60 days after stroke to amphetamine plus 
physiotherapy versus placebo plus physiotherapy. Dexamphetamine (10 mg oral) or 
placebo were administered 2 days per week prior to physiotherapy over a 5-week period 
and motor function and activities of daily living were assessed before, during and 6 and 
12 months after treatment. Significant improvements in motor scales and activities of 
daily living suggest augmentation of physiotherapy by amphetamines  [26] . For lan-
guage recovery, 21 aphasic patients with subacute ischemic infarction were randomly 
assigned to receive either dexamphetamine (10 mg oral) or a placebo. Patients were en-
rolled between days 16 and 45 after onset and were treated on a 3-day/4-day schedule 
for 10 sessions. Thirty minutes after drug/placebo administration, patients received a 
1-hour session of speech/language therapy. There were no differences between the drug 
and placebo groups before treatment. In contrast, by 1 week after treatment, there was 
a significant gain in the dexamphetamine group; however, this difference was lost after 
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6 months  [27] . So far, clinical studies have been small, included only highly selected pa-
tients, and have not addressed possible confounding effects of the drug on mood and 
untreated depression. Furthermore, increased blood pressure and cardiac arrhythmias 
during amphetamine treatment do not support routine use of this drug in patients after 
stroke at this time. Levodopa, which is metabolized to dopamine in the brain and con-
verted to norepinephrine, may have advantages because it avoids most of the clinical 
adverse events seen with amphetamines. In a randomized controlled trial, the effect of 
100 mg oral levodopa daily enhanced the effects of goal-oriented physiotherapy in terms 
of motor recovery from stroke irrespective of stroke severity  [28] . 
 Cholinergics 
 Impaired cholinergic transmission is frequently seen in cognitive dysfunction after trau-
matic brain injury. Injury of cholinergic projections from the nucleus basalis of Meynert 
to the cortex are thought to impair the ability of cortical networks to encode verbal and 
sensorimotor memory. Therefore, impairment within the cholinergic transmission may 
result in cognitive dysfunction and impaired response to rehabilitation. Learning new 
motor skills by motor memory formation is enhanced by the acetylcholinesterase in-
hibitor tacrine in volunteers. The involvement of the cholinergic system in memory en-
coding has been demonstrated in various domains, including sensorimotor improve-
ments in hemiplegic stroke patients  [29] . In a recent pilot study of patients with cognitive 
impairment after right-hemispheric stroke randomly assigned to daily donepezil 5 mg 
versus placebo over 4 weeks significant improvements in the Mini-Mental State Exami-
nations along with increased activation in both prefrontal areas, both inferior frontal 
lobes and the left inferior parietal lobe were shown  [30] . So far, several small trials con-
firm the involvement of the cholinergic system in recovery from brain injury with en-
couraging results for acetylcholinesterase inhibitors in various rehabilitation settings. 
 Serotoninergics 
 The effect of a single dose of fluoxetine on the cerebral motor reorganization has been 
investigated in a series of 8 patients suffering from pure motor subcortical stroke. 
Each patient served as its own control and was studied with functional MRI perform-
ing an experimental active motor task with the affected hand under fluoxetine and 
placebo condition. Under fluoxetine, during the active motor task, hyperactivation in 
the ipsilateral motor cortex could be demonstrated along with improved motor skills. 
No such changes were seen after a passive movement of the paretic hand under fluox-
etine. The researchers conclude that the serotoninergic system amplifies the pyrami-
dal neurons in generating the experimental active motor task. They also suggest that 
chronic fluoxetine application may boost physiotherapeutic results in patients with 
pure motor strokes  [20] . The modulating effect of serotonin on motor recovery after 
stroke has been convincingly shown in a recent double-blind randomized placebo-
controlled trial by the same researchers (ClinicalTrials.gov NCT00657163). One hun-
dred and eighteen patients who suffered a stroke with hemiparesis or hemiplegia were 
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randomly assigned to fluoxetine (20 mg daily) or placebo for 3 months. The patients 
had moderately severe strokes with predominant motor deficits and were enrolled 
within 5–10 days after stroke onset. At the end of the study, day 90, the overall motor 
scores in the fluoxetine group were significantly improved resulting in a 17% increase 
of functionally independent patients in the fluoxetine group  [19] . 
 Signaling Molecules 
 A large number of cytokines are involved in neuronal survival and regeneration. Re-
cent research on neuroprotection and neuroregeneration has focused on two hemo-
poietic factors, EPO and G-CSF, and resulted in phase II clinical trials. These cyto-
kines are studied in various clinical scenarios with most experience coming from tri-
als in acute stroke patients. Disappointing results of the pivotal clinical studies outlined 
below have curtailed further research with these proteins. 
 Erythropoietin 
 EPO and EPO receptors are expressed in the nervous system peaking during brain de-
velopment and have been found to be upregulated following experimental brain injury 
in the adult brain. EPO and some of its variants can cross the intact brain barrier, stimu-
late neurogenesis and differentiation and activate neurotrophic, antiapoptotic, antioxi-
dant and anti-inflammatory signaling. The availability for human use for the treatment 
of renal anemia along with these attractive preclinical properties made EPO a prime 
candidate for clinical use in brain injury, neuroinflammatory and degenerative condi-
tions. A series of studies in stroke patients were initiated as early as 1997. After safety and 
preliminary efficacy in patients with middle cerebral artery strokes within 6 h from on-
set, a phase IIb study enrolled 522 patients [>60% pretreated with intravenous tissue 
plasminogen activator (tPA)] receiving EPO intravenous infusion within 6 h from 
symptom onset and at 24 and 48 h (40,000 IU each) (ClinicalTrials.gov NCT00604630). 
The primary outcome measures, including the modified Rankin scale and Barthel Index 
on day 90, were neutral. In addition, there was an increased risk of serious complications: 
death, intracerebral hemorrhage, brain edema and thromboembolism in the EPO arm 
in particular when cotreated with intravenous tPA. The increased death rate in the re-
combinant tPA population remains unexplained and may result from a combination of 
(as yet unknown) factors and/or potential recombinant tPA-EPO interactions  [31] . 
 Granulocyte Colony-Stimulating Factor 
 G-CSF has long been used to counteract neutropenia for example after chemotherapy 
or mobilizing hematopoietic stem cells from the bone marrow in stem cell transplan-
tation. G-CSF inhibits apoptosis in neurons, stimulates neurogenesis, and enhances 
vascular regeneration in experimental brain ischemia. Similar to EPO, G-CSF is re-
leased by neurons in response to ischemia. Systemically administered G-CSF passes 
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the intact blood-brain barrier and decreases infarct size in experimental models. In 
addition, G-CSF is not only acutely protective but also improves functional recovery 
after stroke when given delayed. Early clinical trials established safety over various 
doses  [32] . A phase II randomized controlled trial enrolled 328 patients (>60% pre-
treated with intravenous tPA) within 9 h from stroke onset receiving 135 μg/kg G-CSF 
over 72 h intravenously (ClinicalTrials.gov NCT00927836). The results, adjusted for 
baseline characteristics age, stoke severity and infarct volume, were neutral for clinical 
and imaging outcome parameters. There were no safety concerns  [33] . 
 Stimulating Regeneration by Neuropharmaceuticals 
 Although it is still debated whether axonal regrowth takes place over longer distances 
(>1 mm) in CNS injury models at all, several recent observations suggest it may occur 
even in humans. A longitudinal study in patients with severe traumatic brain injury 
monitored with diffusion tensor imaging during rehabilitation determined micro-
structural white matter changes of clinical relevance during long-term follow-up. In 
two subsequent diffusion tensor imaging exams, fractional anisotropy increased in the 
internal capsule and in the centrum semiovale primarily in patients with clinical im-
provement  [34] . Such an increase in fractional anisotropy in patients recovering from 
traumatic brain injury suggests that axonal regeneration takes place and may play a 
role in clinical recovery. It is not known what mechanisms induce the increases in frac-
tional anisotropy and whether the patients recover as a result of it, but this invites more 
research on drugs stimulating axonal recovery to enhance recovery after brain injury. 
Obviously, much more research is needed and it is not clear whether drug candidates 
have a favorable side effect profile, can be effectively applied and reveal clinically rel-
evant benefits. 
 Neutralizing Axonal Growth Inhibitors 
 Myelin-associated inhibitors signal through the Nogo receptor present on the growth 
cone of a regenerating axon  [35] , and inhibitory extracellular matrix molecules asso-
ciated with the glial scar have been shown to act through the Rho signaling pathway 
to inhibit axon regeneration. Rho activation and downstream activation of Rho-asso-
ciated kinase leads to a collapse of the growth cone scaffold and to axon growth arrest. 
The convergence of inhibitory signaling pathways on the Rho pathway makes it an 
attractive target for regenerative therapies. At this point, early clinical studies are on-
going in patients with spinal cord injury. 
 Nogo-A is a protein present in CNS myelin that inhibits neurite growth. Models of 
spinal cord injury and unilateral sensorimotor cortex lesions demonstrate that treat-
ment with function-blocking antibodies of Nogo-A results in an upregulation of 
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growth-specific proteins, enhanced regenerative and compensatory sprouting of fi-
bers, and the formation of new functional connections in the spinal cord and brain-
stem. Behavioral tests showed marked improvements of functional recovery in the 
Nogo-A-antibody-treated spinal cord or brain-injured animals. From a clinical per-
spective, a phase I clinical trial applying anti-Nogo-A antibodies to patients with acute 
spinal cord injury has been completed (ClinicalTrials.gov NCT00406016) and a mul-
ticenter phase II trial has started enrollment in summer of 2012. The phase I safety 
trial enrolled more than 50 patients within 2 weeks after complete and incomplete 
spinal cord injury. The drug was applied intrathecally via a pump or repeated injec-
tions over various time periods between 24 h and 4 weeks. There were relevant side 
effects ascribed to anti-Nogo-A antibodies  [36] .
 A Rho activation inhibitor derived from C3 transferase (Cethrin) has been shown 
to reduce the lesion extent and improve functional recovery in rodent models of spi-
nal cord injury. A recent phase I clinical trial found safety and feasibility of intrathecal 
applications of escalating doses of Cethrin (0.3–9 mg) in patients with spinal cord in-
jury (ClinicalTrials.gov NCT00500812). Patients with complete and incomplete cer-
vical and thoracic spinal cord injury within 1 week of spinal cord injury were recruit-
ed in this observational study. The study revealed an overall acceptable safety profile 
of the compound over the range of doses tested and a preliminary efficacy signal sug-
gesting favorable responses in cervical cord injury at doses of 3 mg. It is also intriguing 
that improvements in the motor scale continued up to 1 year after injury suggesting 
clinical efficacy  [37] . A phase II study is planned. 
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 Abstract 
 Therapies for effective neurorehabiltiation are in part based on brain mechanism commonly de-
scribed as neuroplasticity. These therapeutic approaches emphasize the re-learning of functionality 
that was lost due to the injury through reorganization of neural circuits in the remaining intact tissue. 
Important elements of these therapies are intensive and repetitive training, motivation and poten-
tially interactive devices (therapy “robots”) and supportive therapies such as brain stimulation or 
plasticity inducing medications. Because neuroplasticity-based interventions are complex and mul-
tifactorial optimized treatment protocols have to be developed before large clinical trials can provide 
the evidence of efficacy.    Copyright © 2013 S. Karger AG, Basel 
 Neurorehabilitation is a quickly developing field accelerated by advances in neurosci-
ences and rehabilitation engineering. In contrast to acute care medicine with its goal 
to cure, neurorehabilitation aims at minimizing disability and accelerating the return 
to an independent life. Naturally, it has to focus on all the deficits and dysfunctions of 
a patient that stand against these goals. Typically, physical (movement), communica-
tional and cognitive deficits occur and interfere with each other. Therefore, the clas-
sical neurorehabilitative approach combines physio- and occupational therapy with 
speech and language and cognitive training, the latter typically provided by neuropsy-
chologists. 
 Training, i.e. repetitive engagement in challenging exercises, is still the mainstay of 
neurorehabilitative treatment protocols. Training shares certain neural mechanisms 
with healthy learning, i.e., what is commonly described as neuroplasticity, although it 
is unclear in how far these processes overlap or share common mechanisms.
 Whether training can be effectively enhanced by plasticity-encouraging interven-
tions such as brain stimulation or certain drugs remains to be proven by clinical re-
search.
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 What is known from experience as well as science is that higher intensity is more 
effective than lower intensity  [1, 2] , although this may not hold true for early time 
points after injury (in this case, stroke)  [3] . High-intensity training requires excellent 
patient compliance and motivation, the major limiting factors for successful training.
 Mechanisms of Training 
 Animal Models 
 Like motor learning in healthy people, rehabilitative training after a lesion to the motor 
cortex leads to modifications in motor cortices adjacent to the lesion. Motor representa-
tions change in size and shape  [4, 5] and new connections form within and between sen-
sory and motor cortical networks  [6] . The representations of complex movement pat-
terns that can be evoked by long high-frequency pulses to the injured hemisphere – a 
possible reflection of a memory trace for complex movements – are lost after a cortical 
lesion. With rehabilitative training they recover; the degree of restoration of complex 
movement patterns evoked by brain stimulation correlates with behavioral recovery  [7] . 
 Plasticity also occurs in the uninjured hemisphere contralateral to the lesion. Bier-
naski and Corbett  [8] reported enlarged dendritic trees in the uninjured hemisphere 
in animals that were trained in an enriched environment after a focal lesion to the 
motor cortex as compared with control animals that received standard therapy. Indi-
rect evidence for plastic modification was also found in other brain areas that are in-
volved in motor control. In the cerebellum of rats that were subjected to repeated 
treadmill training after a middle cerebral artery occlusion, the 25-kDa synaptosomal-
associated protein and glial fibrillary acidic protein – markers of synaptic plasticity – 
were upregulated as compared with untrained controls  [9] . Similarly in the thalamus, 
synaptic plasticity indexed by synaptophysin expression was increased in the dam-
aged hemisphere in animals that were trained on a rotarod (skilled locomotor train-
ing) as compared to a treadmill (locomotor training of lower difficulty) or no training 
 [10] . In the striatum, expression levels of glutamate, brain-derived neurotrophic fac-
tor, and p-synapsin I were increased by treadmill training after middle cerebral artery 
occlusion  [11] . However, the type of motor training certainly plays a role in the pat-
tern of plastic modification across the rat brain: whereas forelimb precision move-
ment training (typically single pellet reaching tasks) depends more on cortical plastic-
ity, locomotor training likely induces reorganization in larger motor control networks 
including the cerebellum, basal ganglia and thalamus.
 Studies in Humans 
 In humans, evidence for plastic modification of neural circuits comes from imaging 
and electrophysiology. Task-related activation in motor cortices or, in case of cortical 
lesions, the peri-infarct cortex is modified during the course of recovery. After corti-
cospinal tract infarction, initial overactivation of the contralesional motor cortex (ip-
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silateral to the moving hand) reverts to ipsilesional (contralateral) dominance as re-
covery progresses  [12, 13] . The presence of motor potentials evoked from the le-
sioned hemisphere using transcranial magnetic stimulation (TMS) and corticospinal 
tract integrity in diffusion tensor magnetic resonance imaging predicted the response 
to arm training in chronic stroke survivors  [14] . Interfering with the contralesional 
hemisphere by TMS did not affect reaction times with the paretic hand in stroke sur-
vivors with varying degrees of recovery at least 2 years after stroke, but interfering 
with the ipsilesional motor cortex did  [15] . This emphasizes the role of the ipsile-
sional hemisphere (contralateral to the moving limb) for successful recovery. 
 In predicting therapy gains, the degree of injury to descending tracts from primary 
motor and premotor cortices is an important surrogate marker. It correlated with 
gains achieved after hand robotic therapy  [16] . Bilateral arm training improved the 
arm impairment in chronic stroke survivors. This improvement was paralleled by an 
increase in activation of bilateral premotor cortices after as compared to before train-
ing  [17] . As compared with conventional physiotherapy according to neurodevelop-
mental principles, bilateral arm training was as effective but showed a different neural 
response: where conventional physical therapy had no effect on brain activation, bi-
lateral training led to an increase in bilateral premotor cortex activation  [18] . This 
indicated that different therapies operate through different mechanisms even if they 
induce a comparable behavioral response.
 Therapeutic Principles 
 Timing 
 When to start rehabilitation after stroke or trauma is a matter of debate. It seems that 
forcing an animal to train too early increases the infarct volume  [19] . On the other 
hand, stroke induces the expression of specific proplastic genes defining an optimal 
time period in which training should be most effective  [20] . 
 In humans, using high-intensity constraint-induced movement therapy (CIMT; 3 h 
of training based on shaping principles plus immobilizing the intact limb for 90% of the 
waking hours for 10 days) starting around 10 days after stroke results in adverse out-
comes as compared with standard occupational therapy and standard CIMT (2 h of 
shaping plus 6 h of immobilization per day)  [3] . In contrast, Bernhardt et al.  [21]   suggested 
that early – within 24 h – mobilization, i.e., getting the patient out of bed, improves the 
outcome 3 months after the stroke. This finding awaits confirmation in a larger sample.
 Intensity 
 Many studies have compared different training therapies but have shown similar ther-
apeutic responses. Experience suggests that the intensity of training is a major deter-
minant of the training effect. Additional leg training resulted in better walking ability 
and arm training in better dexterity as compared with immobilization in subacute 
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stroke survivors enrolled within 14 days of stroke onset indicating that the intensity 
of training counts  [10] . Similarly, a community-based physical activity program im-
proved walking velocity, balance and quality of life measures as compared with stan-
dard care also emphasizing training intensity  [22] . On the other hand, as mentioned 
above, high intensity early after stroke may result in adverse functional outcomes  [3] . 
 Motivation 
 The main obstacles that prevent high-intensity training are fatigue and motivation. 
Fatigue can be counteracted by sufficient interruptions and rest periods. Motivation 
requires a motivating environment, positive feedback from the therapist or a training 
device that specifically addresses motivational aspects, e.g. by providing rewarding 
schemes in a gaming environment. How to optimally use motivational therapy to im-
prove training outcomes is still unclear. 
 Elements of Effective Training 
 Little is known about which training principles are most effective and for whom. Ac-
tive training is better than passive movement, but also mental imagery of movement 
has a training effect in combination with active training  [23] . Bilateral training is 
similarly effective as unilateral training when looking at the population mean; indi-
vidual patients may respond better to one or the other  [18] . It  remains unknown 
which factors predispose a patient to respond to a specific  treatment. 
 One of the largest randomized controlled trials (n = 222 participants) in neurore-
habilitation showed that CIMT is superior to conventional care in patients between 3 
and 9 months after a stroke  [24] . CIMT was developed on the basis of the finding that 
disuse of an extremity leads to functional deterioration. The constraint element en-
forces active movement of the affected limb by immobilizing the unaffected. While 
this trial clearly demonstrated the lasting benefits of CIMT, the controlled compari-
son depends on the nature of conventional care. In most countries and medical sys-
tems, conventional care in the time frame of 3–9 months is limited to low-frequency 
outpatient therapy, e.g. physiotherapy and occupational therapy once a week. It seems 
expected that such low intensity is less effective than CIMT which engages patients in 
training for several hours per day. Hence, it is unknown whether it is simply the in-
tensity that renders CIMT more effective, or it is the strictly unilateral nature of the 
training, or any other element of therapy.
 Progression is another therapeutic principle that may be a key to success. Adding 
to the complexity, the loading or the velocity of training provides a constant stimulus 
for learning as the patient continues to improve  [25] .
 Therapy Using Robots 
 Robots were initially developed as assistants to the therapist enabling highly repetitive, 
uniform passive movements. In patients with spinal cord injury, robotic gait training may 
be superior to standard overground training  [26] , but further studies are needed to con-
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firm these differences. For patients with brain lesions, various studies using different up-
per or lower extremity robotic training devices were performed and showed inconsistent 
results ranging from inferiority to equality as compared with conventional physiotherapy 
 [27, 28] . 
 Robots, however, enable a form of standardized precision training that differs from 
training under the direction or with the assistance of a therapist. Robots may comple-
ment therapist-based training. Precision movement training is often implemented in 
a computer game. Gaming environments may also increase the motivation for train-
ing by introducing reward or competition with others. Finally, robots may partially 
support the patient’s movement (assistance mode) or may perturb the patient’s move-
ment, e.g. by applying forces that counteract the patient. Whether assistance or per-
turbation per se are effective training elements remains to be investigated.
 Supportive Therapies 
 If training is performed in a setting in which plastic reorganization of the brain is fa-
cilitated, its effects may be higher, faster and/or longer lasting. Repetitive TMS (rTMS) 
or transcranial direct current stimulation provide such a setting. They likely work by 
modulating cortical excitability (in the case of rTMS by increasing or decreasing ex-
citability depending on the frequency of the repetitive stimulation)  [29] . As compared 
with sham stimulation, 10 sessions of rTMS as an adjunct to conventional physical 
and occupational therapy starting 5–10 days after stroke improved disability (as mea-
sured by the Barthel index) and impairment (NIHSS)  [30] . In a small randomized 
trial, rTMS in combination with task-oriented walking exercises improved gait sym-
metry more than walking exercises alone (combined with sham stimulation  [31] . 
Transcranial direct current stimulation in combination with conventional physical 
therapy improved arm impairment and activity of daily living function more than 
physical therapy alone (combined with sham stimulation)  [32] . Positive effects of 
rTMS and transcranial direct current stimulation were also reported for the treatment 
of aphasia  [33, 34] . 
 Drugs potentially improve the effects of rehabilitative training interventions. One 
larger trial in 118 acute ischemic stroke patients found that adding fluoxetine to stan-
dard rehabilitation improves motor impairment at 3 months  [35] . The mechanisms 
by which this selective serotonin reuptake inhibitor exerts this effect are unknown.
 Evidence in Neurorehabilitation 
 Neurorehabilitative interventions are multidimensional often combining different 
treatments such as exercise and brain stimulation. Finding optimal therapy protocols 
is much more complex than in pharmacological therapy because many parameters 
need to be optimized, such as timing, intensity, duration, and rest periods. The de-
sign of a clinical trial in neurorehabilitation is further complicated by the fact that 
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valid control interventions or groups are difficult to define. Because there is no pla-
cebo pill to a training therapy, it is difficult and often impossible to double/single-
blind the trial. This leaves the investigation vulnerable to placebo effects, e.g. seeing 
an expensive robot equipment may introduce a placebo effect over the conventional 
physical therapist. In addition, the outcome measures and scales for movement, 
speech language and cognitive function all have their shortages. There is little agree-
ment which scale best reflects a clinically relevant treatment effect. Because training 
interventions require large amounts of therapist time, trials in neurorehabilitation 
are expensive. 
 These factors all contribute to the fact that little evidence exists in neurorehabilita-
tion today. Large and expensive trials are risky as long as optimal treatment protocols 
are not known. Small studies with less than 100 participants are common. Clinical 
guidelines therefore remain brief and leave much room for personal experience as 
well as treatments that can still be considered experimental. 
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 Abstract 
 Brain-computer interfaces (BCI) register changes in brain activity and utilize this to control comput-
ers. The most widely used method is based on registration of electrical signals from the cerebral 
cortex using extracranially placed electrodes also called electroencephalography (EEG). The fea-
tures extracted from the EEG may, besides controlling the computer, also be fed back to the patient 
for instance as visual input. This facilitates a learning process. BCI allow us to utilize brain activity 
in the rehabilitation of patients after stroke. The activity of the cerebral cortex varies with the type 
of movement we imagine, and by letting the patient know the type of brain activity best associ-
ated with the intended movement the rehabilitation process may be faster and more efficient. The 
focus of BCI utilization in medicine has changed in recent years. While we previously focused on 
devices facilitating communication in the rather few patients with locked-in syndrome, much inter-
est is now devoted to the therapeutic use of BCI in rehabilitation. For this latter group of patients, 
the device is not intended to be a lifelong assistive companion but rather a ‘teacher’ during the 
rehabilitation period.  Copyright © 2013 S. Karger AG, Basel 
 Brain-computer interfaces (BCI) in the broad sense refer to the ability to use signals 
measured in the brain to control computers. The field is growing rapidly these years 
with many new applications and a rapid growth in the number of publications. A re-
cent roadmap of the future of BCI is the result of an international collaboration  [1] . 
The roadmap divides the broad term BCI into pure BCI, in which only the brain sig-
nal is interfaced, and the more heterogeneous group of BNCI (brain neuronal com-
puter interaction), in which other measures like muscle signal and gaze direction are 
taken into account. In this chapter, we will use BCI in the broad sense including 
knowledge of other modalities than electroencephalography (EEG), i.e. muscle activ-
ity, which is important when using BCI in rehabilitation. 
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 There is a number of existing and potential nonmedical uses of BCI like education, 
gaming, neuroeconomics, safety and security not dealt with here. In the medical field, 
BCI may be used in mental state monitoring or detection of certain events like crav-
ing in addicts, which is also not discussed here. This chapter focuses on the use of BCI 
in motor-impaired patients.
 Running a Brain-Computer Interface 
 A typical source of brain signals for BCI is EEG due to high temporal resolution, ease 
of moving around and relatively low cost. Several groups have worked with other sys-
tems like functional magnetic resonance imaging, magnetoencephalography and 
near-infrared spectroscopy. But most research now and in the nearest future is based 
on EEG signals. 
 EEG signals are either recorded from electrodes placed during surgery (invasive) or 
adhered to the skin (noninvasive) ( fig. 1 ). There are advantages and disadvantages of 
both approaches. The invasive techniques give a much better signal-to-noise ratio and 
allow for stable recordings for weeks and months. On the other hand, placing of the 
electrodes is costly and risky and there is an important long-term risk of infections and 
bleeding. The surface electrodes, on the other hand, are risk free and easily adhered to 
the skin but procedures involving hair removal or skin abrasion among other things 
may take up to 20 min every time the system is set up. Furthermore, the use of extra-
cranial electrodes is associated with a decreased signal-to-noise ratio and there is a risk 
of slight imperfection of electrode placement which greatly deteriorates the signal.
 The recorded EEG shows large variations over time depending on sleep, level of 















 Fig. 1. Most of the various 
forms of BCI belong to one of 
the eight groups on the fig-
ure. The area labeled  ‘R’ refers 
to typical rehabilitation use. In 
this field, the recording devic-
es are places on the outer sur-
face of the body and the re-
corded signal is triggered 
from an external source rather 
than being spontaneously 
generated (top right corner of 
the figure). Since other body 
signals play a crucial role, the 
outermost circle best de-
scribes the recorded signals. 
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no specific external stimuli are applied and the subject does not perform specific 
tasks, we talk about spontaneous EEG. The spontaneous EEG pattern changes to a 
task-specific pattern when the subject performs a task. Such a task could be imagin-
ing a movement or actually performing a movement. Typical patterns in these con-
ditions are event-related synchronization or event-related desynchronization, which 
appear over the contralateral motor cortex  [2] . Such patterns are referred to as 
 endogenous.
 EEG patterns may also be secondary to external events. We call those exogenous. 
The external event can be a simple signal initiating or modifying a specific task or it 
can be repeated stimulation like flickering symbols. In the first case, the external event 
helps defining the time at which to look for a physiological signal change. In the case 
of repeated stimulation, simple often short-lasting EEG changes in response to each 
stimulus leads to a so-called evoked potential. One way to use these evoked potentials 
is to compare the timing of objects flickering with different frequency to the recorded 
potentials.
 Use for Disabled People 
 A large number of medical conditions are associated with disabilities. Some rare con-
ditions like amyotrophic lateral sclerosis and locked-in syndrome are associated with 
a normal brain unable to take command of any muscles. For these patients, any way 
to make themselves understood by others is paramount. Many of the first BCI systems 
were designed with these people in mind. A large number of persons suffer a stroke, 
traumatic brain injury or cerebral palsy. They may have a range of different problems 
from language and cognition to motor performance and with varying degrees of dis-
ability. Thus, their need for BCI also varies a lot. Now that BCI are becoming cheaper, 
more flexible and more powerful, many of these persons for whom we previously saw 
no use of BCI may well benefit from these systems in the future. 
 In recent years, BCI have moved out of the laboratories and into the hospitals and 
homes of disabled people. The central task is to improve the lives of the disabled 
through widely different approaches. One approach is that the BCI is used as a per-
sonal assistive technology (PAT) to help the patients with activities of daily living 
like communicating with people around them or via the Internet, controlling a 
wheelchair or drawing the curtains. The other approach is therapy based with the 
goal to train the motor system in disabled patients so that they can eventually give 
up the BCI and interact with their surroundings naturally. Thus, the goal is not to 
provide motor control or facilitate communication, but to produce permanent or 
lasting behavioral changes. Neither the PAT-based nor the therapy-based use of BCI 
can stand alone and has to be integrated with existing empowerments and therapies.
 BCI may be a useful tool for accelerating motor rehabilitation. Motor rehabilitation 
of patients after for instance stroke often involves motor imagery and assisted move-
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ments. If a BCI is included, it may augment the rehabilitation process. A physiothera-
pist often facilitates the rehabilitation process by passive movements accompanied by 
asking the patient to imagine the movement. A skilled therapist will be able to evaluate 
the actual movements and feedback to the patient. However, even the most skilled 
therapist is unable to monitor the brain activity associated with this process without a 
BCI. Thus therapist and patients can obtain additional information if a BCI is employed 
demonstrating which brain activity is associated with a given training activity. Thus, 
the patient not only (re-)learns to activate the muscles but he also learns what consti-
tutes the optimal brain activity associated with the movement. The motor activity may 
be directly observed or measured as electrical muscle signals or accelerometer output. 
Other possible approaches involve BCI directly controlling a training robot  [3, 4] .
 An unfortunate real-world limitation in rehabilitation of stroke patients is the 
amount of resources available for the individual patient. Much research indicates that 
many patients would benefit from more training than they actually get  [5] . When the 
patient is left to do training on his own, the BCI may play an important role in induc-
ing compensatory plasticity. The data recorded may be turned into time-frequency 
maps of event-related potentials or focus on specific frequency bands which are con-
sidered effective tools to monitor motor imagery and may effectively be combined 
with actual motor performance  [6, 7] .
 Not even the most intense training program combined with optimal brain plastic-
ity and treatment leads to full recovery in all patients. When patients do not recover 
fully, they may benefit from PAT helping them do things they will never be able to do 
again in any other way. Thus, the purpose of PAT is not training the patient but as-
sisting him with daily activities at whatever level he is currently functioning.
 Our Brain-Computer Interface Efforts 
 In a fruitful ongoing collaboration between the University of Copenhagen, Rigshos-
pitalet and the Technical University of Denmark, a number of BCI applications have 
been developed. Many of the applications may serve as useful assistive devices for dis-
abled persons or serve as a basis for BCI-based therapy.  Table 1 summarizes some of 
the results we have obtained. 
 The use of endogenous signals to control a spelling device was inspired by Hex-o-
Spell from the Berlin group  [8] . The original approach was based on a 2-class move-
ment of the hands. The left hand signal turned a dial on a hexagon with groups of 
letters in the corners. The right hand signal lengthened the dial until a group of letters 
was selected. Then a new hexagon appeared with individual letters from the selected 
group placed at each corner, and a selection was performed in a similar way. The speed 
was 6–8 letters per minute corresponding to a little more than 1 word per minute and 
accuracy was acceptable. We improved this method in several ways. Organizing the 
letters so that the more common were reached first could increase the speed, but re-
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quired more learning since the order was no longer alphabetical. By adding a 3rd con-
dition, i.e. movement of the right foot, we were able to switch between the spelling 
hexagon and another hexagon with suggestions for how to complete the word, similar 
to what you see on telephone dictionaries. We used the large Danish text corpus ‘Ko-
rpus.dk’ containing 56 million words collected between 1990 and 2000  [9] . This al-
lowed us to speed up spelling and come closer to 2 words per minute with no loss of 
accuracy.




Real and imaginary movements yes Similar results can be obtained whether move-
ment is actually performed or just imagined
Three-class movement BCI yes Adding imaginary feet movements significantly 
increased data transfer
Training imaginary movements yes Training has a positive effect on performance in 
many subjects; however, even more subjects are 
likely to benefit if the classification algorithm is 
adaptive. Some subjects remain BCI illiterates
Optimizing algorithms when
the subject does not use the
BCI
yes By off-line delayed training of systems on individu-
al data acquired in a given subject, better perfor-
mance could be obtained in subsequent on-line 
sessions
Spelling device yes Improved spelling program using 3 imaginary 
movement modalities 
Environmental control yes TV remote control was easily integrated into BCI 
system
Stimulation of brain signals yes Artificial EEG signals perform as well as natural. 
Thus optimal extraction and classification para-
digms may improve the individual device while 
the subject is otherwise engaged. This of course 
does only partially substitute the human training
High-speed visual evoked potential-
based BCI
no Up to 112 bits/min obtained in various paradigms 
of environmental control and simple computer 
games like packman
Going from computer screen to
purpose-built stimulus devices
no Hardware-encoded stimulation in real-time BCI 
leads to more robust systems in tested subjects
Stimulus frequency no Using various encoding schemes for timing of 
stimulus appearance, we found that Kasami se-
quences where superior to commonly used time-
shifted sequences
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 The use of a BCI is rapidly increasing these years based on low cost, ease of use (e.g. 
wireless BCI) and more and more applications. It is important to keep on improving 
the reliability of BCI to meet the moment-to-moment needs of the user  [10] . While 
we previously thought of medical BCI as a PAT for few severely handicapped patients, 
it looks as if we are going in the direction of BCI as a natural empowerment and in-
terface in rehabilitation of a large number of people suffering a stroke and other acute 
neurological conditions. 
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 Abstract 
 The neural mechanisms that support aphasia recovery are not yet fully understood. It has been ar-
gued that the functional reorganization of language networks after left-hemisphere stroke may 
engage perilesional left brain areas as well as homologous right-hemisphere regions. In this chapter, 
we summarize how noninvasive brain stimulation can be used to elucidate mechanisms of plastic-
ity in language networks and enhance language recovery after stroke. We first outline some basic 
principles of transcranial magnetic stimulation (TMS) and transcranial direct current stimulation 
(tDCS). We then present evidence from studies in healthy volunteers for a causal role of the right 
hemisphere in different language functions. Finally, we review recent studies that used TMS or tDCS 
to promote language recovery after stroke. Most of these studies applied noninvasive brain stimu-
lation over contralateral right-hemisphere areas to suppress maladaptive plasticity. However, some 
studies also suggest that right-hemisphere regions may beneficially contribute to recovery in some 
patients. More recently, some investigators have targeted perilesional brain regions to promote 
neurorehabilitation. In sum, these studies indicate that language recovery after stroke may inte-
grate left- as well as right-hemisphere brain regions to a different degree over the time course of 
recovery. Although the results of these preliminary studies provide some evidence that noninvasive 
brain stimulation may promote aphasia recovery, the reported effect sizes are not striking. Future 
studies on larger patient collectives are needed to explore whether noninvasive brain stimulation 
can enhance language functions at a level that is clinically relevant. 
 Copyright © 2013 S. Karger AG, Basel 
 Aphasia is a severely disabling consequence of stroke that typically results from injury 
to cortical and subcortical structures perfused by the left middle cerebral artery  [1] . 
Estimations suggest that more than 20% of patients suffering a stroke develop aphasia. 
While most patients show some degree of spontaneous recovery within the first months 
after stroke, the majority of patients with post-stroke aphasia are left with some degree 
of chronic deficit for which current rehabilitative treatments are marginally effective 
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 [2] . Recent studies suggest that noninvasive brain stimulation techniques such as tran-
scranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS) 
may be of potential benefit in aphasia research in two ways. First, noninvasive brain 
stimulation may be used in evaluating the neural mechanisms of compensation follow-
ing aphasia after stroke. Secondly, due to their potential to modulate cortical excitabil-
ity and plasticity, these techniques may provide effective means in facilitating treat-
ment by promoting adaptive processes when combined with language therapy. 
 Shaping Language-Related Neural Processing with Transcranial Magnetic 
Stimulation 
 TMS is a noninvasive tool for electrical stimulation of the human cortex (for reviews, 
see Barker et al.  [3] and Siebner et al.  [4] ). TMS provides a means of transiently dis-
rupting ongoing neuronal processing in the stimulated cortex and thus permits to 
draw causal conclusions regarding the contribution of the stimulated area to a spe-
cific brain function  [5] . 
 Repetitive TMS (rTMS) refers to the application of prolonged trains of stimuli 
which are either given continuously as long trains at a constant rate (continuous 
rTMS) or intermittently as repetitive bursts (i.e., intermittent or burst-like rTMS).
 There are two different possibilities of applying (r)TMS to investigate cognitive func-
tions: TMS can either be applied during the task (‘online’) or shortly before the task (‘of-
fline’). Online TMS may consist of single pulses or short high-frequency trains given at 
distinct time points during a task to perturb intrinsic neuronal activity in the stimulated 
area (the ‘virtual lesion’ approach). An important advantage of TMS-induced lesions 
relative to studies of structural lesions is that there is insufficient time for functional re-
organization to occur during online TMS and thus, the acute ‘lesion’ effect should not be 
confounded by chronic processes mediating functional recovery locally and at the sys-
tems level  [5] . Of note, the term ‘virtual lesion’ implies that TMS always induces an im-
pairment of brain functions. However, TMS-induced disruption of neuronal activity in 
one area may also lead to a paradoxical improvement or facilitation in task performance.
 In contrast to online TMS, offline TMS involves longer rTMS protocols that are 
applied shortly before subjects perform an experimental task. Usually, the interven-
tional rTMS protocol is ‘inhibitory’  [6] . This means that the rTMS intervention in-
duces a lasting suppression of neuronal excitability in relevant areas. This condition-
ing approach bears some analogies to acute stroke, because inhibitory offline TMS 
gives rise to an acute adaptive reorganization within the nonstimulated functional 
loops of the networks to compensate for the TMS-induced suppression of neuronal 
activity in those components of the network that have been perturbed with TMS. It 
needs to be borne in mind that the local excitation induced in the stimulated cortical 
area can spread transsynaptically to remote brain regions via corticocortical and cor-
ticosubcortical projections. Hence, the behavioral changes induced by the TMS pulse 
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may not only be caused by local neural excitation at the site of stimulation, but also 
by indirect excitation of connected cortical areas.
 In sum, online and offline TMS represent complementary approaches: while on-
line TMS acutely disrupts a specific function, offline TMS impairs cortical processing 
beyond the time of stimulation and thus can be used to induce and examine the capa-
bility of brain networks to undergo acute reorganization. Due to the possibility to 
change cortical excitability beyond the duration of stimulation, offline rTMS proto-
cols are of particular relevance for the use in neurorehabilitation.
 Shaping Language-Related Neural Processing with Transcranial Direct Current 
Stimulation 
 tDCS modulates cortical excitability by application of weak direct electrical currents 
(1–2 mA) between two electrodes applied to the scalp over a relatively extended period 
of time (e.g. 5–20 min). Depending on the orientation of the stimulation electrodes and 
the direct current polarity, tDCS has been shown to elicit polarity-dependent changes 
in cortical excitability, presumably due to direct current-induced changes in the resting 
membrane potentials. In the motor cortex, anodal tDCS may increase motor-cortical 
excitability while cathodal tDCS may decrease excitability  [7] . Emerging evidence sug-
gests that the effects of tDCS can persist beyond the period of stimulation, and chang-
es in task performance were reported for up to 6–12 months after intervention  [8] . 
 An attractive feature of tDCS is the apparent lack of any significant side effects 
when using standard protocols. For instance, tDCS has not been reported to provoke 
seizures in nonacute neurological deficits since intervention protocols are well below 
the threshold of tissue damage  [9] . In contrast to TMS, it is relatively easy to blind the 
patient and examiner to the type of tDCS which enables a double-blind study design. 
Therefore, compared with TMS, tDCS may be a viable option for stimulation of the 
perilesional cortex where the threshold to induce seizures is lower. This makes tDCS 
an appealing form of neurostimulation in chronic stroke populations. Like TMS, 
tDCS may be applied before a certain task (offline) or during task processing (online). 
We also wish to mention that additional transcranial stimulation techniques such as 
alternative direct current stimulation or transcranial random noise stimulation have 
been introduced in recent years which may also be suited as interventional tools to 
modulate the impaired language system after stroke.
 Right-Hemisphere Contributions to Language Processing in the Healthy Brain 
 There is consensus about a dominant role of the left hemisphere in language pro-
cessing and most of the studies investigating language functions in the healthy brain 
with noninvasive brain stimulation techniques were restricted to left-hemisphere 
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brain regions. However, recent TMS studies provided some evidence that the right 
hemisphere is causally involved in different aspects of language processing, includ-
ing phonological decisions, reading, and the processing of paralinguistic features 
such as (emotional) prosody or metaphor processing (for a review, see Hartwigsen 
and Siebner  [10] ). 
 Adopting a novel dual-site approach in which TMS was applied either unilaterally 
over homologous areas in the left or right hemisphere or simultaneously to both 
hemispheres, we recently tested the functional relevance of the previously reported 
activation of the left and right supramarginal gyrus (SMG) for phonological judg-
ments  [11] . We thus applied 10 Hz online rTMS over either the left, right or bilateral 
SMG while subjects performed phonological judgments (does a word have 2 or 3 syl-
lables?) or semantic judgments (does a word represent a natural or man-made item?).
 We hypothesized that if right supramarginal activation is redundant to phonolog-
ical processing, then task performance should only be impaired when online TMS was 
applied over the left SMG but not the right SMG. In contrast, if the right SMG also 
contributes to phonological decisions, then task performance should also be disrupt-
ed with TMS of right SMG. The simultaneous application of TMS over the left and 
right SMG enabled us to test whether both areas can compensate a virtual lesion to 
the respective other area. We expected that if phonological decisions are possible with 
either the left or right SMG, the lesion effect should be greater when TMS was applied 
over both the left and right SMG. In contrast, if the left and right SMG are equally 
necessary for efficient phonological decisions, the effect of TMS should be the same 
irrespective of whether it was applied unilaterally or bilaterally.
 TMS relative to an ineffective sham procedure significantly impaired task perfor-
mance for phonological decisions, but not for the semantic task independent of the 
stimulated hemisphere. Additionally, we found that both hemispheres were equally 
sensitive to the disruptive effect of TMS. Together, these findings indicate that both 
hemispheres are equally necessary for intact phonological processing. Furthermore, 
the results suggest that efficient phonological judgments require both the left and the 
right SMG in healthy subjects without any evidence that both areas can compensate 
a lesion to the respective other area.
 In sum, these results indicate that the involvement of right-hemisphere language 
areas is not limited to aphasia recovery after stroke but is also essential for phono-
logical processing in healthy subjects.
 Other studies reported increased task-related neuronal activity in right-hemi-
sphere areas during language processing after the contralateral homologous area had 
been suppressed with offline rTMS  [12] . These studies show how offline TMS can be 
used to investigate short-term plasticity in language networks in the healthy brain 
which might ultimately contribute to the understanding how such networks reorga-
nize after long-term disruption such as occurring after stroke.
 With respect to potential beneficial effects of right-hemisphere noninvasive brain 
stimulation on language functions, Ross et al.  [13] recently demonstrated that anodal 
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tDCS over the right anterior temporal lobe improved naming possibilities in 15 
healthy subjects. These results suggest that anodal tDCS may have some potential to 
promote language recovery in patients with post-stroke aphasia.
 Reorganization of Language Networks after Stroke – Evidence from Repetitive 
Transcranial Magnetic Stimulation Studies 
 The majority of rTMS studies in post-stroke aphasia used low-frequency rTMS to 
inhibit contralateral homologous areas (for an overview, see Chrysikou and Hamil-
ton  [14] ). These studies were based on the assumption that following left-hemi-
sphere stroke, the right hemisphere is released from transcallosal inhibition and 
thus exerts an increased transcallosal inhibitory effect on perilesional regions of the 
left hemisphere, thereby suppressing language-related left-hemisphere activity. Ac-
cording to this interhemispheric inhibition model, improvements in language func-
tion after a left-hemisphere lesion can be achieved either by inhibition of right-
hemisphere activity or via facilitation of left-hemisphere activity  [15] ( fig. 1 a, c). For 
instance, in 4 patients with chronic aphasia after stroke, Naeser et al.  [16] showed 
that repeated daily application of 1 Hz rTMS over the right anterior inferior frontal 
gyrus significantly improved picture naming abilities for up to 2 months after treat-
ment. More recent studies suggest that the reported benefits in naming after 1 Hz 
























 Fig. 1. Different accounts of plasticity in language systems in chronic aphasia.  a After unilateral left-
hemisphere stroke (in gray), some language functions may be subserved by perilesional areas (in white). 
 b Right perisylvian areas (in white) may be recruited to subserve some language functions, a process 
facilitated by decreased transcallosal inhibition of the right hemisphere by the damaged left hemi-
sphere.  c By contrast, right-hemisphere activity may be deleterious. Released from interhemispheric in-
hibition, right-hemisphere structures (in black) may exert an increased inhibitory influence on left peri-
sylvian areas, impeding functional recovery of lesional and perilesional areas in the left hemisphere (in 
black). Modified and reprinted from Hamilton et al. [2], copyright (2011), with permission from Elsevier. 
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fluent aphasia generalize to other language abilities like spontaneous speech and 
auditory comprehension  [17] . 
 Of note, not all aphasic patients benefit from suppression of right-hemisphere ac-
tivation and lesion location might be a critical determinant of recovery success. It was 
further suggested that aphasia recovery might depend on the extent to which some 
areas are affected or spared by stroke  [18] .
 While many studies demonstrated that suppression of right-hemisphere activity 
after left-hemisphere stroke may promote recovery, evidence from other TMS studies 
suggests that the right hemisphere might also be critically contributing to language 
performance in some patients  [19, 20] ( fig. 1 b). This may indicate that although re-
covery from post-stroke aphasia seems to depend more on an effective integration of 
available perilesional left-hemisphere regions, right-hemisphere areas may be suc-
cessfully integrated in some cases  [19] . While the role of the contralesional right hemi-
sphere in language recovery is more controversial than that of the left hemisphere, a 
beneficial contribution of right-hemisphere areas to the successful reorganization of 
language networks after stroke is compatible with the results from previous neuroim-
aging studies (for a review, see Saur and Hartwigsen  [21] ). It has been argued that ad-
ditional factors such as premorbid laterality of language representation, the time 
course of recovery, and the lesion size are important determinants that might influ-
ence the successful integration of right-hemisphere activity during post-stroke reor-
ganization of language networks  [14] .
 A recent study explored the possibility of facilitating cortical activity in the left 
hemisphere to improve language recovery. Szaflarski et al.  [22] applied intermittent 
theta burst stimulation over Broca’s area in 8 chronic stroke patients with aphasia. In 
6 of the 8 patients, semantic fluency was improved after intermittent theta burst stim-
ulation, and subsequent functional magnetic resonance imaging data demonstrated a 
leftward shift in language-related activation. These preliminary results suggest that 
the application of facilitatory protocols over left-hemisphere perilesional areas may 
enhance language recovery.
 In sum, the potential of TMS to promote aphasia recovery after stroke remains to 
be determined as the results of the above-cited studies are heterogeneous and limited 
by the small number of patients included. Moreover, it is unclear whether TMS should 
target perilesional left-hemisphere areas or contralateral right-hemisphere areas to 
enhance neurorehabilitation. The use of TMS in clinical settings is further limited by 
the fact that stimulation can be unpleasant, especially if frontal regions like Broca’s 
area are targeted at high intensities. While the high focality of figure-of-eight-shaped 
TMS coils allows for the functional segregation of subareas, it requires anatomical 
specific hypotheses with respect to the precise desired stimulation site (e.g. anterior 
vs. posterior part of Broca’s area). Since accurate placement of the TMS coil over the 
cortical area of interest and continuous monitoring of the coil throughout the TMS 
experiment is crucial to assure high spatial accuracy, TMS may not be used simulta-
neously with language therapy.
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 Reorganization of Language Networks after Stroke – Evidence from Transcranial 
Direct Current Stimulation Studies 
 To date, only a few studies have applied tDCS in post-stroke aphasic patients to fa-
cilitate treatment in language recovery (see  table 1 for details). The majority of these 
studies investigated the effects of cathodal tDCS over perilesionel left-hemispheric 
regions to facilitate picture naming. For instance, Monti et al.  [23] showed that cath-
Table 1.  tDCS studies in aphasia

















L Broca 1 session: 10 min, 




Improved accuracy after 













5 days: 20 min, 




Improved accuracy after 
anodal vs. sham tDCS





21–71 Wernicke’s L Wernicke 5 days: 20 min, 




Improved accuracy after 
anodal vs. sham tDCS on 















3 days: 2 × 20 min, 
1 mA online, 




Improved accuracy for 
anodal vs. cathodal 




8 L posterior cortical or 
subcortial





Faster reaction times 
after anodal vs. sham 


















ing accuracy after cath-




6 L frontal 15–120 Broca’s R inferior
frontal
gyrus
3 days: 20 min,





Increased fluency with 
















10 sessions in two 









prehension for cathodal 
vs. anodal or sham tDCS
 L = Left; R = right.
 Naritomi H, Krieger DW (eds): Clinical Recovery from CNS Damage.
Front Neurol Neurosci. Basel, Karger, 2013, vol 32, pp 101–111 ( DOI: 10.1159/000346431) 
108 Hartwigsen · Siebner 
odal tDCS significantly improved picture naming in 8 ischemic stroke patients with 
aphasia. It was concluded that the effect of cathodal stimulation may be a downregu-
lation of overactive inhibitory cortical interneurons in the lesioned hemisphere that 
ultimately give rise to increased activity and function in the damaged left hemisphere. 
In contrast, several other investigators have reported improved language performance 
after either anodal stimulation of the left hemisphere or cathodal stimulation of the 
right hemisphere  [24–26] . Recently, two studies found significant language improve-
ment after anodal tDCS over the right hemisphere  [27, 28] . These preliminary results 
suggest that an upregulation of right-hemisphere activity may be beneficial for lan-
guage recovery in some patients. 
 The above-cited studies show that tDCS might be of potential benefit in promoting 
aphasia recovery after stroke. However, the results are heterogeneous and it is cur-
rently impossible to judge the value of tDCS as a means to enhance neurorehabilita-
tion of language. For instance, it remains to be determined whether anodal or cath-
odal tDCS should be applied to perilesional left-hemisphere regions or contralateral 
right-hemisphere areas.
 With respect to the usability of tDCS in clinical settings, an important advantage 
of tDCS compared with TMS is the relatively easy application and the absence of any 
severe side effects if tDCS is applied within the published safety guidelines. Finally, 
tDCS can be administered concurrently with language therapy and may be easily ap-
plied in double-blind settings.
 A Hierarchical Model of Aphasia Recovery after Stroke 
 While many of the studies discussed above were based on the assumption that sup-
pression of activity in the ‘overactive’ right hemisphere after left-hemisphere stroke 
may promote language recovery, others provided some evidence that the right hemi-
sphere might play a beneficial role in aphasia recovery. Consequently, it was argued 
that language recovery is a dynamic process that may involve a variety of plastic 
changes in both hemispheres  [2] . In their hierarchical model of language recovery, 
Heiss and Thiel  [29] assumed that with small left-hemisphere lesions, complete or 
near-complete language recovery may be achieved by restoration of normal patterns 
of activation in left-hemisphere language networks. If lesions of the left hemisphere 
damage important language centers, perilesional regions may be recruited to subserve 
language functions. However, when left-hemisphere networks are more severely im-
paired, the right hemisphere appears to be capable of assuming some functions. While 
right-hemisphere recruitment for language tasks may contribute to overall language 
recovery in severely affected patients, the remodeled language network in these pa-
tients is likely inefficient compared with premorbid intact left-hemisphere perisylvian 
regions. The hierarchical model of effective aphasia recovery is based on the assump-
tion that best recovery is achieved when left-hemisphere language networks recover 
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normal function. According to this model, good recovery is achieved when perile-
sional left-hemisphere areas compensate for damaged left-hemisphere language re-
gions. In contrast, a preferential recruitment of the right hemisphere during language 
tasks is associated with limited recovery from aphasia because of limited right-hemi-
spheric processing capacities with respect to language. 
 Conclusions and Future Directions 
 Recent studies provide some first evidence that noninvasive brain stimulation tech-
niques might be beneficial in promoting aphasia recovery after stroke. However, al-
though these preliminary results are interesting, they should be interpreted with cau-
tion and the therapeutic potential of the various transcranial cortex stimulation pro-
tocols still remains to be determined. The reported findings are inconsistent and 
partly contradictory. For instance, there is strong variation across studies with respect 
to the outcome of different stimulation protocols (e.g. anodal vs. cathodal tDCS) and 
the optimal stimulation site (i.e., perilesional left-hemisphere regions vs. right hemi-
sphere homologues). Further, previous studies only included a small number of pa-
tients (usually less than 10 patients per group) and the reported effect sizes were mod-
erate. Some studies lacked control groups and subject blinding. The literature on non-
invasive brain stimulation in aphasia recovery is further limited by the fact that there 
are no long-term investigations on the duration of the reported effects. Future studies 
should investigate larger patient collectives to explore whether noninvasive brain 
stimulation can enhance language functions at a level that is clinically relevant beyond 
the time of stimulation. Here, the combination of brain stimulation and language 
therapy seems promising. These studies should also address the optimal time point of 
intervention (i.e., before, during or after language therapy). Finally, it might also be 
promising to use multifocal approaches allowing for the simultaneous application of 
TMS over multiple brain sites within specific language networks. 
 One possible explanation for the partly inconsistent findings across different stud-
ies is that language recovery is a dynamic process that involves both hemispheres at 
different times to different degrees  [30] . Future studies should systematically investi-
gate the use of different protocols over the time course of recovery to advance the cur-
rent knowledge about critical areas for specific language functions during language 
reorganization. For instance, it might be worthwhile to apply facilitatory protocols 
over right-hemisphere homologue regions in the subacute phase after stroke while an 
enhancement of left-hemisphere functions may be more beneficial in the chronic 
phase after stroke.
 A possible way forward is to use multimodal approaches combining different meth-
ods, such as functional and structural imaging with transcranial stimulation tech-
niques in both healthy volunteers and stroke patients with aphasia to identify critical 
networks for different language functions across the time course of recovery  [21] . 
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 Abstract 
 In recent years, efforts have focused on investigating the neurophysiological changes that occur in 
the brain after stroke, and on developing novel strategies such as additional brain stimulation to 
enhance sensorimotor and cognitive recovery. In the 1990s, repetitive transcranial magnetic stimu-
lation (rTMS) was introduced as a therapeutic tool for improving the efficacy of rehabilitation for 
recovery after stroke. It is evident that disturbances of interhemispheric processes after stroke result 
in a pathological hyperactivity of the intact hemisphere. The rationale of using rTMS as a comple-
mentary therapy is mainly to decrease the cortical excitability in regions that are presumed to hinder 
optimal recovery by low-frequency rTMS delivered to the unaffected hemisphere, while high-fre-
quency rTMS delivered to the affected hemisphere facilitates cortical excitability. However, the exact 
mechanisms of how rTMS works are still under investigation. There is a growing body of research in 
stroke patients investigating the effect of rTMS on facilitating recovery by modifying cortical and 
subcortical networks. Clinical trials applying rTMS already yielded promising results in improving 
recovery of sensorimotor and cognitive functions. Altogether, in combination with conventional 
therapeutic approaches, rTMS has a potential to become a complementary strategy to enhance 
stroke recovery by modulating the excitability of targeted brain areas. In future studies, emphasis 
should be placed on selecting patient populations to determine whether treatment response de-
pends on age, lesion acuteness, or stroke severity. Furthermore, it is important to identify parameters 
optimizing the beneficial effects of rTMS on stroke recovery, and to monitor their long-term effects. 
 Copyright © 2013 S. Karger AG, Basel 
 Stroke is a leading cause of disability and the burden of stroke is borne disproportion-
ately by older people who have a greater incidence and prevalence of ischemic stroke 
than younger individuals. For each successive 10 years after 55 years of age, the stroke 
rate more than doubles in both men and women; 65% of all strokes occur in individ-
uals older than 65 years. Five million survivors are left permanently disabled, with 
complications including motor (50–83%), cognitive (50%) and language impairments 
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(23–36%), as well as psychological disturbances (20%)  [1] . Estimates indicate that 
33–42% of patients still require assistance for activities of daily living 6 years after 
stroke, and that 36% of patients remain disabled after 5 years  [2] . 
 Recovery after stroke is complex. Many interventions have been developed to sup-
port recovery of impairment and associated functions, and a number of randomized 
controlled trials and systematic reviews investigated their effectiveness in stroke re-
habilitation  [3] .
 Additionally to established therapies (e.g. constraint-induced movement therapy, 
robotic-assisted strategies, repetitive task training, cognitive training and speech ther-
apy), a noninvasive brain stimulation technique, such as transcranial magnetic stimu-
lation (TMS), has been developed. This stimulation interacts with spontaneous brain 
activity and influences sensorimotor and higher-order cognitive abilities.
 In the 1980s, TMS was originally introduced in clinical neurophysiology for the 
evaluation of the functional state of the corticospinal pathway  [4] .
 In the 1990s, technological advances allowed the delivery of rhythmic trains of 
magnetic pulses in a rapid sequence up to a 100-Hz repetition rate, which was referred 
to as repetitive TMS (rTMS). It was reported that rTMS interacts with cortical activ-
ity more effectively than TMS. In recent years, rTMS has been rapidly developed as a 
potential therapeutic tool in many other clinical fields  [5] .
 Principles of Repetitive Transcranial Magnetic Stimulation and Biological Aspects 
 The primary property of magnetic stimulation is its ability to penetrate all body struc-
tures, allowing stimulation of regions below layers of bone (e.g. the brain). 
 Single-pulse TMS applied on the scalp overlying the primary motor cortex (M1) 
assesses the excitability and conductivity of corticospinal motor pathways. This ap-
proach has primarily been applied in studies of movement physiology in patients 
with neurological disorders and in postlesion follow-up studies of plastic cerebral 
reorganization. Paired-pulse techniques have been shown to provide measures of 
intracortical facilitation and inhibition as well as corticocortical interactions, which 
are important when evaluating changes in functionality. When multiple stimuli of 
TMS are delivered in trains, one can differentiate conventional and patterned pro-
tocols of repetitive stimulation. For conventional protocols, there is agreement on 
the term rTMS. Application of rTMS influences neural excitability of selected brain 
areas. Low-frequency rTMS of  ≤ 1 Hz was found to suppress while high-frequency 
rTMS of  ≥ 5 Hz was observed to facilitate local neural activities  [6] . Nevertheless, it 
is speculated that low-frequency rTMS to the nonaffected hemisphere reduces in-
terhemispheric inhibition towards the affected hemisphere, leading to facilitation of 
beneficial functional reorganization in the affected hemisphere  [7] . Patterned rTMS 
refers to a repetitive application of short rTMS bursts at a high inner frequency, 
which are separated by short pauses of no stimulation. Theta burst stimulation 
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(TBS) is the most commonly used method of patterned rTMS. In TBS, short bursts 
of 50-Hz rTMS are repeated as a continuous or intermittent train at a rate in the 
theta range (5 Hz). The excitatory and inhibitory effects of this type of stimulation 
can be manipulated by continuous or intermittent delivery of these theta bursts over 
time  [8] . The TBS protocol has been used to modulate motor thresholds  [8] and 
cognitive functions  [9] . Recently, quadripulse stimulation, which is able to induce 
long-term changes in cortical excitability, has been added to the patterned rTMS 
procedures  [9] . 
 Moreover, it was reported that 1-Hz cortical inhibitory effects on a stimulated area 
were dependent on both GABA and NMDA receptor system activity, whereas high-
frequency stimulation might rely on the same system but have opposite effects. Both, 
long-term depression and long-term potentiation have been postulated as likely 
mechanisms to explain the persistent effects of rTMS on cortical activity.
 The use of rTMS in the clinical practice depends mainly on its ability to transient-
ly interact with the stimulated neural network rather than its ability to modulate cor-
tical excitability. Therefore, rTMS can be used with two distinct approaches: on-line 
stimulation (rTMS is applied during the performance of a task) and off-line stimula-
tion (rTMS is applied before). In general, it is assumed that on-line rTMS induces an 
alteration of cortical activity within a specific targeted area that can significantly im-
pair performance, and the effect of on-line rTMS is short-lived. In the case of off-line 
stimulation, rTMS affects the modulation of cortical excitability and aims to change 
the cognitive and motor performance.
 Nevertheless, modification of the activity of a neural network by rTMS carries im-
portant behavioral implications for neurorehabilitation, which will be considered lat-
er. It was reported that the effects induced by several off-line rTMS approaches were 
site specific, but not site limited. Thus, the long-term consequences induced by sus-
tained repetitive brain stimulation were most likely due to activity changes in a given 
network of cortical and subcortical areas rather than a local inhibition or excitation 
of an individual brain area. In other words, brain stimulation can modulate the on-
going properties of a neuronal network by facilitation or reduction of its activity. 
Since the brain mainly operates through flexible and interactive distributed networks, 
we can expect that the modification of a node of the network would affect the entire 
network.
 Repetitive Transcranial Magnetic Stimulation Modifies Sensorimotor and Cognitive 
Recovery 
 The most common impairment caused by stroke is motor impairment, appearing as 
a limitation or loss of function in motor control or a limitation in mobility. Therefore, 
the focus of stroke rehabilitation is often on the recovery of impaired movement and 
the associated functions based on the paradigm of motor learning. In recent years, ef-
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forts have focused on investigating the neurophysiological changes that occur in the 
brain after stroke, and on developing novel strategies such as additional brain stimu-
lation to enhance motor recovery. In particular, rTMS is known as a therapeutic tool 
for improving the efficacy of rehabilitation for motor recovery after stroke. In addi-
tion to producing effects on cortical excitability, stroke may affect the balance of trans-
callosal inhibitory pathways between primary motor areas in both hemispheres: the 
affected hemisphere may be disrupted not only by the infarct itself but also by the 
resulting asymmetric inhibition from the unaffected hemisphere. Therefore, rTMS 
could be used therapeutically to restore the balance of interhemispheric inhibition 
after stroke. According to the interhemispheric competition model, there are two 
therapeutic strategies for improvement of motor function using rTMS: downregula-
tion of the excitability of the primary motor cortex in the nonaffected hemisphere 
with low-frequency stimulation, and upregulation of excitability of the primary motor 
cortex in the affected hemisphere with high-frequency stimulation  [6] . All in all, stud-
ies have not determined if the facilitation of the affected hemisphere  [10] or the inhi-
bition of the unaffected contralateral hemisphere  [11–13] is more effective in improv-
ing the hampered function. 
 The downregulation strategy has been proven to be effective in consecutive multi-
session trials for acute and chronic stroke in children and adults. On the other hand, 
the upregulation strategy has rarely been applied, primarily due to safety concerns, 
since it was thought that high-frequency rTMS would increase the risk of seizures. 
Nevertheless, Corti et al.  [14] recently reviewed the evidence regarding the safety, and 
efficacy of high-frequency rTMS to the motor cortex of the affected hemisphere was 
collated. The studies included in this systematic review investigated the concurrent 
effects of rTMS on the excitability of corticospinal pathways and upper-limb motor 
function in adults after stroke. The authors concluded that rTMS applied to the af-
fected hemisphere is a safe technique and could be considered as an effective approach 
for modulating brain function and contributing to motor recovery after stroke. More-
over, some researchers studying the motor cortex have suggested that the stimulation 
of both areas would be the most effective strategy  [15] .
 Another frequent motor symptom following stroke is dysphagia. Up to one third 
of patients experience swallowing problems in the period immediately after a stroke. 
Most patients recover swallowing ability within a few weeks, but the extent of recov-
ery varies widely from patient to patient. Previous studies using TMS have demon-
strated the presence of a direct corticobulbar projection to swallowing muscles from 
the motor cortex  [16] . The projection is bilateral, but is often asymmetric, indepen-
dent of handedness. Hamdy  [16] has suggested that if a stroke affects the dominant 
swallowing hemisphere, then dysphagia is more likely to occur than if the nondom-
inant hemisphere is affected. Several lines of evidence show that the cortex retains 
its potential for reorganization after stroke, both in the damaged and undamaged 
hemispheres. This offers the possibility to modify the corticobulbar network by 
stimulation.
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 A recent study reported that 5 daily sessions of rTMS over the esophageal motor 
cortex of the affected hemisphere improve clinical recovery of swallowing functions 
in patients with acute monohemispheric stroke, and that, compared with the sham 
group, this recovery was maintained for at least 2 months  [17] . In addition, the elec-
trophysiological measures on 10 patients who received real rTMS indicate that the 
recovery is associated with an increase in the excitability of the corticobulbar projec-
tions from both hemispheres. Furthermore, Khedr and Abo-Elfetoh  [18] have shown 
in a randomized controlled study that active rTMS applied to each hemisphere (af-
fected and unaffected) – compared with sham rTMS – improved swallowing function 
in patients with acute lateral medullary or other brainstem infarctions. This improve-
ment was maintained over 2 months of follow-up.
 Cognitive impairment is a frequent consequence of stroke, with estimates of 50% 
of patients presenting cognitive impairment in the early phase after stroke  [1] , and up 
to 32% of patients demonstrating persistent cognitive impairment up to 3 years after 
the onset of their first stroke  [19] .
 Approximately 40–81% of stroke patients after stroke demonstrate hemineglect, 
and this symptom is sustained in approximately one third of these patients  [20] . 
Hemispatial neglect can result from lesions to different structures within an extended 
attentional network, such as the inferior and posterior parietal lobe, the superior tem-
poral lobe, the inferior frontal lobe, basal ganglia and thalamus, and connecting fiber 
tracts  [21] . Furthermore, hemineglect interferes with the rehabilitative process and is 
associated with a poor functional outcome.
 rTMS – as a noninvasive technique modulating cortical activity – gains growing 
importance in the field of hemispatial neglect treatment. In neglect patients after 
stroke, it has been proposed that neuronal activities in contralesional homologous 
regions are increased due to a loss of active interhemispheric inhibition  [5] . In line 
with this finding, it has been reported in few small studies that reducing activity in the 
left nonaffected parietal lobe by applying inhibitory low-frequency rTMS can improve 
hemineglect by reducing abnormally increased interhemispheric transcallosal inhibi-
tion from the nonaffected to the affected cortex  [22, 23] .
 In a recent study by Song et al.  [24] , the effects of repeated applications of low-
frequency rTMS over the posterior parietal cortex were investigated in a total of 14 
right-hemispheric neglect patients. Seven patients were treated with rTMS during 
2 weeks, twice a day, whereas 7 patients had no stimulation. Repeated application of 
low-frequency rTMS resulted in a significant improvement lasting 2 weeks, whereas 
no improvement was found in the control group without stimulation. In this study, 
confounding learning effects were controlled and spontaneous remission was ac-
counted for. However, since the study did not include a sham stimulation group, it is 
difficult to exclude unspecific placebo-like effects.
 Newly developed protocols such as TBS present shorter stimulation times and their 
repeated application can significantly prolong the effects on cortical excitability. The 
repeated TBS application has thus a promising future as rehabilitative approach in 
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neglect  [25] . Moreover, in a recent review it was concluded that rTMS is a promising 
approach to reduce the interhemispheric imbalance in neglect patients and to ame-
liorate symptoms  [26] .
 Aphasia is a frequent consequence of stroke with serious effects on the patient’s 
autonomy. Although speech therapy significantly improves language and communi-
cation deficits particularly in very early stroke recovery, residual aphasia has a multi-
factorial impact on quality of life and participation.
 With reference to the theory of transcallosal disinhibition  [27] , recent studies in 
stroke patients with chronic aphasia suggest that the restoration of the left-hemi-
spheric language network by inhibition of the overactive right homologous frontal 
speech areas with rTMS as a complementary treatment is linked to better recovery in 
language and communication deficits  [28] . Moreover, a recent functional imaging 
study proposed that inhibitory rTMS of the right-hemispheric Broca homolog to-
gether with subsequent speech therapy prevents establishing right-hemispheric later-
alization and that this normalization of the activation pattern might be accompanied 
by better clinical improvement  [29] .
 In a recent article, Naeser et al.  [30] concluded that new rTMS studies suggested 
that the use of 1-Hz rTMS for a series of at least 10 rTMS treatments results in sig-
nificant improvement in naming, and often in phrase length during propositional 
speech. These improvements are long lasting, up to 2 months, or even as long as 
2 years, after TMS. Moreover, when rTMS is combined with speech therapy, addi-
tional improvement has been observed, beyond rTMS alone.
 Although the stimulation protocol varies ( table 1 ), most of the mentioned studies 
concluded that rTMS is an effective, safe and feasible complementary therapy for 
stroke rehabilitation.
 The idea behind rTMS is that modification of the cortical excitability leads to a re-
organization of the functional network responsible for the impaired function. The 
function may be restored by mechanisms that involve structural as well as functional 
changes of the neuronal circuits. Following the loss of a part of the neural population 
after stroke, a reduction of excitability of cortical neurons within the affected area 
might induce a depression of the circuit underlying the function, resulting in an im-
paired function. Thus, rTMS can induce a partial recovery of sensorimotor and cog-
nitive abilities, which may be due to a strengthening of the synaptic activity of the 
surviving neurons in the stimulated network.
 Another aspect is that areas – connected or adjacent to the lesion – become ‘silent’ 
due to diaschisis, and therefore lesion-induced effects are weakening the synaptic ac-
tivity resulting in silent synapses. In line with this, rTMS might induce a readjustment 
of an intact but ‘functionally’ suppressed area due to a reduction in synaptic strength. 
On the other hand, strengthening the synaptic activity by applying rTMS leads to 
more effective processing within the functional network.
 Finally, it has been suggested that lesion-induced plasticity might be stronger 
when it occurs shortly after stroke, and this plasticity becomes weaker as more time 
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is over. Several experiments have reported that plasticity changes were not caused 
by rTMS alone; they also require a focused rehabilitation procedure. Therefore, the 
best way to facilitate recovery is to stimulate the area and activate the network 
 supporting the specific function. This approach can be achieved by combining ex-
ogenously induced plasticity by applying rTMS with a specific training-induced 
plasticity like focused rehabilitation procedures.
 Altogether, rTMS – which as a technique is able to noninvasively modulate cortical 
activity – gains growing importance in the field of stroke recovery. The possibility of 
noninvasively interacting with the functioning of the brain and its plasticity mecha-
nisms opens new scenarios in the neurorehabilitation field.
 Conclusion 
 A growing body of research in stroke patients indicated that cortical and subcortical 
networks are involved in sensorimotor and cognitive dysfunction and that rTMS can 
facilitate recovery of motor and cognitive functions. The literature provides evidence 
for the disturbance of interhemispheric rivalry processes as a central pathophysio-
logical mechanism in sensorimotor and cognitive dysfunctions, resulting in a patho-
logical hyperactivity of the intact nonaffected hemisphere. Thus, a reduction of this 
pathological hyperactivity by means of inhibitory rTMS seems to be an effective ap-
proach to improve sensorimotor and cognitive symptoms after stroke. However, it 
is still debatable which paradigm of rTMS (downregulation with low-frequency 
rTMS vs. upregulation with high-frequency rTMS) should be applied to enhance re-
covery after stroke. 
 Clinical trials applying rTMS already yielded very promising results. The results of 
rTMS studies suggest that rTMS has a potential role in terms of facilitating motor and 
cognitive recovery after stroke, and thus findings support the merits of noninvasive 
cortical interventions as adjuvant strategies during sensorimotor and cognitive reha-
bilitation. In recent studies, it has been shown that particularly the repeated applica-
tion of newly developed stimulation protocols such as TBS seems to be able to dispro-
portionately prolong the positive stimulation effects by means of significantly shorter 
stimulation times than conventional protocols. However, further research is needed 
to assess stimulation effects not only on clinical testing, but also in terms of disability 
improvement. Beneficial effects of rTMS on recovery after stroke in the framework of 
prospective, randomized, double-blind, sham-controlled clinical trials with larger 
sample sizes are needed to validate this novel therapeutic approach. Moreover, pos-
sible interactions in the combination of rTMS with conventional therapeutic ap-
proaches should also be assessed.
 In future studies, emphasis should be placed on selecting patient populations to 
determine whether treatment response depends on age, lesion acuteness, or stroke 
severity. Additional aspects need to be considered, such as the timing of rTMS ap-
 Naritomi H, Krieger DW (eds): Clinical Recovery from CNS Damage.
Front Neurol Neurosci. Basel, Karger, 2013, vol 32, pp 112–121 ( DOI: 10.1159/000346433 )
120 Pinter · Brainin 
 References 
 1 Paul SL, Srikanth VK, Thrift AG: The large and 
growing burden of stroke. Curr Drug Targets 2007; 
 8: 786–793. 
 2 Feigin VL, Barker-Collo S, McNaughton H, Brown 
P, Kerse N: Long-term neuropsychological and func-
tional outcomes in stroke survivors: current evi-
dence and perspectives for new research. Int J Stroke 
2008; 3: 33–40. 
 3 Langhorne P, Bernhardt J, Kwakkel G: Stroke reha-
bilitation. Lancet 2011; 377: 1693–1702. 
 4 Barker AT, Jalinous R, Freeston IL: Non-invasive 
magnetic stimulation of human motor cortex. Lan-
cet 1985;i:1106–1107. 
 5 Hummel FC, Cohen LG: Non-invasive brain stimu-
lation: a new strategy to improve neurorehabilitation 
after stroke? Lancet Neurol 2006; 5: 708–712. 
 6 Fitzgerald PB, Fountain S, Daskalakis ZJ: A compre-
hensive review of the effects of rTMS on motor corti-
cal excitability and inhibition. Clin Neurophysiol 
2006; 117: 2584–2596. 
 7 Mansur CG, Fregni F, Boggio PS, Riberto M, Galluc-
ci-Neto J, Santos CM, Wagner T, Rigonatti SP, Mar-
colin MA, Pascual-Leone A: A sham stimulation-
controlled trial of rTMS of the unaffected hemisphere 
in stroke patients. Neurology 2005; 64: 1802–1804. 
 8 Huang YZ, Edwards MJ, Rounis E, Bhatia, KP, Roth-
well JC: Theta burst stimulation of the human motor 
cortex. Neuron 2005; 45: 201–206. 
 9 Miniussi C, Rossini PM: Transcranial magnetic stim-
ulation in cognitive rehabilitation. Neuropsychol Re-
habil 2011; 236: 138–144. 
 10 Chang WH, Kim YH, Yoo WK, Goo KH, Park CH, 
Kim ST, Pascual-Leone A: rTMS with motor training 
modulates cortico-basal ganglia-thalamocortical cir-
cuits in stroke patients. Restor Neurol Neurosci 
2012; 30: 179–189. 
 11 Kakuda W, Abo M, Shimizu M, Sasanuma J, Oka-
moto T, Yokoi A, Taguchi K, Mitani S, Harashima H, 
Urushidani N, Urashima M: A multi-center study on 
low-frequency rTMS combined with intensive occu-
pational therapy for upper limb hemiparesis in post-
stroke patients. J Neuroeng Rehabil 2012; 9: 4. 
 12 Avenanti A, Coccia M, Ladavas E, Provinciali L, Cer-
avolo MG: Low-frequency rTMS promotes use-de-
pendent motor plasticity in chronic stroke: a ran-
domized trial. Neurology 2012; 78: 256–264. 
 13 Seniów J, Bilik M, Lesniak M, Waldowski K, Iwanski 
S, Czlonkowska A: Transcranial magnetic stimula-
tion combined with physiotherapy in rehabilitation 
of poststroke hemiparesis: a randomized, double-
blind, placebo-controlled study. Neurorehabil Neu-
ral Repair 2012; 26: 1072–1079. 
 14 Corti M, Patten C, Triggs W: Repetitive transcranial 
magnetic stimulation of motor cortex after stroke: a 
focused review. Am J Phys Med Rehabil 2012; 91: 
 254–270. 
 15 Takeuchi N, Tada T, Toshima M, Matsuo Y, Ikoma 
K: Repetitive transcranial magnetic stimulation over 
bilateral hemispheres enhances motor function and 
training effect of paretic hand in patients after stroke. 
J Rehabil Med 2009; 41: 1049–1054. 
 16 Hamdy S: The organisation and reorganisation of 
human swallowing motor cortex. Suppl Clin Neuro-
physiol 2003; 56: 204–210. 
 17 Khedr EM, Abo-Elfetoh N, Rothwell JC: Treatment 
of post-stroke dysphagia with repetitive transcranial 
magnetic stimulation. Acta Neurol Scand 2009; 119: 
 155–161. 
 18 Khedr EM, Abo-Elfetoh N: Therapeutic role of 
rTMS on recovery of dysphagia in patients with lat-
eral medullary syndrome and brainstem infarction. J 
Neurol Neurosurg Psychiatry 2010; 81: 495–499. 
 19 Patel M, Coshall C, Rudd A, Wolfe C: Natural his-
tory of cognitive impairment after stroke and factors 
associated with its recovery. Clin Rehabil 2003; 7: 
 158–166. 
 20 Arene NU, Hillis AE: Rehabilitation of unilateral 
spatial neglect and neuroimaging. Eura Medicophys 
2007; 43: 255–269. 
 21 Verdon V, Schwartz S, Lovblad KO, Hauert CA, Vuil-
leumier P: Neuroanatomy of hemispatial neglect and 
its functional components: a study using voxel-based 
lesion-symptom mapping. Brain 2010; 133: 880–894. 
 22 Shindo K, Sugiyama K, Huabao L, Nishijima K, Kon-
do T, Izumi S: Long-term effect of low-frequency re-
petitive transcranial magnetic stimulation over the 
unaffected posterior parietal cortex in patients with 
unilateral spatial neglect. J Rehabil Med 2006; 38: 65–
67. 
plication after stroke, the duration of the rehabilitation protocol, the type of fre-
quency as well as the ideal area that should be stimulated. Furthermore, it is impor-
tant to identify parameters optimizing the beneficial effects of rTMS on stroke re-
covery, and to monitor their long-term effects. 
 Naritomi H, Krieger DW (eds): Clinical Recovery from CNS Damage.
Front Neurol Neurosci. Basel, Karger, 2013, vol 32, pp 112–121 ( DOI: 10.1159/000346433 )
 Role of rTMS in Stroke Rehabilitation 121
 23 Koch G, Oliveri M, Cheeran B, Ruge D, Lo Gerfo E, 
Salerno S, Torriero S, Marconi B, Mori F, Driver J, 
Rothwell JC, Caltagirone C: Hyperexcitability of pa-
rietal-motor functional connections in the intact 
left-hemisphere of patients with neglect. Brain 2008; 
 131: 3147–3155. 
 24 Song W, Du B, Xu Q, Hu J, Wang M, Luo Y: Low-
frequency transcranial magnetic stimulation for vi-
sual spatial neglect: a pilot study. J Rehabil Med 2009; 
 41: 162–165. 
 25 Nyffeler T, Cazzoli D, Hess CW, Müri RM: One ses-
sion of repeated parietal theta burst stimulation 
trains induces long-lasting improvement of visual 
neglect. Stroke 2009; 40: 2791–2796. 
 26 Cazzoli D, Müri RM, Hess CW, Nyffeler T: Treat-
ment of hemispatial neglect by means of rTMS – A 
review. Restor Neurol Neurosci 2010; 28: 499–510. 
 27 Heiss WD, Thiel A: A proposed regional hierarchy in 
recovery of post-stroke aphasia. Brain Lang 2006; 98: 
 118–123. 
 28 Abo M, Kakuda W, Watanabe M, Morooka A, 
Kawakami K, Senoo A: Effectiveness of low-frequen-
cy rTMS and intensive speech therapy in poststroke 
patients with aphasia: a pilot study based on evalua-
tion by fMRI in relation to type of aphasia. Eur Neu-
rol 2012; 68: 199–208. 
 29 Weiduschat N, Thiel A, Rubi-Fessen I, Hartmann A, 
Lessöer J, Merl P, Kracht L, Rommel T, Heiss WD: 
Effects of repetitive transcranial magnetic stimula-
tion in aphasic stroke: a randomized controlled pilot 
study. Stroke 2011; 42: 409–415. 
 30 Naeser MA, Martin PI, Ho M, Treglia E, Kaplan E, 
Bashir S, Pascual-Leone A: Transcranial magnetic 
stimulation and aphasia rehabilitation. Arch Phys 
Med Rehabil 2012; 93(1 suppl 1):26–34. 
 Michaela M. Pinter 
 Department for Clinical Neurosciences and Preventive Medicine
Danube University Krems ,  Dr. Karl-Dorrek-Strasse 30 
 AT–3500 Krems (Austria) 
 E-Mail michaela.pinter   @   donau-uni.ac.at 
Naritomi H, Krieger DW (eds): Clinical Recovery from CNS Damage.
Front Neurol Neurosci. Basel, Karger, 2013, vol 32, pp 122–128 ( DOI: 10.1159/000346428 )
 Abstract 
 The protective effect of therapeutic hypothermia in cerebral ischemia is well accepted in experimen-
tal models, and some clinical studies show that there is benefit in humans as well. Long-term obser-
vations in animal and clinical studies have documented recovery of neurological function following 
hypothermia treatment. Diminished damage by hypothermic protection should contribute to the 
recovery in many ways, but hypothermia appears to enhance regeneration of brain tissue as well. 
Since regeneration of the brain after damage initiates within hours and is active days and weeks af-
ter stroke, prolonged hypothermia might affect regenerative processes which have been document-
ed to occur in these time frames. As there is a lack of data at the basic and clinical levels, the mecha-
nism of neuroregeneration by hypothermia is unclear. Yet, we speculate that hypothermia 
enhances regeneration by positively influencing neurogenesis, angiogenesis, gliogenesis and syn-
apse/circuit formation after stroke. In this chapter, we will provide up-to-date data from experimen-
tal studies and clinical reports on the effect of therapeutic hypothermia on neuroregeneration, with 
perspectives on future research.  Copyright © 2013 S. Karger AG, Basel 
 Recent studies have demonstrated that neurogenesis is evident following injury in the 
adult brain within the germinal niches in the subventricular zone of the lateral ven-
tricle and the subgranular zone as well as the neocortex, spinal cord, tegmentum, sub-
stantia nigra, amygdala, brain stem and regions adjacent to the injury  [1] . Neurogen-
esis is thought to be stimulated by cytokines, chemokines, neurotransmitters, and 
reactive oxygen/nitrogen species released by dying neurons and activated macro-
phages, microglia, and astrocytes  [2] . Complete neurogenesis requires multiple steps 
including proliferation, migration, differentiation, survival, and integration of new 
neurons into the existing circuitry of the brain. However, while neurogenesis signals 
 Influence of Therapeutic Hypothermia on 
Regeneration after Cerebral Ischemia 
 M.A. Yenari a  • H.S. Han b 
 a   Department of Neurology, University of California, and San Francisco Veterans Affairs Medical Center, 
 San Francisco, Calif. , USA;  b   Department of Physiology, Kyungpook National University School of Medicine, 
 Daegu , Republic of Korea
 
Naritomi H, Krieger DW (eds): Clinical Recovery from CNS Damage.
Front Neurol Neurosci. Basel, Karger, 2013, vol 32, pp 122–128 ( DOI: 10.1159/000346428 )
 Hypothermic Neuroregeneration 123
appear after injury, successful replacement or regeneration of the damaged brain is 
scarcely observed. Thus, attempts at successful neurogenesis often fail. 
 Abrupt changes after stroke disrupt brain homeostasis and shift the environmental 
condition from maintenance of mature brain cells to resurrection of dormant stem 
cells. The initial environment after stroke is considered as proregenerative. But with 
the progression of brain injury, the environment becomes antiregenerative again. 
Thus, therapies should be explored that can promote successful regeneration of in-
jured brain by preventing or reducing this antiregenerative environment. Therapeutic 
hypothermia is not only known to prevent serious damage by inhibiting cell death and 
suppressing the damaging effects of inflammation, but it also stimulates stem cells by 
modulating a wide spectrum of biological events  [3, 4] . We expect that these features 
of hypothermia lead to an overall net benefit to brain regeneration. Especially when 
maintained for longer durations, therapeutic hypothermia would be expected to mod-
ulate many steps of the regenerative processes. In this chapter, we will provide up-to-
date data from experimental studies including stroke, traumatic brain injury and oth-
er acute brain injury models, and clinical reports on hypothermic neuroregeneration 
and suggest areas in need of further investigation.
 Hypothermia and Regeneration in Experimental Models 
 In contrast to neuroprotection, which targets the salvage of dying cells, neuroregen-
eration strategies attempt to enhance signaling pathways involved in the regeneration 
and remodeling of damaged tissue. Neurotrophic factors in the brain control synaptic 
function and plasticity and sustain neuronal cell survival, morphology, and differen-
tiation. In studies in which hypothermia had neuroprotective effects against ischemic 
brain insults, brain levels of brain-derived neurotrophic factor  [5, 6] , glial-derived 
neurotrophic factor  [7] and neurotrophin  [8] were all increased. The scope of regen-
eration will be discussed as it pertains to neurogenesis, neuronal connectivity, angio-
genesis, and gliogenesis. 
 Neurogenesis 
 While neurogenesis in the uninjured aged brain is markedly reduced, some rodent 
studies have shown that acute brain insults initiate the proliferation of neural stem 
cells in the subventricular zone and the hippocampal subgranular zone  [9] . After 
stroke, ischemic neurons also lose synaptic connectivity and undergo cell death. It is 
becoming increasingly recognized that endogenous recovery processes are also acti-
vated after stroke, leading to neurogenesis and synaptogenesis. However, these regen-
erative processes are probably not successful or are incomplete, as evidenced by the 
permanent disability in most stroke patients. Furthermore, rodent studies indicate 
that neurogenesis is reduced in aged brains, and stroke seen more frequently in the 
elderly  [10] . 
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 Strategies to improve regenerative processes should attempt to enhance prolifera-
tion of neuronal precursor cells, migration of precursor cells to the injury area, dif-
ferentiation of these precursor cells into mature neurons and reconnection between 
neurons. A few experimental studies have demonstrated the beneficial effects of hy-
pothermia on neurogenesis  [3, 11–13] . Cooling has been shown to differentially affect 
neurogenesis in uninjured animals. In one study that examined neurogenesis in the 
developing brain, reduction of brain temperature to 30  °  C for 21 h decreased the num-
ber of proliferating cells in the subgranular zone of the hippocampus, but not the peri-
ventricular zone  [14] . However, under conditions of hypoxia-ischemia in the devel-
oping brain, hypothermia to 33  °  C enhanced the maturation of neural progenitor cells 
in the striatum and inhibited apoptosis of proliferating neural stem cells that were 
already increased by ischemic stimuli  [13] .
 In addition to it, obvious beneficial properties could also be used as a model to un-
derstand the underlying mechanisms of how to promote endogenous recovery of the 
injured brain. The mechanism of how cooling may enhance regenerative properties 
could be explained, in part, by its effect on reducing apoptosis. For example, enhanced 
neural stem cell survival seems to be linked to the cooling-induced upregulation of 
the antiapoptotic protein Bcl-2  [13] . In a study of cultured neural stem cells, mild hy-
pothermia also inhibited apoptosis, increased the number of nestin-positive cells and 
inhibited stem cell differentiation into astrocytes  [15] . Adult rodents exposed to fore-
brain ischemia and subjected to mild hypothermia had increased numbers of new-
born neurons in the dentate gyrus compared to animals exposed to ischemia without 
cooling  [3] . By contrast, another study in adult rats with forebrain ischemia showed 
that hypothermia had no effect on neurogenesis  [16] ; however, the duration of hypo-
thermia in this study was rather short (33  °  C for 45 min) and occurred relatively early, 
either during the ischemic period or during the immediate reperfusion phase. There-
fore, it is possible that hypothermia may not have any effect on neurogenesis if it is 
not applied during a critical time window (or windows), which has yet to be clearly 
defined. More research in this area is needed, in particular to determine the optimal 
conditions under which cooling might be expected to positively influence neurogen-
esis and whether cooling may improve neurogenesis in aged brains exposed to isch-
emia and related insults.
 Neuronal Connectivity 
 In addition to stem cell genesis, repair of neuronal connectivity is crucial to function-
al recovery after stroke. To repair the loss of neuronal connectivity, neurite outgrowth 
and formation of new synapses are essential. A few studies have examined the role of 
hypothermia on neuronal circuit repair. At the morphological level, neurite and axo-
nal outgrowth were enhanced by applying deep hypothermia (17  °  C) in organotypic 
brain slices  [17] . A genomic analysis study in a rat model of traumatic brain injury 
demonstrated that mild hypothermia had a significant effect on gene expression. An 
analysis of hippocampal gene expression profiles from rats exposed to hypothermia 
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following traumatic brain injury revealed statistically significant differences in 133 
transcripts compared to injured normothermic rats. Of these, 57 transcripts were up-
regulated and 76 were downregulated after injury. Those genes involved in synapse 
organization and biogenesis were especially upregulated in hypothermic animals 
compared to the normothermic group  [18] . Although the scientific literature is still 
scant, current data suggest that overall, hypothermia supports regenerative processes 
by enhancing synapse formation and reorganization. The precise mechanisms ex-
plaining the hypothermic effects are not clear. We assume inflammation is one of the 
key players since hypothermia influences the inflammatory response after brain in-
jury and inflammatory cytokines play a major role in modulating neurite outgrowth 
and regeneration  [17, 19] . 
 Angiogenesis 
 Mild hypothermia has been shown to enhance angiogenesis in focal cerebral ischemia 
 [20] , spinal cord injury  [21] and traumatic brain injury models  [22] . Although these 
angiogenic effects by hypothermia are presumably beneficial to repair processes, their 
clinical significance is still uncertain. In fact, a few studies suggest that angiogenesis 
may actually be detrimental to brain repair. For example, one study of acute stroke 
patients showed that an early dominance of proangiogenic factors, including platelet-
derived growth factors, vascular endothelial growth factors and their receptors, stro-
mal cell-derived factor 1 and hepatocyte growth factor, was associated with mild 
short-term neurological deficits, but that an acute antiangiogenic status (as defined 
by elevated plasma endostatin levels) also predicted a worse long-term functional out-
come  [23] . Furthermore, pharmacologic stimulation of angiogenesis using high-dose 
vascular endothelial growth factor impeded recovery of neurological function in a rat 
model of global cerebral ischemia and caused neuronal damage in uninjured control 
brains  [24] . However, neuroblasts which will further differentiate into fully function-
al neurons were identified in close proximity around the immature newly created vas-
cular network after stroke  [25] . In another study, hypothermia reduced secretion of 
vascular endothelial growth factor by cultured retinal pigment epithelial cells  [26] , 
which suggests that the effect of hypothermia on angiogenesis might be diverse de-
pending on the tissue. 
 Gliogenesis 
 Oligodendrocytes succumb to brain insults and undergo cell death with a suscepti-
bility that is similar to neurons, and hypothermia attenuates oligodendrocyte death, 
demyelination and circuit dysfunction  [27] . Hypothermia (32   °   C) increased the 
number of oligodendrocyte precursor cells in a primary culture taken from embry-
onic mouse brains  [28] . As a result, greater numbers of oligodendrocyte precursor 
cells that undergo cell cycle progression were maintained in a less well-differentiated 
state. However, an in vivo  study using a hypoxia model in preterm fetal sheep dem-
onstrated that hypothermia (30  °  C) was associated with an overall reduction in hy-
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poxia-induced loss of immature oligodendrocytes, but did not prevent the hypoxia-
induced reduced proliferation of oligodendrocytes within the periventricular white 
matter  [29] . 
 Reports of the effects of hypothermia on endogenous cell genesis in the injured and 
uninjured brains are somewhat conflicting. Some reports  [14, 29] indicate that hypo-
thermia suppresses stem cell proliferation, whereas many reports indicate the oppo-
site  [3, 15, 28] , and some even suggest that cooling promotes progenitor cell differen-
tiation towards neurogenesis over gliogenesis  [13, 15] . Hypothermia to temperatures 
lower than 30  °  C seems to suppress cell proliferation and phase-specific and nonspe-
cific cell cycle arrest as a result of reduced energy supply  [14] . However, small tem-
perature decreases seem to protect against progenitor cell death  [15, 29] . Thus, we 
speculate that mild hypothermia enables the differentiation of precursor cells while 
preventing apoptosis, and that cooling to lower temperatures seems detrimental to 
cells and blocks their proliferation.
 Astrocytes comprise the largest population of cells in the ischemic core during the 
subacute to chronic period after stroke  [30] , and reactive astrocytes are the main com-
ponent of the glial scar. However, glial scar formation in the brain can obstruct neurite 
outgrowth and regeneration  [31] , and blocking astrocyte activation and related reac-
tions can exacerbate inflammation and increase injury responses  [31] . Thus, enhance-
ment of gliogenesis may do some harm. How hypothermia affects gliogenesis has not 
yet been studied in any depth.
 Conclusion and Future Perspectives 
 Although the effect of therapeutic hypothermia in brain regeneration after stroke is far 
from clear, under specific conditions it seems to have beneficial roles in survival, pro-
liferation, differentiation and migration of stem/progenitor cells, and reconstruction 
of neural circuitry. Clearly, more research is needed in this area. To date, most of the 
studies addressing this topic applied cooling relatively early on. Yet, its effects on re-
generation were observed days to months later. Thus, identifying the key events linking 
early cooling and its downstream effects on regenerative processes need to be identi-
fied. It is also conceivable that the beneficial effects of therapeutic cooling may not re-
quire early intervention, and would have obvious implications at the clinical level 
where intervention may potentially be initiated days to weeks and even months later. 
 Although there is no specific treatment to enhance or promote neuroregeneration 
at present, there is substantial ongoing research in this area, such as small-molecule, 
growth factor and cell-based therapies. When such therapies become available, com-
bination therapy with therapeutic cooling and pharmacological interventions should 
certainly be explored. Therapeutic hypothermia has the potential to enhance the 
brain’s endogenous restorative mechanisms, possibly with the aid of pharmacological 
or cell-based treatments. In case of drug combination therapy, very little is currently 
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known about the effects of hypothermia on the pharmacokinetics and pharmacody-
namics of drugs and this will be another field of future interest. As neuroregeneration 
strategies develop, there will be increasing needs for neurological or biological mark-
ers to predict outcomes in patients as we are facing the need in case of the patients 
resuscitated after cardiac arrest  [32, 33] . These prognostic biomarkers will be crucial 
in informing treatment decisions. Neuroregeneration is still a field in its infancy, and 
there are still many questions that remain as to whether and how therapeutic cooling 
may play a role. 
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 Abstract 
 Development of a safe method to increase brain-derived neurotrophic factor (BDNF) levels in the 
brain is expected to enhance learning and memory, induce tolerance to cerebral infarction or tol-
erance to depressive state, improve glucose metabolism, and suppress appetite and body weight. 
We have shown that repetitive applications of high-voltage electric potential (HELP) to the body 
increase BDNF levels in the brain, improving learning and memory in mice. Here, we investigated 
the effects of HELP treatment for a chronic period on the BDNF levels in the mouse brain, and on 
body weight in mice and humans. Adult mice were exposed to 3.1 or 5.4 kV HELP (on the body), 5 
h a day for 24 weeks, and BDNF levels in the brain and alterations in body weight were analyzed. 
Humans [age, 53.2 ± 15.5 years old; BMI, 27.8 ± 5.6 (mean ± SD, n = 6)] were exposed to 3.9 kV HELP 
(on the body) for 1 h a day, continuing for 33 months (2.8 years) under the monitor of body weight. 
In mice, the HELP application elevated BDNF levels in the brain at least temporarily, affecting body 
weight in a voltage- and time-dependent manner. In humans, the HELP treatment reduced body 
weight compared to the pretreated initial values without any aversive effects (p < 0.002, one-way 
ANOVA with the post hoc Holm-Sidak test). The results in mice indicated that 3.1 kV HELP was con-
sidered insufficient for a continuous elevation of intracerebral BDNF, and 5.4 kV HELP was consid-
ered as excessive. HELP with an appropriate voltage can be utilized to increase BDNF levels in the 
brain for a prolonged period. We anticipate further investigations to clarify the effect of the opti-
mal-leveled HELP therapy on memory disturbances, neurological deficits after stroke, depression, 
diabetes, obesity and metabolic syndrome.  Copyright © 2013 S. Karger AG, Basel 
High Voltage Electric Potentials to 
Enhance Brain-Derived Neurotrophic 
Factor Levels in the Brain 
 Hiroji Yanamoto a–c  • Yukako Nakajo a, c, d  • Hiroharu Kataoka b  • 
Koji Iihara b 
 a   Laboratory of Neurology and Neurosurgery and  b   Department of Neurosurgery, National Cerebral and 
Cardiovascular Research Center, and  c   Department of Cardiovascular Science, Division of Surgical Medicine, 
Osaka University Graduate School of Medicine,  Suita , and  d   Research Laboratory, Rakuwakai Otowa Hospital, 
 Kyoto , Japan
 
Naritomi H, Krieger DW (eds): Clinical Recovery from CNS Damage.
Front Neurol Neurosci. Basel, Karger, 2013, vol 32, pp 129–138 ( DOI: 10.1159/000346422 )
130  Yanamoto · Nakajo · Kataoka · Iihara 
 Brain-derived neurotrophic factor (BDNF), the most abundant neurotrophin in the 
brain  [1] , is known to promote neuronal differentiation/maturation in the developing 
central nervous system  [2, 3] , participates in multiple forms of learning and memory by 
promoting dendritic outgrowth and synaptic formation  [4] , and protects neurons from 
lethal ischemic stresses by inducing tolerance to cerebral infarction (infarct tolerance)  [5] . 
 In addition to the role in memory and infarct tolerance, BDNF in the brain plays a 
critical role in energy balance, glucose metabolism, and in reward centers of the brain 
impacting on feeding behavior and body weight  [6–8] . Genetic impairment of BDNF 
synthesis caused hyperphagia and aggressiveness  [9] , obesity, hyperglycemia, hyper-
insulinemia, hyper-low-density-lipoproteinemia, and a short life span in mice  [10] . 
In contrast, increased BDNF levels in the brain by a direct infusion of exogenous 
BDNF suppressed appetite, decreased blood glucose levels by increasing insulin sen-
sitivity, and caused body weight loss in a dose-dependent manner without any meta-
bolic toxicity in normal rats  [11] . Furthermore, genetic BDNF insufficiency was linked 
to severe obesity in humans  [12] . Therefore, increased BDNF levels, if achieved by a 
safe method, should suppress normal or excessive appetite and reduce body weight.
 Specific Types of Electric Stimulation  
 A brief period of direct current electrification (3 VDC, 100 μs, 20 Hz for 1 h)  [13] ; 
epileptiform discharges  [14] , chronic electroconvulsive therapy for the treatment of 
major depression  [15] , and repetitive spreading depression  [16] have been shown to 
elevate BDNF levels in the brain. However, none of these types of stimulation is ap-
plicable to healthy individuals to increase BDNF levels in the brain, improve cerebral 
functions or glucose metabolism, and to increase cerebral viability.
 Recently, we have demonstrated that the treatment with high-voltage electric poten-
tial (HELP), characterized by a selected voltage on the body, increased BDNF levels in the 
mouse brain  [17] . Animals with increased BDNF levels by the HELP treatment showed 
improved learning and memory, and achieved infarct tolerance  [17] . In addition, HELP 
treatment suppressed age-dependent body weight gain at least for 12 weeks in mice  [17] .
 The High-Voltage Electric Field Therapy  
 Repetitive exposure of the body to various levels of electric field (EF) for 1 to several 
hours a day, by direct contact with a working electrode ( ≤ 30 kV RMS, 50 or 60 Hz), 
under the condition that the body is insulated from surrounding electrotransformable 
materials (metals), making indirect (air-) contact with the ground electrode (= 0 V), 
was approved in 1963 by the Ministry of Health, Labor and Welfare, Japan as a safe 
alternative therapy to be utilized for improving headache, shoulder/neck stiffness, in-
somnia, and chronic constipation. Although a selected EF level generated by 7.0 kV 
(50 or 60 Hz) at the generator suppressed a restrained stress-induced increase in plas-
ma lactate levels in rats  [18] , the underlying biological mechanisms by which EF acts 
on the body, the optimum protocols, the maximum length of improving period, and 
the optimal EF level for the improvement of these symptoms have been unclear.
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 In this study, we investigated the effect of HELP treatments with either of 2 selected 
(high or low) voltages at the body for a prolonged period (24 weeks) on the BDNF lev-
els in the mouse brain, or the effect of a HELP treatment with a specific voltage on the 
body, considered as optimal, for 33 months on human body weight. Fundamentally, the 
voltage at the output level generated at the transformer diminishes in the electric cord 
connecting to the working electrode (HELP supplier), affected by the resistance be-
tween surfaces of the working electrode and the body (due to attachment area, clothes, 
skin or hair conditions), the body weight (the size of impedance), and by the surround-
ing structures of the HELP application system (the extent of leakage of electric potential 
from the insulated elevated zone to the outer zero level). Therefore, it was essential to 
measure and regulate electric potential (= voltage level) on the body, not at the output 
level of the transformer, or essentially variable EF levels in the air around the body.
 Experimental Procedure and Treatment Protocol 
 The experimental protocols were approved by the NCVC animal research committee. 
All efforts were made to minimize suffering and the number of animals used. In the 
clinical trial, participants agreed to set and use the medical apparatus, a HELP applier, 
in their house. The specific HELP level designed in this study was generated by a 
medical apparatus (an EF generator  ≤ 9.0 kV) approved by the government for the 
treatment of headache; chronic constipation; neck/shoulder stiffness, and/or insom-
nia. Informed consent to use the HELP method (with a definition/regulation; 3.9 kV 
on the body) in individual homes, and to monthly monitoring of body weight with or 
without treatment was obtained from every participant. 
 Experiment 1 (Experimental Procedure in Mice) 
 Male adult C57BL/6J mice (8–9 weeks old, 22–24 g, Clear Japan Inc., Osaka, Japan) 
were placed in a temperature-controlled room under a regular light/dark cycle and 
had free access to food and water ad libitum throughout the experiment. Each mouse 
cage, 17 × 23 × 12 cm in size, composed of 2-mm-thick acryl boards, housed 5–6 mice. 
A mattress type HELP supplier, 30 × 50 cm in size, connected to the HELP generator 
(an AC transformer; 60 Hz) made originally for humans, was placed under the cage. 
The counter electrode, 50 × 150 cm in size and grounded (= 0 V), was located below 
the HELP supplier (>20 cm from the animal). The elevated electric potential area, 
consisting of the HELP supplier, the cage, and the mice, was electrically insulated 
from the surroundings. Mice in the cage received HELP at a single voltage, making 
indirect contact with 0 V (ground) via air. 
 In the setting, the HELP generator elevated the electric potential at the surface of the 
body to 0 V (control), 3.1 or 5.4 kV, for 5 h a day over consecutive 3, 6, 12, or 24 weeks. 
The EF level generated by the HELP supplier in the cage was approximately 14–15 V/m, 
or 24–25 kV/m, respectively, in a vertical direction in the absence of animals.
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 After the 3.1- or 5.4-kV HELP treatment over 3, 6, 12 or 24 weeks, BDNF levels 
in the forebrain were measured using ELISA (n = 24–25 per group), and the escape 
latencies were monitored for the analysis of spatial learning, comprising cognition/
orientation, working memory/consolidation, and recall/navigation (n = 24–25 per 
group), using the Morris water maze test arranged for mice, 4 sessions per a day for 
consecutive 5 days with a cutoff time set at 300 s, as described in detail elsewhere 
 [17] .
 Experiment 2 (Treatment Protocol in Humans) 
 Male or female volunteers [body mass index (BMI) >22, normal, overweight, or obese] 
were enrolled. The distribution of age was from 33 to 71 years old (53.2 ± 15.5, mean ± 
SD; n = 6, male: 4, female: 2). The BMI in the HELP-treated group was from 22.1 to 
36.8 (27.8 ± 5.6). An EF generator, i.e. a medical apparatus originally made for hu-
mans (K-7 or K-9, Hakuju, Co. Ltd., Tokyo) for the usage in the clinic or at home, 
with a multistep function to freely adjust the output levels (AC 60 Hz,  ≤ 7.0 or 9.0 kV 
at the transformer), was set in individual homes as a HELP applier. The safety of this 
system for humans was established by the Japanese government in 1963. 
 A mattress type HELP supplier set on the bed, 30 × 50 cm in size, was connected 
to the generator. The ground under the floor in the room (= 0 kV, >20 cm away from 
the body surface) was utilized as a counter electrode. The zone of elevated electric po-
tential, consisting of the HELP supplier and the body, was electrically insulated from 
the surroundings by means of an insulating (rubber) mattress, so that the HELP-ex-
posed human body makes indirect contact with the ground via air.
 A specific HELP, adjusted to 3.9 kV on the body compared to the ground level 
(0 kV), was applied via the HELP generator. The treatment was performed for 1 h a 
day over consecutive 33 months at night while sleeping by setting a timer.
 The selection of the voltage was based on the findings that various ranges of HELP 
differently increase BDNF levels in the mouse brain for a temporary or a prolonged 
period in mice, differently improving learning and memory function, and reducing 
or increasing body weight at a chronic phase. Family members of the enrolled persons, 
who were supposed to have the same diet menu in the same house during the study 
period, served as references. The distribution of age in the reference group was from 
22 to 65 years (46.0 ± 16.9, mean ± SD; n = 6, male: 4, female: 2), and the BMI range 
was from 23.6 to 29.8 (27.7 ± 2.8, mean ± SD). There was no significant difference in 
physical conditions between the treated and the reference groups.
 Statistical Analysis 
 Alterations in body weight before and after the HELP treatment were analyzed using 
one-way ANOVA with the post hoc Holm-Sidak test. A value of p < 0.05 was consid-
ered significant, and the results were presented as mean ± SD. Intention-to-treat anal-
ysis was used in the assessment of the human study that accepts all data obtained from 
every participant. 
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 Results 
 Alterations in Brain-Derived Neurotrophic Factor Levels in the Mouse Brain 
(Experiment 1) 
 After the HELP treatment, the BDNF levels in the brain increased in a mono- (3.1 kV) 
or biphasic manner (5.4 kV), compared with the corresponding 0-volt-treated con-
trols during the same period ( fig. 1 ). There were significant increases in the BDNF 
level after 3, 6, and 24 weeks in the 5.4-kV HELP-treated group (p < 0.05), or after 3, 
6, and 12 weeks in the 3.1-kV HELP-treated group (p < 0.05). 
 Alterations in Learning and Memory in Mice (Experiment 1) 
 After the 3.1- or 5.4-kV HELP treatment, the time needed to escape to the platform 
(escape latency) decreased significantly, compared with the corresponding 0-volt-
treated controls ( fig. 2 ). Among the treated and control groups, the greatest improve-
ment in the escape latency score was 6 weeks after 3.1 kV HELP (p < 0.001), and 3 or 
12 weeks after 5.4 kV HELP (p < 0.001). It was found that 0-kV-treated control ani-
mals showed a steady and significant improvement in spatial learning from young 
adulthood to middle-aged time. 
 Alterations in the Mouse Body Weight (Experiment 1) 
 After HELP treatment for 6 weeks, the body weight was significantly reduced, com-
pared with the corresponding 0-kV-treated controls (p < 0.05) ( fig. 3 ). In the 3.1-kV 
HELP-treated group, the significant reduction at 12 weeks disappeared at 24 weeks. 
Although improvement was observed in the Morris water maze test, a significant 






























 Fig. 1. Alterations in BDNF 
levels in the mouse brain. The 
treatment with HELP (3.1 and 
5.4 kV) for 12 weeks signifi-
cantly reduced body weight 
compared with the corre-
sponding untreated controls. 
 *  p < 0.05;  * *  p < 0.01; 
 * * *  p < 0.001. n = 24–25; 
 error bars indicate SD. 
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 Alterations in Body Weight in Humans (Experiment 2) 
 The body weight was reduced gradually by the 3.9-kV HELP treatment ( fig. 4 ). After 
the induction of HELP, the reduction pattern of the body weight was biphasic, achiev-
ing the first reduction compared to the pretreated control value at 12 months, which 
disappeared but appeared again from 26 to 33 months (p < 0.001, t = 3.16–4.70) 
( fig. 4 ). There was no significant side effect in subjective or objective aspects, during 
or after the treatment. 
 The BMI at the end of the observation period was –4.8 ± 1.4 compared to the pre-
treated initial value in the treated group, and +3.5 ± 2.0 compared to the initial value 
in the reference group (p < 0.001, t-test).
 As regards the compliance with the protocol, every participant in the treated group 
reported that they followed the protocol throughout the period except for some days 
(<30 days in a year) when they were away from home. A person in the reference group 
(initial BMI: 29.8) had lost more than 10 kg during the initial 12 months, but encoun-
tered a rebound phenomenon, ending up with 3 kg more compared to the initial value.
 Discussion 
 Increased BDNF levels in the brain act as a suppressant of appetite and body weight 
gain  [11, 19] . In the present study, a chronic HELP treatment with a selected voltage 
on the body significantly suppressed body weight of normal (by 5.8% per 33 months, 
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 Fig. 2. Alterations in learning 
and memory function in the 
Morris water maze test. After 
HELP treatment with either 
voltage, spatial learning sig-
nificantly improved in the 
Morris water maze test com-
pared to the corresponding 
untreated controls.  *  p < 0.05; 
 * * *  p < 0.001. n = 24–25; error 
bars indicate SEM. 
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3.1 kV on the body surface
5.4 kV on the body surface
 Fig. 3. Alterations in body weight in mice. Twelve weeks after HELP treatment with either voltage, 
body weight was significantly reduced compared to controls. Twenty-four weeks after HELP, there 
was no significant reduction in the 3.1-kV-treated group, but a significant increase (considered as a 
rebound phenomenon) was observed in the 5.4-kV-treated group. Alteration in body weight fol-
lowed weeks after the alterations in BDNF levels in the brain (fig. 1).  *  p < 0.05;  * *  p < 0.01, compared 
with the corresponding controls. n = 24–25; error bars indicate SD. 
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 Fig. 4. Alterations in body weight after the HELP treatment in humans. There were significant, 
 biphasic reductions in body weight after the exposure to 3.9 kV HELP, performed for 1 hour per day, 
for 33 months.  *  p < 0.01;  * *  p < 0.001. n = 6; error bars indicate SD. 
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per year). Statistical differences between values before and after the treatment were 
detected in a biphasic manner. The characteristic alterations in the human body 
weight was consistent with the observation that 5.4 kV HELP, i.e. a relatively higher 
voltage than 3.9 kV, induced biphasic increases in BDNF levels in the mouse brain 
( fig. 1 ). Although BDNF levels in the human brain before and after the HELP treat-
ment were not analyzed in the present study, consistent and stable reduction in the 
body weight after the HELP application may indicate that the BDNF levels in the hu-
man brain were increased for a prolonged period. 
 Mice engineered to overexpress BDNF demonstrated enhanced performance in 
spatial learning  [20] . Significant improvements in spatial learning were observed after 
a HELP therapy, at the time point when BDNF levels in the brain increased, especial-
ly in the cortex  [21] , which was in accordance with the evidence that increased BDNF 
levels in the cortex enhance spatial learning and memory  [22] .
 Restoration of decreased BDNF levels in the brain has been an aim of antidepres-
sant treatment  [23] . Interestingly, the 4 symptoms that are improved by the EF ther-
apy are major symptoms of masked depression. Increased BDNF levels after the EF 
therapy using various EF levels may improve depressive mood disorder, which may 
be resulting in improvements of the 4 symptoms, at least for a temporary period.
 In our previous study, intracerebral infusion of recombinant BDNF (8 μg total) 
continuing for 1 or 2 weeks (prolonged and slow injection), but not for 3 days (short 
and rapid injection), was associated with the development of infarct tolerance in rats 
 [5] . Repetitive spreading depression stimulations that increase BDNF levels in the 
brain  [24] induced infarct tolerance, 2 weeks after repetitive spreading depression in 
rats and 1 week after spreading depression in mice  [25, 26] . Importantly, the rate of 
passage of biological time is inversely correlated to [body weight] 2 , as represented by 
longevity and the heart/respiration rate among animal species  [27] . The biological 
time of 1 week in mice is considered to be several months in humans.
 Thus, the development of infarct tolerance appears to require prior and prolonged 
elevation of intracerebral BDNF levels. However, BDNF levels in the brain do not 
necessarily last for a long time after various HELP therapies but fluctuate and some-
times decline, depending on its voltage level and the treatment period ( fig. 1 ). Because 
there was a rebound-like phenomenon of the body weight in mice ( fig. 3 ), possibly 
caused by a rapid and excessive increase and the following unresponsive, silent period 
( fig. 1 , the decline at 12 weeks in the 5.4-kV group), the selection of voltage in HELP 
treatment is extremely important to elevate intracerebral BDNF levels for a prolonged 
period. In the present study, we selected 3.9 kV on the body for the human therapy, a 
mathematically simulated value that can elevate BDNF levels for a prolonged time, 
taken from data obtained in our experimental studies using mice, which ranged be-
tween 3.1 kV (insufficient) and 5.4 kV (excessive).
 As regards safe and practical methods to increase BDNF levels, physical exercise 
 [28] and chronic dietary restriction  [29] have been shown to upregulate BDNF in the 
brain. In addition to these safe methods that are not necessarily applicable to many 
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people, HELP with an appropriate voltage for 1 h per day may have the potential to 
increase BDNF levels in the brain for a prolonged period. Increased BDNF theoreti-
cally improves neurological, emotional, and metabolic disorders associated with re-
duced or subnormal BDNF levels in the brain  [30] . Additional studies focusing on the 
effect of HELP with an appropriate voltage on the body surface (not unstable, exces-
sive or insufficient) on impaired cognitive/learning function, depressive mood disor-
ders, and other neurological, mental and metabolic disorders are required to better 
understand the significance of HELP therapy. A sophisticated HELP therapy with an 
optimal voltage on the body, rather than the traditional EF therapy with various elec-
tric powers, has the potential as an innovative, macrobiotic new intervention to re-
cover or improve human health.
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 Abstract 
 In spite of appropriate treatment in the acute phase of stroke, quite a few patients with hemiparetic 
stroke become disabled and stay in a wheelchair or bedridden state in the chronic phase. In stroke 
patients, gait dysfunction results mainly from severe hemiparesis due to ischemic damage to the 
motor neuron tract and partly from disuse muscle atrophy in paretic and nonparetic legs. Disuse 
muscle atrophy occurs even in healthy subjects as early as 4 days after bed rest immobilization and 
progresses further correlating with the duration of immobilization. Although detailed mechanisms 
of disuse muscle atrophy remain unclear, free radical scavengers are known to play an important role 
in the development of disuse muscle atrophy. One of the neuroprotective agents, edaravone, a free 
radical scavenger, succeeded in proving clinical usefulness in a phase III clinical trial in Japan. In this 
trial, stroke patients were administered edaravone for 14 days consecutively. The results of the eda-
ravone trial are taken to indicate that long-term administration of a free radical scavenger may pre-
vent disuse atrophy thereby improving functional outcome. We performed a randomized pilot study 
in hemiparetic stroke patients to test the validity of this view. Acute stroke patients were randomly 
allocated to two groups, one receiving edaravone for 3 days (short-term group) and the other for 
10–14 days (long-term group). At 3 months after stroke, the grade of femoral muscle atrophy was 
significantly milder and the maximum walking speed was significantly faster in the long-term group 
than in the short-term group. The study suggests that long-term administration of a free radical scav-
enger may prevent the development of leg disuse atrophy thereby ameliorating locomotor function. 
Attention should be paid to myoprotective drug therapy in acute stroke, since it may be easier and 
clinically more effective than neuroprotective therapy from the viewpoint of functional prognosis. 
 Copyright © 2013 S. Karger AG, Basel 
 Motor weakness is one of the most common symptoms of stroke which largely disturbs 
activities of daily living in stroke patients. Even with optimal therapy, 15–30% of stroke 
patients are permanently disabled and 20% require institutional care at 3 months after 
onset  [1] . Such a long-term functional disability is caused mainly by damage to the 
motor neuron tract at the frontal cortex, the corona radiata, the internal capsule or the 
pons which leads to hemiparetic weakness of the contralateral upper and lower limbs. 
The impaired function of the motor tract may be restored afterwards by the compen-
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satory development of the motor neuron tract as discussed by several authors in this 
book. Yet, even after the compensatory development of the motor neuron tract, motor 
dysfunction may remain unaltered, if disuse muscle atrophy is developed in the pa-
retic limb associated with muscle weakness and/or articular contracture during the 
acute and subacute phases. Disuse muscle atrophy occurs most likely in the paretic 
lower limb of elderly stroke patients who are bedridden during the acute phase of 
stroke. The antigravity muscles of the lower limbs, such as the soleus, gastrocnemius, 
and vastus lateralis, are most commonly affected by immobilization  [2, 3] . Stroke is 
primarily a central nervous system disease. However, we should be reminded that sec-
ondary muscle changes play an important role in the persistence of lower-limb disabil-
ity in the chronic phase. The muscle changes may partly be reversible and may be treat-
able with rehabilitation. Yet, delayed treatment of muscle changes likely fails to restore 
normal muscle structure and muscle strength eventually leading to articular contrac-
ture. Therefore, myoprotective drug therapy should be initiated in the early phase of 
stroke. Myoprotection is considered easier and clinically more effective as compared 
with neuroprotection. Unfortunately, however, little attention has been paid to myo-
protective drug therapy in the past history of acute stroke management. 
 Muscle Changes with Ageing 
 During normal ageing, muscle tissue gradually changes in its distribution with advancing 
age; fast-twitch muscle fibers (MHC type IIa and IIb) decrease and mitochondria-rich 
slow-twitch muscle fibers (MHC type I) increase. This change in fiber type distribution 
results from motor unit denervation and subsequent reinnervation from adjacent intact 
muscle fibers. The changes result in reduction of muscle strength. According to the study 
of Kostka  [4] , muscle strength decreases by 18% between 30 and 60 years of age, and fur-
ther decreases by another 20% between 60 and 90 years of age. Thus, elderly subjects are 
in a preparatory condition for motor weakness even prior to stroke. Once stroke occurs 
in elderly subjects, it likely causes severe hemiparesis which forces elderly patients to stay 
bedridden for 1–2 weeks or longer. Immobilization due to the bedridden state likely 
causes disuse muscle atrophy in the paretic leg as well as the nonparetic leg ( fig. 1 ). 
 Immobilization and Disuse Muscle Atrophy 
 Long-term muscle disuse due to immobilization or chronic bed rest is known to in-
duce muscle atrophy and muscle strength reduction particularly in legs  [5, 6] . Disuse 
atrophy of lower-limb muscles was confirmed to occur following 35 days of bed rest 
in healthy young subjects with a mean age of 24 years  [7] . Disuse atrophy occurs more 
rapidly in older subjects. In the study of Kortebein et al.  [8] , lower-limb disuse atrophy 
was observed following 10 days of bed rest in healthy subjects with a mean age of 
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67 years. In the study of Paddon-Jones  [9] , elderly patients showed the same amount 
of lean leg muscle mass after 3 days of hospitalization as healthy older subjects expe-
rienced after 10 days of inactivity, and a 3-fold greater loss of lean leg muscle mass 
than a younger cohort confined to bed for 28 days. Thus, elderly subjects may develop 
disuse muscle atrophy even a few days after bed rest immobilization. Early develop-
ment of disuse atrophy was confirmed to occur in rats with hind limb unloading  [10] . 
The soleus muscle mass began to decrease at 4 days after hind limb immobilization. 
 Mechanisms of Disuse Atrophy 
 Recent advances in cellular and molecular biology have provided quite a few pieces of 
evidence for understanding the pathophysiology of disuse atrophy. Disuse atrophy of 
skeletal muscle occurs due to both a decrease in muscle protein synthesis and an increase 
in the rate of proteolysis  [11, 12] . It has not yet been fully clarified how a decrease in mus-
cle protein synthesis and an increase in proteolysis are initiated. However, experimental 
studies indicated a close relationship between oxidative stress and disuse muscle atrophy 
 [13–15] . More specifically, atrophic muscles of rats showed elevated levels of thiobarbi-
turic acid reactive substances and oxidized glutathione, which are both markers of oxida-
tive stress. Furthermore, an increase in the formation of superoxide radical anions (O 2 – ) 
was indicated by elevated Cu/Zn-containing superoxide dismutase activity in the cyto-
plasm of atrophic muscle cells, and 12 days of disuse atrophy showed a 2.2-fold rise in 
xanthine oxidase levels relative to controls. Histochemical studies using transmission 
electron microscopy have revealed elevated levels of reactive oxygen species such as H 2 O 2 
in atrophic muscles. Metal compounds such as iron have also been shown to increase 




 Fig. 1. Femoral muscle vol-
ume changes in a 64-year-old 
stroke patient with severe 
hemiparesis. Femoral CT 
shows bilateral muscle atro-
phy at 3 months after stroke. 
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deferoxamine, suppressed the increase in thiobarbituric acid reactive substances and 
oxidized glutathione in the atrophic muscles of rats  [16] . In more recent years, the role of 
iron in oxidative stress has attracted close attention in the field of physiology  [17, 18] . 
 Another factor that may be involved in the development of muscle atrophy is eleva-
tion of the intracellular calcium ion (Ca 2+ ) levels during muscle inactivity  [13–15] . 
Ca 2+ levels in the cytoplasm of atrophic muscle cells were approximately 4-fold high-
er than levels in normal muscle cells. This accumulation of intracellular Ca 2+ during 
muscular disuse may occur due to ionic disturbances of the cell membrane, which 
retards cellular removal of Ca 2+ . This resulting elevation of cytosolic Ca 2+ may lead to 
the activation of calcium-dependent proteases that mediate, thus leading to the break-
down of muscle tissue.
 In addition to inducing muscle atrophy during disuse, oxidative stress was shown 
to be enhanced following remobilization in rats  [19] . Oxidative stress markers in-
creased rapidly when rabbits with leg immobilization began to move the immobilized 
leg. This suggests that the production of free radicals occurs continuously in patients 
who start moving paretic limbs. In order to prevent disuse muscle atrophy, therefore, 
free radicals need to be suppressed continuously for a considerably long duration.
 Long-Term Free Radical Scavenger Improves Functional Outcome of Stroke 
 Edaravone, a free radical scavenger, was shown to have neuroprotective action and to 
ameliorate functional outcome of acute stroke patients in a placebo-controlled double-
blind study performed in Japan  [20] . Edaravone is now widely used clinically for the 
treatment of acute ischemic stroke in Japan. This is the only drug in the world which 
has been approved as a neuroprotective drug and permitted for clinical use in the man-
agement of acute stroke. During the last 2 decades, more than 30 substances with neu-
roprotective action were subjected to phase III clinical trials to confirm the efficacy in 
improving the clinical outcome of acute stroke patients  [21–25] . However, all of them 
including free radical scavengers, except for edaravone, failed to show clinical effective-
ness. Questions are raised here. Why could only edaravone prove clinical usefulness? 
Are free radical scavengers superior to the other types of neuroprotective agents, such 
as NMDA receptor antagonists or Ca 2+ channel blockers? If free radical scavengers are 
superior to the other types of neuroprotective drugs, then why did the other free radical 
scavengers, such as tirilazad  [21] or NXY-059  [22] , fail to show clinical effectiveness? In 
order to find the answers to these questions, we should pay attention to the design of 
the phase III clinical trial of edaravone which quite differs from that of all the other neu-
roprotective drugs. In the edaravone trial, ischemic stroke patients admitted within 72 h 
after onset were enrolled into the study. They were randomly allocated to two groups. 
In one group, edaravone was intravenously administered twice daily for 14 days, and in 
the other group, placebo was given in a similar manner for 14 days. Thus, the time lim-
it of initial drug administration and the duration of drug administration are enormous-
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ly longer in the edaravone trial as compared with the other phase III trials of neuropro-
tective drugs. In almost all the phase III trials of neuroprotectants, the drugs were ini-
tially administered within 6–12 h after stroke onset and were continued for 1–3 days. 
For instance, in the clinical trials testing the efficacy of a free radical scavenger, tirilazad, 
the drug was first given within 4–12 h after onset and was continued for 3–4 days  [21] . 
Likewise in the SAINT II study for evaluating the efficacy of a free radical scavenger, 
NXY-059, the drug was initially administered within 6 h after onset and was continued 
for 3 days  [22] . Such an early and short-term administration of drugs is reasonable for 
testing the clinical usefulness of neuroprotective drugs, since irreversible changes likely 
occur within 6 h in the majority of ischemic neuronal cells and the process of neuronal 
cell death may be completed within several days after onset. In most phase III clinical 
trials of other types of neuroprotective agents, the drugs were given in a similar manner 
as in the SAINT II study or tirilazad studies. The results in these studies were all unsuc-
cessful. In the edaravone phase III trial, the initial administration of the drug was con-
siderably late; the average time for the first drug administration was 37.3 h after onset. 
Thus, the initiation of edaravone administration was unfavorably late for testing the 
clinical efficacy of neuroprotective drugs. Presumably, in the edaravone trial, neuronal 
cells in the majority of ischemic areas may have had irreversible changes prior to eda-
ravone administration. Edaravone was given consecutively for 14 days in all the pa-
tients. Such a long-term administration of a free radical scavenger may be meaningless 
from the viewpoint of neuronal protection, since the process of neuronal cell death is 
likely completed within several days after onset. On the other hand, delayed and long-
term administration of a free radical scavenger for 14 days is meaningful, if the target is 
myoprotection, since the process of disuse muscle atrophy begins at several days after 
immobilization and is enforced at the time of remobilization. The results of the phase 
III clinical trial of edaravone suggest that the beneficial effects of the drug may be at-
tributable to myoprotective effects rather than to neuroprotective effects. 
 Prevention of Muscle Atrophy with a Free Radical Scavenger 
 In order to test the hypothesis that long-term administration of a free radical scavenger 
may prevent disuse muscle atrophy of lower limbs and improve locomotor function in 
stroke patients, we performed a pilot study (Muscle Atrophy Restraint with Vigilant 
Edaravone Long-Term Use after Stroke: MARVELOUS) in patients with ischemic 
stroke  [26] . The study was an open-label, multicentered, randomized, controlled pilot 
study performed in Japan. Written consent was obtained from all patients prior to reg-
istration. The study protocol was permitted by the local ethics committees of all the 
 institutes that participated. Acute ischemic stroke patients with hemiparesis were ran-
domly allocated to receive edaravone for 3 days (short-term group) or 10–14 days (long-
term group). These two durations were determined on the basis of the assumption that 
3-day administration likely exerts neuroprotective effects and 10- to 14-day administra-
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tion may provide both neuro- and myoprotective effects. Inclusion criteria were: (1) age 
20–79 years, (2) definitive paresis or paralysis of the leg of the diseased side, (3) admis-
sion within 24 h after onset of stroke, (4) no neurological deficits prior to stroke, (5) no 
thrombolytic therapy and (6) well-maintained consciousness level. Edaravone (30 mg, 
twice daily) was administered intravenously during the first 3 days of admission in the 
short-term group and during the first 10–14 days of admission in the long-term group. 
All the patients were admitted to an acute stroke center and underwent bedside reha-
bilitation therapy followed by out-of-bed rehabilitation therapy. In order to evaluate 
changes in femoral muscle volume, the circumference of the thigh was measured at 15, 
10 and 5 cm above the upper end of the patella bilaterally in a position with legs stretched 
on the floor. The circumference of the lower leg was also measured at its largest part bi-
laterally in the same manner to evaluate crural muscle volume. The first measurement 
of the leg circumference was performed within 4 days after admission, and the values 
were regarded to represent the baseline leg muscle volume. The second and third mea-
surements were performed at 3 weeks and 3 months after stroke onset, respectively. The 
reduction of leg circumference at 3 weeks and 3 months after stroke onset as compared 
with the baseline value was expressed as percentage reduction and was cited to represent 
the degree of muscle atrophy. The primary endpoints of the study included the degree 
of leg muscle atrophy and the severity of leg locomotor dysfunction at 3 months after 
stroke onset. The severity of locomotor dysfunction was evaluated with maximum walk-
ing speed (MWS) over a distance of 10 m. Data are expressed as percentages for categor-
ical variables or means for continuous variables. A Pearson χ 2 or Fisher exact test was 
used for the statistical comparison of qualitative or categorical variables. An unpaired 
Student t test was also used to compare differences in the degree of disuse muscle atro-
phy and MWS between the two groups. A p value of <0.05 was considered to be statisti-
cally significant. 
 A total of 47 patients were enrolled in the study, and 3-month follow-up was com-
pleted in 41 patients (21 in the short-term group and 20 in the long-term group). As 
shown in  table 1 , there was no significant difference in age, gender, and severity of 
neurological symptoms on admission. Edaravone was administered for 3 days in all 
the patients in the short-term group and for 13.6 ± 1.2 days in the long-term group. 
Bedside rehabilitation was performed within 3 days of admission in 67% of patients 
in the short-term group and in 70% of patients in the long-term group. By the end of 
3 weeks after stroke onset, rehabilitation therapy was performed for 16 ± 5 days in the 
short-term group and for 16 ± 7 days in the long-term group. There was no significant 
difference in the state of rehabilitation between the two groups.
 Table 2 shows the state of gait disability and grade of muscle atrophy at 3 weeks and 
3 months after stroke onset. Changes in femoral volume measured at 15 cm above the 
patella are demonstrated as representative markers of leg disuse atrophy. At 3 weeks 
after onset, 48% of patients in the short-term group and 50% of patients in the long-term 
group had gait disability either requiring a wheelchair or remaining in a bedridden state. 
Disuse muscle atrophy was more or less developed bilaterally in almost all the patients 
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in both groups. The grade of muscle atrophy was 5.0 ± 3.4% in the paretic leg and 3.7 ± 
4.4% in the nonparetic leg in the short-term group and 4.4 ± 4.1% in the paretic leg and 
2.0 ± 3.8% in the nonparetic leg in the long-term group. There was no significant dif-
ference in the grade of atrophy between the two groups. At 3 months after stroke, mus-
cle atrophy in the short-term group became more remarkable as compared with 3 weeks 
after stroke, whereas the atrophy in the long-term group became less remarkable as 
compared with 3 weeks after stroke. The grade of atrophy was 8.3 ± 5.2% in the paretic 
leg and 5.7 ± 6.4% in the nonparetic leg in the short-term group and 3.6 ± 5.9% in the 
paretic leg and 1.5 ± 6.0% in the nonparetic leg in the long-term group. The grade of 
atrophy in the long-term group was significantly less prominent both for the paretic leg 
(p < 0.01) and nonparetic leg (p < 0.05) as compared with that in the short-term group. 
The MWS over the 10-meter distance was 53.6 ± 54.8 cm/s in the short-term group and 





Age, mean ± SD, years 70±7 69±8
Male gender, n 13 14
Median NIHSS score on admission 7 9
Severe weakness in paretic leg1 11 (52.4%) 10 (50.0%)
Duration of edaravone administration, mean ± SD, days 3.0±0.0 13.6±1.2
Bedside rehabilitation within 3 days 14 (67%) 14 (70%)
Total rehabilitation within 3 weeks, mean ± SD, days 16±5 16±7
 NIHSS = National Institutes of Health Stroke Scale.
1 Severe weakness was defined as an NIHSS motor subscore of 3–4.





3 weeks after stroke
Paretic leg atrophy, mean ± SD, % 5.0±3.4 4.4±4.1
Nonparetic leg atrophy, mean ± SD, % 3.7±4.4 2.0±3.8
Gait disability, n (%) 10 (48) 9 (45)
3 months after stroke
Paretic leg atrophy, mean ± SD, % 8.3±5.2 3.6±5.9**
Nonparetic leg atrophy, mean ± SD, % 5.7±6.4 1.5±6.03*
Maximum walking speed, cm/s 53.6±54.8 97.9±67.3*
Gait disability was defined as patients in a wheelchair or bedridden state. Leg atrophy was repre-
sented by femoral volume reduction at 15 cm above the patella. *p < 0.05 vs. short-term group; 
** p < 0.01 vs. short-term group.
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97.9 ± 67.3 cm/s in the long-term group. The MWS was significantly faster in the long-
term group than in the short-term group (p < 0.05). There was a significant negative 
correlation between the grade of paretic leg atrophy and MWS (r = –0.87, p < 0.001).
 Thus, the pilot study suggests that a free radical scavenger may prevent the devel-
opment of leg disuse atrophy and ameliorate locomotor function in hemiparetic 
stroke patients, if administered for a considerably long time. It remains unclear why 
anti-atrophic effects were not remarkable at 3 weeks after stroke and became promi-
nent at 3 months after stroke. This may be explained by the delayed involvement of 
apoptosis during the course of disuse muscle atrophy, which eventually leads to mus-
cular cell shrinkage and/or death  [17, 18] . As a result, the clinical manifestation of 
muscle atrophy may not become apparent until changes in the muscular intracellular 
environment have taken place, which may occur over a period of several weeks. Eda-
ravone is a drug with neuroprotective action. Therefore, the possibility that the pre-
vention of muscle atrophy is mediated partly by neuroprotective action cannot be 
excluded completely. It seems, however, obvious that the prevention of disuse muscle 
atrophy is closely connected with improvement of functional outcome.
 Conclusions 
 Leg motor weakness and resulting locomotor dysfunction in stroke patients are attribut-
able to both ischemic brain damage and disuse muscle atrophy. In the brain, neurons are 
unable to survive for extended periods of time under ischemic conditions, and the pro-
tection of such vulnerable brain tissue with drug therapy is difficult in a clinical setting. 
In contrast, muscle is a robust tissue, and the process of disuse muscle atrophy takes 
place gradually following stroke, which may provide a larger therapeutic window of op-
portunity. Therefore, agents that offer myoprotection may provide an easier and more 
effective treatment option to ameliorate the functional disability of stroke patients. 
Based on the results of the MARVELOUS study, the use of antioxidant therapy for as 
long as possible appears to be warranted to provide the maximal level of both neuropro-
tection and myoprotection. Larger, randomized controlled clinical trials are required to 
confirm the beneficial effects of free radical scavengers in the management of stroke. 
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